9133560	Blood Glucose	Yoshioka M	A novel locus, Mody4, distal to D7Mit189 on chromosome 7 determines early-onset NIDDM in nonobese C57BL/6 (Akita) mutant mice.	Diabetes	1997	169
9784493	Blood Glucose	Shimomura I	Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy.	Genes & development	1998	151
11070087	Blood Glucose	Jones ME	Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity.	Proceedings of the National Academy of Sciences of the United States of America	2000	141
12552113	Blood Glucose	Gelling RW	Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice.	Proceedings of the National Academy of Sciences of the United States of America	2003	136
12819790	Blood Glucose	Hess D	Bone marrow-derived stem cells initiate pancreatic regeneration.	Nature biotechnology	2003	110
12941770	Blood Glucose	Butler AE	Increased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid.	Diabetes	2003	104
14716305	Blood Glucose	Inoue H	Role of STAT-3 in regulation of hepatic gluconeogenic genes and carbohydrate metabolism in vivo.	Nature medicine	2004	88
15914643	Blood Glucose	Barber AJ	The Ins2Akita mouse as a model of early retinal complications in diabetes.	Investigative ophthalmology & visual science	2005	156
15986236	Blood Glucose	Calcinaro F	Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse.	Diabetologia	2005	69
17088535	Blood Glucose	Lee RH	Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice.	Proceedings of the National Academy of Sciences of the United States of America	2006	186
18690216	Blood Glucose	Zhan Y	Cytosporone B is an agonist for nuclear orphan receptor Nur77.	Nature chemical biology	2008	66
18984744	Blood Glucose	Martin B	Exendin-4 improves glycemic control, ameliorates brain and pancreatic pathologies, and extends survival in a mouse model of Huntington's disease.	Diabetes	2009	64
19095836	Blood Glucose	Loepke AW	The effects of neonatal isoflurane exposure in mice on brain cell viability, adult behavior, learning, and memory.	Anesthesia and analgesia	2009	60
19883376	Blood Glucose	Wang F	Brd2 disruption in mice causes severe obesity without Type 2 diabetes.	The Biochemical journal	2009	46
20660625	Blood Glucose	Bindom SM	Angiotensin I-converting enzyme type 2 (ACE2) gene therapy improves glycemic control in diabetic mice.	Diabetes	2010	43
20980457	Blood Glucose	Chen HY	The protective role of Smad7 in diabetic kidney disease: mechanism and therapeutic potential.	Diabetes	2011	59
21557308	Blood Glucose	Yoshikawa Y	Genetic evidence points to an osteocalcin-independent influence of osteoblasts on energy metabolism.	Journal of bone and mineral research 	2011	43
22355316	Blood Glucose	Liang Y	Effect of canagliflozin on renal threshold for glucose, glycemia, and body weight in normal and diabetic animal models.	PloS one	2012	47
22499789	Blood Glucose	Kodama K	Expression-based genome-wide association study links the receptor CD44 in adipose tissue with type 2 diabetes.	Proceedings of the National Academy of Sciences of the United States of America	2012	45
23142079	Blood Glucose	Dominy JE Jr	The deacetylase Sirt6 activates the acetyltransferase GCN5 and suppresses hepatic gluconeogenesis.	Molecular cell	2012	63
23152292	Blood Glucose	Vallon V	Knockout of Na-glucose transporter SGLT2 attenuates hyperglycemia and glomerular hyperfiltration but not kidney growth or injury in diabetes mellitus.	American journal of physiology. Renal physiology	2013	58
23160527	Blood Glucose	Longuet C	Liver-specific disruption of the murine glucagon receptor produces α-cell hyperplasia: evidence for a circulating α-cell growth factor.	Diabetes	2013	29
24847880	Blood Glucose	Madiraju AK	Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase.	Nature	2014	164
25581519	Blood Glucose	Tang C	Loss of FFA2 and FFA3 increases insulin secretion and improves glucose tolerance in type 2 diabetes.	Nature medicine	2015	30
26023930	Blood Glucose	Liu Z	High-fat diet induces hepatic insulin resistance and impairment of synaptic plasticity.	PloS one	2015	16
26843191	Blood Glucose	Yang G	Timing of expression of the core clock gene Bmal1 influences its effects on aging and survival.	Science translational medicine	2016	29
2993906	Peptides	Cuttitta F	Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer.	Nature	1985	169
3041594	Peptides	Rappolee DA	Wound macrophages express TGF-alpha and other growth factors in vivo: analysis by mRNA phenotyping.	Science	1988	154
12118245	Peptides	Fulda S	Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo.	Nature medicine	2002	133
12509463	Peptides	Weng AP	Growth suppression of pre-T acute lymphoblastic leukemia cells by inhibition of notch signaling.	Molecular and cellular biology	2003	145
12937412	Peptides	Borsello T	A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia.	Nature medicine	2003	174
14709552	Peptides	Wong GT	Chronic treatment with the gamma-secretase inhibitor LY-411,575 inhibits beta-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation.	The Journal of biological chemistry	2004	162
14871849	Peptides	Blank C	PD-L1/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8+ T cells.	Cancer research	2004	171
15156202	Peptides	Jimi E	Selective inhibition of NF-kappa B blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo.	Nature medicine	2004	124
15647826	Peptides	Sun YX	Skeletal localization and neutralization of the SDF-1(CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo.	Journal of bone and mineral research 	2005	105
15653572	Peptides	Kelly KA	Detection of vascular adhesion molecule-1 expression using a novel multimodal nanoparticle.	Circulation research	2005	114
15958392	Peptides	Ishihama Y	Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein.	Molecular & cellular proteomics 	2005	513
16061848	Peptides	Arumugam T	S100P promotes pancreatic cancer growth, survival, and invasion.	Clinical cancer research 	2005	65
18000063	Peptides	Ghosh A	Selective inhibition of NF-kappaB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease.	Proceedings of the National Academy of Sciences of the United States of America	2007	119
18391062	Peptides	Cash JL	Synthetic chemerin-derived peptides suppress inflammation through ChemR23.	The Journal of experimental medicine	2008	105
18577591	Peptides	Serada S	IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis.	Proceedings of the National Academy of Sciences of the United States of America	2008	93
18806224	Peptides	Wu B	Effective rescue of dystrophin improves cardiac function in dystrophin-deficient mice by a modified morpholino oligomer.	Proceedings of the National Academy of Sciences of the United States of America	2008	79
18829396	Peptides	Karmali PP	Targeting of albumin-embedded paclitaxel nanoparticles to tumors.	Nanomedicine 	2009	58
19228811	Peptides	Tschen SI	Age-dependent decline in beta-cell proliferation restricts the capacity of beta-cell regeneration in mice.	Diabetes	2009	115
19255147	Peptides	Beauvais DM	Syndecan-1 regulates alphavbeta3 and alphavbeta5 integrin activation during angiogenesis and is blocked by synstatin, a novel peptide inhibitor.	The Journal of experimental medicine	2009	81
19273909	Peptides	Singh MV	Ca2+/calmodulin-dependent kinase II triggers cell membrane injury by inducing complement factor B gene expression in the mouse heart.	The Journal of clinical investigation	2009	48
19528258	Peptides	Campbell JD	Peptide immunotherapy in allergic asthma generates IL-10-dependent immunological tolerance associated with linked epitope suppression.	The Journal of experimental medicine	2009	64
19635862	Peptides	Gabrysová L	Negative feedback control of the autoimmune response through antigen-induced differentiation of IL-10-secreting Th1 cells.	The Journal of experimental medicine	2009	45
19907488	Peptides	Moellering RE	Direct inhibition of the NOTCH transcription factor complex.	Nature	2009	232
20068138	Peptides	Arakawa M	Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4.	Diabetes	2010	102
20544025	Peptides	Jin G	An antimicrobial peptide regulates tumor-associated macrophage trafficking via the chemokine receptor CCR2, a model for tumorigenesis.	PloS one	2010	43
20703838	Peptides	Kim YS	Intestinal goblet cells and mucins in health and disease: recent insights and progress.	Current gastroenterology reports	2010	164
21742730	Peptides	Loureiro J	Blocking TGF-β1 protects the peritoneal membrane from dialysate-induced damage.	Journal of the American Society of Nephrology 	2011	42
22267161	Peptides	Ronesi JA	Disrupted Homer scaffolds mediate abnormal mGluR5 function in a mouse model of fragile X syndrome.	Nature neuroscience	2012	73
22268099	Peptides	Trevaskis JL	Glucagon-like peptide-1 receptor agonism improves metabolic, biochemical, and histopathological indices of nonalcoholic steatohepatitis in mice.	American journal of physiology. Gastrointestinal and liver physiology	2012	38
22622039	Peptides	LaBelle JL	A stapled BIM peptide overcomes apoptotic resistance in hematologic cancers.	The Journal of clinical investigation	2012	62
22826029	Peptides	Mima A	Protective effects of GLP-1 on glomerular endothelium and its inhibition by PKCβ activation in diabetes.	Diabetes	2012	34
23241962	Peptides	Leoni G	Annexin A1, formyl peptide receptor, and NOX1 orchestrate epithelial repair.	The Journal of clinical investigation	2013	67
23533277	Peptides	Kamaly N	Development and in vivo efficacy of targeted polymeric inflammation-resolving nanoparticles.	Proceedings of the National Academy of Sciences of the United States of America	2013	43
23714121	Peptides	Shi P	Elastin-based protein polymer nanoparticles carrying drug at both corona and core suppress tumor growth in vivo.	Journal of controlled release 	2013	26
24325867	Peptides	Gomez-Sanchez CE	Development of monoclonal antibodies against human CYP11B1 and CYP11B2.	Molecular and cellular endocrinology	2014	51
24919967	Peptides	Chen G	Connexin-43 induces chemokine release from spinal cord astrocytes to maintain late-phase neuropathic pain in mice.	Brain 	2014	42
25695999	Peptides	Fredman G	Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice.	Science translational medicine	2015	59
25818419	Peptides	Jiang L	Overcoming drug-resistant lung cancer by paclitaxel loaded dual-functional liposomes with mitochondria targeting and pH-response.	Biomaterials	2015	20
25990016	Peptides	Jones MV	Pathogenic aquaporin-4 reactive T cells are sufficient to induce mouse model of neuromyelitis optica.	Acta neuropathologica communications	2015	16
26912858	Peptides	Delong T	Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion.	Science	2016	52
27428901	Peptides	Wirnsberger G	Inhibition of CBLB protects from lethal Candida albicans sepsis.	Nature medicine	2016	10
27524110	Peptides	Ratsimandresy RA	The AIM2 inflammasome is a central regulator of intestinal homeostasis through the IL-18/IL-22/STAT3 pathway.	Cellular & molecular immunology	2017	15
28024296	Peptides	Matsumoto A	mTORC1 and muscle regeneration are regulated by the LINC00961-encoded SPAR polypeptide.	Nature	2017	26
11880505	Minocycline	Wu DC	Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease.	The Journal of neuroscience 	2002	264
11986668	Minocycline	Zhu S	Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice.	Nature	2002	212
12930891	Minocycline	Wang X	Minocycline inhibits caspase-independent and -dependent mitochondrial cell death pathways in models of Huntington's disease.	Proceedings of the National Academy of Sciences of the United States of America	2003	92
16571744	Minocycline	Karimi-Abdolrezaee S	Delayed transplantation of adult neural precursor cells promotes remyelination and functional neurological recovery after spinal cord injury.	The Journal of neuroscience 	2006	112
17188268	Minocycline	Bye N	Transient neuroprotection by minocycline following traumatic brain injury is associated with attenuated microglial activation but no changes in cell apoptosis or neutrophil infiltration.	Experimental neurology	2007	65
17406652	Minocycline	Choi Y	Minocycline attenuates neuronal cell death and improves cognitive impairment in Alzheimer's disease models.	Neuropsychopharmacology 	2007	64
18385061	Minocycline	Bosco A	Reduced retina microglial activation and improved optic nerve integrity with minocycline treatment in the DBA/2J mouse model of glaucoma.	Investigative ophthalmology & visual science	2008	84
18477398	Minocycline	Henry CJ	Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia.	Journal of neuroinflammation	2008	135
20818791	Minocycline	Cibelli M	Role of interleukin-1beta in postoperative cognitive dysfunction.	Annals of neurology	2010	137
21543484	Minocycline	Libbey JE	Interleukin-6, produced by resident cells of the central nervous system and infiltrating cells, contributes to the development of seizures following viral infection.	Journal of virology	2011	40
22584394	Minocycline	Biscaro B	Inhibition of microglial activation protects hippocampal neurogenesis and improves cognitive deficits in a transgenic mouse model for Alzheimer's disease.	Neuro-degenerative diseases	2012	37
23470532	Minocycline	Kobayashi K	Minocycline selectively inhibits M1 polarization of microglia.	Cell death & disease	2013	101
23824974	Minocycline	Dziembowska M	High MMP-9 activity levels in fragile X syndrome are lowered by minocycline.	American journal of medical genetics. Part A	2013	35
26576678	Minocycline	Scholz R	Minocycline counter-regulates pro-inflammatory microglia responses in the retina and protects from degeneration.	Journal of neuroinflammation	2015	15
26585233	Minocycline	Solga AC	RNA Sequencing of Tumor-Associated Microglia Reveals Ccl5 as a Stromal Chemokine Critical for Neurofibromatosis-1 Glioma Growth.	Neoplasia	2015	18
7585012	Bromodeoxyuridine	Holmgren L	Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression.	Nature medicine	1995	246
10375497	Bromodeoxyuridine	Hellström M	Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse.	Development	1999	355
11739500	Bromodeoxyuridine	Allman D	Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cell maturation.	Journal of immunology	2001	179
11983855	Bromodeoxyuridine	Lu M	Abnormal development of the hippocampal dentate gyrus in mice lacking the CXCR4 chemokine receptor.	Proceedings of the National Academy of Sciences of the United States of America	2002	120
12101245	Bromodeoxyuridine	Migliorini D	Mdm4 (Mdmx) regulates p53-induced growth arrest and neuronal cell death during early embryonic mouse development.	Molecular and cellular biology	2002	113
14598258	Bromodeoxyuridine	Mishra A	Intratracheal IL-13 induces eosinophilic esophagitis by an IL-5, eotaxin-1, and STAT6-dependent mechanism.	Gastroenterology	2003	95
14633615	Bromodeoxyuridine	Virag JI	Myofibroblast and endothelial cell proliferation during murine myocardial infarct repair.	The American journal of pathology	2003	76
14734483	Bromodeoxyuridine	Tang XH	Oral cavity and esophageal carcinogenesis modeled in carcinogen-treated mice.	Clinical cancer research 	2004	85
15161630	Bromodeoxyuridine	Galiano RD	Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells.	The American journal of pathology	2004	144
15745963	Bromodeoxyuridine	Chen J	Endothelial nitric oxide synthase regulates brain-derived neurotrophic factor expression and neurogenesis after stroke in mice.	The Journal of neuroscience 	2005	74
15825074	Bromodeoxyuridine	Bachem MG	Pancreatic carcinoma cells induce fibrosis by stimulating proliferation and matrix synthesis of stellate cells.	Gastroenterology	2005	149
16007252	Bromodeoxyuridine	Lin F	Intrarenal cells, not bone marrow-derived cells, are the major source for regeneration in postischemic kidney.	The Journal of clinical investigation	2005	95
16140970	Bromodeoxyuridine	Zhou HJ	SRC-3 is required for prostate cancer cell proliferation and survival.	Cancer research	2005	82
16874803	Bromodeoxyuridine	Horky LL	Fate of endogenous stem/progenitor cells following spinal cord injury.	The Journal of comparative neurology	2006	76
16876159	Bromodeoxyuridine	Rola R	Alterations in hippocampal neurogenesis following traumatic brain injury in mice.	Experimental neurology	2006	62
17077815	Bromodeoxyuridine	Li Y	Erythropoietin-induced neurovascular protection, angiogenesis, and cerebral blood flow restoration after focal ischemia in mice.	Journal of cerebral blood flow and metabolism 	2007	65
17287398	Bromodeoxyuridine	Christov C	Muscle satellite cells and endothelial cells: close neighbors and privileged partners.	Molecular biology of the cell	2007	119
17525183	Bromodeoxyuridine	Bock F	Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis.	Investigative ophthalmology & visual science	2007	68
17908937	Bromodeoxyuridine	McCaughtry TM	Thymic emigration revisited.	The Journal of experimental medicine	2007	97
17979981	Bromodeoxyuridine	Gibson DL	MyD88 signalling plays a critical role in host defence by controlling pathogen burden and promoting epithelial cell homeostasis during Citrobacter rodentium-induced colitis.	Cellular microbiology	2008	54
18086861	Bromodeoxyuridine	Poulin LF	The dermis contains langerin+ dendritic cells that develop and function independently of epidermal Langerhans cells.	The Journal of experimental medicine	2007	131
18371453	Bromodeoxyuridine	Humphreys BD	Intrinsic epithelial cells repair the kidney after injury.	Cell stem cell	2008	245
18375791	Bromodeoxyuridine	Sawanobori Y	Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice.	Blood	2008	105
18496841	Bromodeoxyuridine	Kivisäkk P	Localizing central nervous system immune surveillance: meningeal antigen-presenting cells activate T cells during experimental autoimmune encephalomyelitis.	Annals of neurology	2009	75
18664375	Bromodeoxyuridine	Clark PJ	Intact neurogenesis is required for benefits of exercise on spatial memory but not motor performance or contextual fear conditioning in C57BL/6J mice.	Neuroscience	2008	87
18803808	Bromodeoxyuridine	Yamasaki N	Alpha-CaMKII deficiency causes immature dentate gyrus, a novel candidate endophenotype of psychiatric disorders.	Molecular brain	2008	100
19072981	Bromodeoxyuridine	Chu P	Characterization of a subpopulation of colon cancer cells with stem cell-like properties.	International journal of cancer	2009	51
19342421	Bromodeoxyuridine	Takakura A	Renal injury is a third hit promoting rapid development of adult polycystic kidney disease.	Human molecular genetics	2009	63
19752185	Bromodeoxyuridine	Zhu SN	GM-CSF regulates intimal cell proliferation in nascent atherosclerotic lesions.	The Journal of experimental medicine	2009	52
20051385	Bromodeoxyuridine	Yang G	Cystathionine gamma-lyase deficiency and overproliferation of smooth muscle cells.	Cardiovascular research	2010	42
20073084	Bromodeoxyuridine	Kojima T	Subventricular zone-derived neural progenitor cells migrate along a blood vessel scaffold toward the post-stroke striatum.	Stem cells	2010	76
20075333	Bromodeoxyuridine	Cottage CT	Cardiac progenitor cell cycling stimulated by pim-1 kinase.	Circulation research	2010	41
20432234	Bromodeoxyuridine	Laffont S	Intestinal inflammation abrogates the tolerogenic properties of MLN CD103+ dendritic cells.	European journal of immunology	2010	58
20811150	Bromodeoxyuridine	Teekakirikul P	Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-β.	The Journal of clinical investigation	2010	132
20940729	Bromodeoxyuridine	Li J	Estrogen enhances neurogenesis and behavioral recovery after stroke.	Journal of cerebral blood flow and metabolism 	2011	36
21343390	Bromodeoxyuridine	Chang Q	Hypoxia predicts aggressive growth and spontaneous metastasis formation from orthotopically grown primary xenografts of human pancreatic cancer.	Cancer research	2011	58
22262260	Bromodeoxyuridine	Kamphuis W	Differential cell proliferation in the cortex of the APPswePS1dE9 Alzheimer's disease mouse model.	Glia	2012	31
22895262	Bromodeoxyuridine	Jackson JR	Satellite cell depletion does not inhibit adult skeletal muscle regrowth following unloading-induced atrophy.	American journal of physiology. Cell physiology	2012	39
24284627	Bromodeoxyuridine	Li Q	Oncogenic Nras has bimodal effects on stem cells that sustainably increase competitiveness.	Nature	2013	32
24586944	Bromodeoxyuridine	Di Martino MT	In vitro and in vivo activity of a novel locked nucleic acid (LNA)-inhibitor-miR-221 against multiple myeloma cells.	PloS one	2014	24
24744439	Bromodeoxyuridine	Zhou D	Sonic hedgehog is a novel tubule-derived growth factor for interstitial fibroblasts after kidney injury.	Journal of the American Society of Nephrology 	2014	28
24786973	Bromodeoxyuridine	Heidt T	Differential contribution of monocytes to heart macrophages in steady-state and after myocardial infarction.	Circulation research	2014	75
24884509	Bromodeoxyuridine	Tu K	Fbxw7 is an independent prognostic marker and induces apoptosis and growth arrest by regulating YAP abundance in hepatocellular carcinoma.	Molecular cancer	2014	30
25028469	Bromodeoxyuridine	Zhang YX	Antiproliferative effects of CDK4/6 inhibition in CDK4-amplified human liposarcoma in vitro and in vivo.	Molecular cancer therapeutics	2014	29
25144366	Bromodeoxyuridine	Nascimento M	Ly6Chi monocyte recruitment is responsible for Th2 associated host-protective macrophage accumulation in liver inflammation due to schistosomiasis.	PLoS pathogens	2014	21
25577171	Bromodeoxyuridine	Huang J	Propofol Administration During Early Postnatal Life Suppresses Hippocampal Neurogenesis.	Molecular neurobiology	2016	10
26908603	Bromodeoxyuridine	Toonen JA	NF1 germline mutation differentially dictates optic glioma formation and growth in neurofibromatosis-1.	Human molecular genetics	2016	13
9024701	Proteoglycans	Danielson KG	Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility.	The Journal of cell biology	1997	298
9731537	Proteoglycans	Xu T	Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice.	Nature genetics	1998	123
11160142	Proteoglycans	Echtermeyer F	Delayed wound repair and impaired angiogenesis in mice lacking syndecan-4.	The Journal of clinical investigation	2001	112
12039798	Proteoglycans	Pare G	Estrogen receptor-alpha mediates the protective effects of estrogen against vascular injury.	Circulation research	2002	88
12102052	Proteoglycans	Corsi A	Phenotypic effects of biglycan deficiency are linked to collagen fibril abnormalities, are synergized by decorin deficiency, and mimic Ehlers-Danlos-like changes in bone and other connective tissues.	Journal of bone and mineral research 	2002	92
12464176	Proteoglycans	Li Q	Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury.	Cell	2002	238
12975602	Proteoglycans	Reed CC	The role of decorin in collagen fibrillogenesis and skin homeostasis.	Glycoconjugate journal	2002	99
15800624	Proteoglycans	Glasson SS	Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis.	Nature	2005	280
15800625	Proteoglycans	Stanton H	ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro.	Nature	2005	198
15964849	Proteoglycans	Bi Y	Extracellular matrix proteoglycans control the fate of bone marrow stromal cells.	The Journal of biological chemistry	2005	75
16025156	Proteoglycans	Schaefer L	The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages.	The Journal of clinical investigation	2005	195
16322790	Proteoglycans	Li QZ	Identification of autoantibody clusters that best predict lupus disease activity using glomerular proteome arrays.	The Journal of clinical investigation	2005	81
16518859	Proteoglycans	Zhang G	Decorin regulates assembly of collagen fibrils and acquisition of biomechanical properties during tendon development.	Journal of cellular biochemistry	2006	122
17597062	Proteoglycans	Zhu J	Relationships between transforming growth factor-beta1, myostatin, and decorin: implications for skeletal muscle fibrosis.	The Journal of biological chemistry	2007	77
18180376	Proteoglycans	Belnoue E	APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells.	Blood	2008	81
18550571	Proteoglycans	Bi X	Genetic deficiency of decorin causes intestinal tumor formation through disruption of intestinal cell maturation.	Carcinogenesis	2008	52
18688028	Proteoglycans	Goldoni S	An antimetastatic role for decorin in breast cancer.	The American journal of pathology	2008	52
18798267	Proteoglycans	Goldoni S	Tumor microenvironment: Modulation by decorin and related molecules harboring leucine-rich tandem motifs.	International journal of cancer	2008	69
18842903	Proteoglycans	Dimou L	Progeny of Olig2-expressing progenitors in the gray and white matter of the adult mouse cerebral cortex.	The Journal of neuroscience 	2008	137
19136671	Proteoglycans	Zhang G	Genetic evidence for the coordinated regulation of collagen fibrillogenesis in the cornea by decorin and biglycan.	The Journal of biological chemistry	2009	72
20599895	Proteoglycans	Huang FJ	Pericyte deficiencies lead to aberrant tumor vascularizaton in the brain of the NG2 null mouse.	Developmental biology	2010	54
21123584	Proteoglycans	Tripathi RB	NG2 glia generate new oligodendrocytes but few astrocytes in a murine experimental autoimmune encephalomyelitis model of demyelinating disease.	The Journal of neuroscience 	2010	69
21907924	Proteoglycans	Sugiarto S	Asymmetry-defective oligodendrocyte progenitors are glioma precursors.	Cancer cell	2011	72
25547119	Proteoglycans	Yuan P	Chondroitin sulfate proteoglycan 4 functions as the cellular receptor for Clostridium difficile toxin B.	Cell research	2015	21
25793273	Proteoglycans	Hippert C	Müller glia activation in response to inherited retinal degeneration is highly varied and disease-specific.	PloS one	2015	22
26465118	Proteoglycans	Stallcup WB	NG2 Proteoglycan-Dependent Contributions of Pericytes and Macrophages to Brain Tumor Vascularization and Progression.	Microcirculation	2016	11
9887098	Hyaluronic Acid	Yu Q	Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion.	Genes & development	1999	145
11731267	Hyaluronic Acid	Csoka AB	The six hyaluronidase-like genes in the human and mouse genomes.	Matrix biology 	2001	112
11935029	Hyaluronic Acid	Teder P	Resolution of lung inflammation by CD44.	Science	2002	184
12668637	Hyaluronic Acid	Fülöp C	Impaired cumulus mucification and female sterility in tumor necrosis factor-induced protein-6 deficient mice.	Development	2003	106
17853945	Hyaluronic Acid	Wu H	TLR4 activation mediates kidney ischemia/reperfusion injury.	The Journal of clinical investigation	2007	259
18362172	Hyaluronic Acid	McDonald B	Interaction of CD44 and hyaluronan is the dominant mechanism for neutrophil sequestration in inflamed liver sinusoids.	The Journal of experimental medicine	2008	68
19164299	Hyaluronic Acid	Garantziotis S	Hyaluronan mediates ozone-induced airway hyperresponsiveness in mice.	The Journal of biological chemistry	2009	56
19218337	Hyaluronic Acid	Bharadwaj AG	Spontaneous metastasis of prostate cancer is promoted by excess hyaluronan synthesis and processing.	The American journal of pathology	2009	52
19965872	Hyaluronic Acid	Takahashi E	Tumor necrosis factor-alpha regulates transforming growth factor-beta-dependent epithelial-mesenchymal transition by promoting hyaluronan-CD44-moesin interaction.	The Journal of biological chemistry	2010	58
20007931	Hyaluronic Acid	Garantziotis S	TLR4 is necessary for hyaluronan-mediated airway hyperresponsiveness after ozone inhalation.	American journal of respiratory and critical care medicine	2010	46
20197461	Hyaluronic Acid	Xu Y	CD44 attenuates activation of the hippo signaling pathway and is a prime therapeutic target for glioblastoma.	Cancer research	2010	59
20823158	Hyaluronic Acid	Kobayashi N	Hyaluronan deficiency in tumor stroma impairs macrophage trafficking and tumor neovascularization.	Cancer research	2010	43
21387290	Hyaluronic Acid	Urakawa H	Inhibition of hyaluronan synthesis in breast cancer cells by 4-methylumbelliferone suppresses tumorigenicity in vitro and metastatic lesions of bone in vivo.	International journal of cancer	2012	35
22835643	Hyaluronic Acid	Purcell BP	Synergistic effects of SDF-1α chemokine and hyaluronic acid release from degradable hydrogels on directing bone marrow derived cell homing to the myocardium.	Biomaterials	2012	32
23463525	Hyaluronic Acid	Preston M	Digestion products of the PH20 hyaluronidase inhibit remyelination.	Annals of neurology	2013	26
24790187	Hyaluronic Acid	Arranz AM	Hyaluronan deficiency due to Has3 knock-out causes altered neuronal activity and seizures via reduction in brain extracellular space.	The Journal of neuroscience 	2014	21
25892224	Hyaluronic Acid	Guidotti LG	Immunosurveillance of the liver by intravascular effector CD8(+) T cells.	Cell	2015	31
26485284	Hyaluronic Acid	Cui Y	Therapeutic lymphangiogenesis ameliorates established acute lung allograft rejection.	The Journal of clinical investigation	2015	17
9630215	Bile Acids and Salts	Peet DJ	Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha.	Cell	1998	286
10809780	Bile Acids and Salts	Yu C	Elevated cholesterol metabolism and bile acid synthesis in mice lacking membrane tyrosine kinase receptor FGFR4.	The Journal of biological chemistry	2000	102
11030617	Bile Acids and Salts	Sinal CJ	Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis.	Cell	2000	342
11158324	Bile Acids and Salts	Hayhurst GP	Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis.	Molecular and cellular biology	2001	288
15236191	Bile Acids and Salts	Fickert P	Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice.	Gastroenterology	2004	78
16075061	Bile Acids and Salts	Ito S	Impaired negative feedback suppression of bile acid synthesis in mice lacking betaKlotho.	The Journal of clinical investigation	2005	76
16473946	Bile Acids and Salts	Inagaki T	Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor.	Proceedings of the National Academy of Sciences of the United States of America	2006	172
17183066	Bile Acids and Salts	Kim I	Spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice.	Carcinogenesis	2007	102
17283114	Bile Acids and Salts	Yang F	Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor.	Cancer research	2007	132
17571164	Bile Acids and Salts	Temel RE	Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetimibe.	The Journal of clinical investigation	2007	101
19047134	Bile Acids and Salts	Modica S	Nuclear bile acid receptor FXR protects against intestinal tumorigenesis.	Cancer research	2008	64
20080590	Bile Acids and Salts	Tomiyama K	Relevant use of Klotho in FGF19 subfamily signaling system in vivo.	Proceedings of the National Academy of Sciences of the United States of America	2010	49
20138038	Bile Acids and Salts	Wang DH	Aberrant epithelial-mesenchymal Hedgehog signaling characterizes Barrett's metaplasia.	Gastroenterology	2010	50
21224055	Bile Acids and Salts	Allen K	Bile acids induce inflammatory genes in hepatocytes: a novel mechanism of inflammation during obstructive cholestasis.	The American journal of pathology	2011	94
21703998	Bile Acids and Salts	Van Rooyen DM	Hepatic free cholesterol accumulates in obese, diabetic mice and causes nonalcoholic steatohepatitis.	Gastroenterology	2011	55
21735468	Bile Acids and Salts	Wang YD	The G-protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor κ light-chain enhancer of activated B cells (NF-κB) in mice.	Hepatology	2011	75
22057115	Bile Acids and Salts	Modica S	Selective activation of nuclear bile acid receptor FXR in the intestine protects mice against cholestasis.	Gastroenterology	2012	42
22264787	Bile Acids and Salts	Quante M	Bile acid and inflammation activate gastric cardia stem cells in a mouse model of Barrett-like metaplasia.	Cancer cell	2012	102
22290395	Bile Acids and Salts	Tanaka N	Disruption of phospholipid and bile acid homeostasis in mice with nonalcoholic steatohepatitis.	Hepatology	2012	53
22722865	Bile Acids and Salts	Devkota S	Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice.	Nature	2012	308
22796522	Bile Acids and Salts	Sodhi CP	Intestinal epithelial Toll-like receptor 4 regulates goblet cell development and is required for necrotizing enterocolitis in mice.	Gastroenterology	2012	64
22993202	Bile Acids and Salts	Duboc H	Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases.	Gut	2013	76
23460643	Bile Acids and Salts	McMahan RH	Bile acid receptor activation modulates hepatic monocyte activity and improves nonalcoholic fatty liver disease.	The Journal of biological chemistry	2013	42
23524965	Bile Acids and Salts	Alemi F	The TGR5 receptor mediates bile acid-induced itch and analgesia.	The Journal of clinical investigation	2013	44
23686672	Bile Acids and Salts	Péan N	The receptor TGR5 protects the liver from bile acid overload during liver regeneration in mice.	Hepatology	2013	36
24268772	Bile Acids and Salts	Anakk S	Bile acids activate YAP to promote liver carcinogenesis.	Cell reports	2013	31
24531544	Bile Acids and Salts	Lien F	Metformin interferes with bile acid homeostasis through AMPK-FXR crosstalk.	The Journal of clinical investigation	2014	21
25346390	Bile Acids and Salts	Uriarte I	Ileal FGF15 contributes to fibrosis-associated hepatocellular carcinoma development.	International journal of cancer	2015	17
26197299	Bile Acids and Salts	Flynn CR	Bile diversion to the distal small intestine has comparable metabolic benefits to bariatric surgery.	Nature communications	2015	19
26511794	Bile Acids and Salts	McGavigan AK	TGR5 contributes to glucoregulatory improvements after vertical sleeve gastrectomy in mice.	Gut	2017	20
26529078	Bile Acids and Salts	Baghdasaryan A	Inhibition of intestinal bile acid absorption improves cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitis.	Journal of hepatology	2016	14
26740296	Bile Acids and Salts	Parséus A	Microbiota-induced obesity requires farnesoid X receptor.	Gut	2017	24
26838806	Bile Acids and Salts	Zhang Y	Bcl2 is a critical regulator of bile acid homeostasis by dictating Shp and lncRNA H19 function.	Scientific reports	2016	17
27351453	Bile Acids and Salts	Donepudi AC	G-protein-coupled bile acid receptor plays a key role in bile acid metabolism and fasting-induced hepatic steatosis in mice.	Hepatology	2017	9
27770549	Bile Acids and Salts	Zhang L	Long noncoding RNA MEG3 induces cholestatic liver injury by interaction with PTBP1 to facilitate shp mRNA decay.	Hepatology	2017	12
9661897	Doxorubicin	Baselga J	Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts.	Cancer research	1998	130
14566054	Doxorubicin	Jacoby JJ	Cardiomyocyte-restricted knockout of STAT3 results in higher sensitivity to inflammation, cardiac fibrosis, and heart failure with advanced age.	Proceedings of the National Academy of Sciences of the United States of America	2003	92
15756033	Doxorubicin	Cohen BD	Combination therapy enhances the inhibition of tumor growth with the fully human anti-type 1 insulin-like growth factor receptor monoclonal antibody CP-751,871.	Clinical cancer research 	2005	86
15763623	Doxorubicin	Lee ES	Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor.	Journal of controlled release 	2005	95
16079837	Doxorubicin	Braig M	Oncogene-induced senescence as an initial barrier in lymphoma development.	Nature	2005	348
16361566	Doxorubicin	Primeau AJ	The distribution of the anticancer drug Doxorubicin in relation to blood vessels in solid tumors.	Clinical cancer research 	2005	101
17415413	Doxorubicin	Biswas S	Inhibition of TGF-beta with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression.	The Journal of clinical investigation	2007	100
17823410	Doxorubicin	Corney DC	MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth.	Cancer research	2007	223
18037988	Doxorubicin	Suliman HB	The CO/HO system reverses inhibition of mitochondrial biogenesis and prevents murine doxorubicin cardiomyopathy.	The Journal of clinical investigation	2007	89
18818206	Doxorubicin	Nasser MW	Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1.	The Journal of biological chemistry	2008	137
19092120	Doxorubicin	Ronconi E	Regeneration of glomerular podocytes by human renal progenitors.	Journal of the American Society of Nephrology 	2009	155
19103993	Doxorubicin	Zhu W	Acute doxorubicin cardiotoxicity is associated with p53-induced inhibition of the mammalian target of rapamycin pathway.	Circulation	2009	55
19433796	Doxorubicin	Lee J	A tumor suppressive coactivator complex of p53 containing ASC-2 and histone H3-lysine-4 methyltransferase MLL3 or its paralogue MLL4.	Proceedings of the National Academy of Sciences of the United States of America	2009	64
19584283	Doxorubicin	Fornari F	MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells.	Cancer research	2009	117
19628668	Doxorubicin	Dai C	Wnt/beta-catenin signaling promotes podocyte dysfunction and albuminuria.	Journal of the American Society of Nephrology 	2009	129
20007346	Doxorubicin	Ohse T	De novo expression of podocyte proteins in parietal epithelial cells during experimental glomerular disease.	American journal of physiology. Renal physiology	2010	45
20299353	Doxorubicin	Cao Q	IL-10/TGF-beta-modified macrophages induce regulatory T cells and protect against adriamycin nephrosis.	Journal of the American Society of Nephrology 	2010	60
20388796	Doxorubicin	Yoo BK	Molecular mechanism of chemoresistance by astrocyte elevated gene-1.	Cancer research	2010	46
20442777	Doxorubicin	Bandyopadhyay A	Doxorubicin in combination with a small TGFbeta inhibitor: a potential novel therapy for metastatic breast cancer in mouse models.	PloS one	2010	50
20460510	Doxorubicin	Adhikari AS	CD117 and Stro-1 identify osteosarcoma tumor-initiating cells associated with metastasis and drug resistance.	Cancer research	2010	80
20495188	Doxorubicin	Horie T	Acute doxorubicin cardiotoxicity is associated with miR-146a-induced inhibition of the neuregulin-ErbB pathway.	Cardiovascular research	2010	47
20505657	Doxorubicin	Kang YS	Inhibition of integrin-linked kinase blocks podocyte epithelial-mesenchymal transition and ameliorates proteinuria.	Kidney international	2010	45
20668064	Doxorubicin	Zhang X	Oncogenic Wip1 phosphatase is inhibited by miR-16 in the DNA damage signaling pathway.	Cancer research	2010	48
20829328	Doxorubicin	Lockman PR	Heterogeneous blood-tumor barrier permeability determines drug efficacy in experimental brain metastases of breast cancer.	Clinical cancer research 	2010	135
20884632	Doxorubicin	Zhao Y	Nox2 NADPH oxidase promotes pathologic cardiac remodeling associated with Doxorubicin chemotherapy.	Cancer research	2010	56
20935265	Doxorubicin	Calcagno AM	Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics.	Journal of the National Cancer Institute	2010	76
22152097	Doxorubicin	Pham PV	Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy.	Journal of translational medicine	2011	36
22281424	Doxorubicin	Xiao Y	Multifunctional unimolecular micelles for cancer-targeted drug delivery and positron emission tomography imaging.	Biomaterials	2012	42
22308459	Doxorubicin	Meirelles K	Human ovarian cancer stem/progenitor cells are stimulated by doxorubicin but inhibited by Mullerian inhibiting substance.	Proceedings of the National Academy of Sciences of the United States of America	2012	39
22405901	Doxorubicin	Yang FY	Focused ultrasound and interleukin-4 receptor-targeted liposomal doxorubicin for enhanced targeted drug delivery and antitumor effect in glioblastoma multiforme.	Journal of controlled release 	2012	33
23104132	Doxorubicin	Zhang S	Identification of the molecular basis of doxorubicin-induced cardiotoxicity.	Nature medicine	2012	183
23289892	Doxorubicin	Meng H	Codelivery of an optimal drug/siRNA combination using mesoporous silica nanoparticles to overcome drug resistance in breast cancer in vitro and in vivo.	ACS nano	2013	68
23559584	Doxorubicin	Zhou L	Loss of Klotho contributes to kidney injury by derepression of Wnt/β-catenin signaling.	Journal of the American Society of Nephrology 	2013	62
23582862	Doxorubicin	Xu W	Aptamer-conjugated and doxorubicin-loaded unimolecular micelles for targeted therapy of prostate cancer.	Biomaterials	2013	36
23636175	Doxorubicin	Lu J	Discrete functions of M2a and M2c macrophage subsets determine their relative efficacy in treating chronic kidney disease.	Kidney international	2013	30
23648833	Doxorubicin	Taratula O	Nanostructured lipid carriers as multifunctional nanomedicine platform for pulmonary co-delivery of anticancer drugs and siRNA.	Journal of controlled release 	2013	35
23917356	Doxorubicin	Hoshino A	Cytosolic p53 inhibits Parkin-mediated mitophagy and promotes mitochondrial dysfunction in the mouse heart.	Nature communications	2013	80
23949798	Doxorubicin	Peired A	Proteinuria impairs podocyte regeneration by sequestering retinoic acid.	Journal of the American Society of Nephrology 	2013	30
24004438	Doxorubicin	Jang SC	Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors.	ACS nano	2013	62
24197130	Doxorubicin	Alizadeh D	Doxorubicin eliminates myeloid-derived suppressor cells and enhances the efficacy of adoptive T-cell transfer in breast cancer.	Cancer research	2014	62
24502925	Doxorubicin	Bergfeld SA	Bone marrow-derived mesenchymal stromal cells promote survival and drug resistance in tumor cells.	Molecular cancer therapeutics	2014	20
24522112	Doxorubicin	Wang X	Ghrelin inhibits doxorubicin cardiotoxicity by inhibiting excessive autophagy through AMPK and p38-MAPK.	Biochemical pharmacology	2014	21
24590287	Doxorubicin	Daehn I	Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis.	The Journal of clinical investigation	2014	57
24733904	Doxorubicin	Ma X	Essential role for TrpC5-containing extracellular vesicles in breast cancer with chemotherapeutic resistance.	Proceedings of the National Academy of Sciences of the United States of America	2014	22
25079333	Doxorubicin	Tavora B	Endothelial-cell FAK targeting sensitizes tumours to DNA-damaging therapy.	Nature	2014	21
25153718	Doxorubicin	Datta A	SPHK1 regulates proliferation and survival responses in triple-negative breast cancer.	Oncotarget	2014	22
25348805	Doxorubicin	Paranjape AN	Bmi1 regulates self-renewal and epithelial to mesenchymal transition in breast cancer cells through Nanog.	BMC cancer	2014	31
25368020	Doxorubicin	Park EY	Targeting of miR34a-NOTCH1 axis reduced breast cancer stemness and chemoresistance.	Cancer research	2014	38
25453970	Doxorubicin	Ruan S	Tumor microenvironment sensitive doxorubicin delivery and release to glioma using angiopep-2 decorated gold nanoparticles.	Biomaterials	2015	24
25689250	Doxorubicin	Mallipattu SK	Krüppel-like factor 6 regulates mitochondrial function in the kidney.	The Journal of clinical investigation	2015	17
25759382	Doxorubicin	Cheung KG	Sirtuin-3 (SIRT3) Protein Attenuates Doxorubicin-induced Oxidative Stress and Improves Mitochondrial Respiration in H9c2 Cardiomyocytes.	The Journal of biological chemistry	2015	23
25789975	Doxorubicin	Hall JR	Long noncoding RNA lincRNA-p21 is the major mediator of UVB-induced and p53-dependent apoptosis in keratinocytes.	Cell death & disease	2015	16
26552700	Doxorubicin	Picaud S	Generation of a Selective Small Molecule Inhibitor of the CBP/p300 Bromodomain for Leukemia Therapy.	Cancer research	2015	36
26726877	Doxorubicin	Zhang T	CaMKII is a RIP3 substrate mediating ischemia- and oxidative stress-induced myocardial necroptosis.	Nature medicine	2016	50
26787820	Doxorubicin	Blake SJ	Suppression of Metastases Using a New Lymphocyte Checkpoint Target for Cancer Immunotherapy.	Cancer discovery	2016	15
27890659	Doxorubicin	Pi F	RNA nanoparticles harboring annexin A2 aptamer can target ovarian cancer for tumor-specific doxorubicin delivery.	Nanomedicine 	2017	7
28340339	Doxorubicin	Baar MP	Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging.	Cell	2017	39
11544530	Carcinogens	Krimpenfort P	Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice.	Nature	2001	140
12878730	Carcinogens	Fingerle-Rowson G	The p53-dependent effects of macrophage migration inhibitory factor revealed by gene targeting.	Proceedings of the National Academy of Sciences of the United States of America	2003	96
14727734	Carcinogens	Klaunig JE	PPARalpha agonist-induced rodent tumors: modes of action and human relevance.	Critical reviews in toxicology	2003	103
15343391	Carcinogens	Chan KS	Disruption of Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesis.	The Journal of clinical investigation	2004	136
16103220	Carcinogens	List K	Deregulated matriptase causes ras-independent multistage carcinogenesis and promotes ras-mediated malignant transformation.	Genes & development	2005	70
16314486	Carcinogens	Stearman RS	Analysis of orthologous gene expression between human pulmonary adenocarcinoma and a carcinogen-induced murine model.	The American journal of pathology	2005	91
17283139	Carcinogens	Krelin Y	Interleukin-1beta-driven inflammation promotes the development and invasiveness of chemical carcinogen-induced tumors.	Cancer research	2007	73
19029379	Carcinogens	Iguchi-Manaka A	Accelerated tumor growth in mice deficient in DNAM-1 receptor.	The Journal of experimental medicine	2008	52
19139015	Carcinogens	Czerninski R	Targeting mammalian target of rapamycin by rapamycin prevents tumor progression in an oral-specific chemical carcinogenesis model.	Cancer prevention research	2009	47
19841737	Carcinogens	Davis R	Nicotine promotes tumor growth and metastasis in mouse models of lung cancer.	PloS one	2009	51
20924108	Carcinogens	Elyakim E	hsa-miR-191 is a candidate oncogene target for hepatocellular carcinoma therapy.	Cancer research	2010	42
21159633	Carcinogens	Wang L	IL-17 enhances tumor development in carcinogen-induced skin cancer.	Cancer research	2010	52
21670304	Carcinogens	Schioppa T	B regulatory cells and the tumor-promoting actions of TNF-α during squamous carcinogenesis.	Proceedings of the National Academy of Sciences of the United States of America	2011	60
22532166	Carcinogens	Ho PL	Stat3 activation in urothelial stem cells leads to direct progression to invasive bladder cancer.	Cancer research	2012	34
23273920	Carcinogens	Schwitalla S	Loss of p53 in enterocytes generates an inflammatory microenvironment enabling invasion and lymph node metastasis of carcinogen-induced colorectal tumors.	Cancer cell	2013	60
23695550	Carcinogens	Alitalo AK	VEGF-C and VEGF-D blockade inhibits inflammatory skin carcinogenesis.	Cancer research	2013	26
23771523	Carcinogens	Quinn BJ	Inhibition of lung tumorigenesis by metformin is associated with decreased plasma IGF-I and diminished receptor tyrosine kinase signaling.	Cancer prevention research	2013	30
24280935	Carcinogens	Chan IH	Interleukin-23 is sufficient to induce rapid de novo gut tumorigenesis, independent of carcinogens, through activation of innate lymphoid cells.	Mucosal immunology	2014	22
25363767	Carcinogens	Westcott PM	The mutational landscapes of genetic and chemical models of Kras-driven lung cancer.	Nature	2015	58
26412304	Carcinogens	Pontel LB	Endogenous Formaldehyde Is a Hematopoietic Stem Cell Genotoxin and Metabolic Carcinogen.	Molecular cell	2015	36
11106738	Cisplatin	Romanienko PJ	The mouse Spo11 gene is required for meiotic chromosome synapsis.	Molecular cell	2000	222
15148457	Cisplatin	Mishra J	Neutrophil gelatinase-associated lipocalin: a novel early urinary biomarker for cisplatin nephrotoxicity.	American journal of nephrology	2004	112
17292828	Cisplatin	Reinhardt HC	p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damage.	Cancer cell	2007	174
17400889	Cisplatin	Faubel S	Cisplatin-induced acute renal failure is associated with an increase in the cytokines interleukin (IL)-1beta, IL-18, IL-6, and neutrophil infiltration in the kidney.	The Journal of pharmacology and experimental therapeutics	2007	67
17410096	Cisplatin	Wei Q	The pathological role of Bax in cisplatin nephrotoxicity.	Kidney international	2007	59
17942965	Cisplatin	Imberti B	Insulin-like growth factor-1 sustains stem cell mediated renal repair.	Journal of the American Society of Nephrology 	2007	70
18206965	Cisplatin	Lim ST	Nuclear FAK promotes cell proliferation and survival through FERM-enhanced p53 degradation.	Molecular cell	2008	151
18256356	Cisplatin	Zhang B	TLR4 signaling mediates inflammation and tissue injury in nephrotoxicity.	Journal of the American Society of Nephrology 	2008	76
18316592	Cisplatin	Ohta T	Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth.	Cancer research	2008	174
18509321	Cisplatin	Zhou H	Urinary exosomal transcription factors, a new class of biomarkers for renal disease.	Kidney international	2008	53
19805294	Cisplatin	Bertolini G	Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment.	Proceedings of the National Academy of Sciences of the United States of America	2009	248
19875815	Cisplatin	Tadagavadi RK	Renal dendritic cells ameliorate nephrotoxic acute kidney injury.	Journal of the American Society of Nephrology 	2010	49
20049901	Cisplatin	Morigi M	Life-sparing effect of human cord blood-mesenchymal stem cells in experimental acute kidney injury.	Stem cells	2010	51
20110413	Cisplatin	Ciarimboli G	Organic cation transporter 2 mediates cisplatin-induced oto- and nephrotoxicity and is a target for protective interventions.	The American journal of pathology	2010	74
20139070	Cisplatin	Hasegawa K	Kidney-specific overexpression of Sirt1 protects against acute kidney injury by retaining peroxisome function.	The Journal of biological chemistry	2010	56
20145120	Cisplatin	Holland SJ	R428, a selective small molecule inhibitor of Axl kinase, blocks tumor spread and prolongs survival in models of metastatic breast cancer.	Cancer research	2010	121
20215556	Cisplatin	Sikora AG	Targeted inhibition of inducible nitric oxide synthase inhibits growth of human melanoma in vivo and synergizes with chemotherapy.	Clinical cancer research 	2010	43
20386864	Cisplatin	Bhatt K	MicroRNA-34a is induced via p53 during cisplatin nephrotoxicity and contributes to cell survival.	Molecular medicine	2010	43
20395368	Cisplatin	Oliver TG	Chronic cisplatin treatment promotes enhanced damage repair and tumor progression in a mouse model of lung cancer.	Genes & development	2010	66
20530669	Cisplatin	Jiang T	High levels of Nrf2 determine chemoresistance in type II endometrial cancer.	Cancer research	2010	80
20705711	Cisplatin	Bolisetty S	Heme oxygenase-1 inhibits renal tubular macroautophagy in acute kidney injury.	Journal of the American Society of Nephrology 	2010	54
21068376	Cisplatin	Doles J	Suppression of Rev3, the catalytic subunit of Pol{zeta}, sensitizes drug-resistant lung tumors to chemotherapy.	Proceedings of the National Academy of Sciences of the United States of America	2010	62
21068378	Cisplatin	Xie K	Error-prone translesion synthesis mediates acquired chemoresistance.	Proceedings of the National Academy of Sciences of the United States of America	2010	67
21124918	Cisplatin	Leung EL	Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties.	PloS one	2010	115
21160028	Cisplatin	Brooks C	Fragmented mitochondria are sensitized to Bax insertion and activation during apoptosis.	American journal of physiology. Cell physiology	2011	48
21532889	Cisplatin	Rattan R	Metformin suppresses ovarian cancer growth and metastasis with enhancement of cisplatin cytotoxicity in vivo.	Neoplasia	2011	85
21633170	Cisplatin	Pabla N	Inhibition of PKCδ reduces cisplatin-induced nephrotoxicity without blocking chemotherapeutic efficacy in mouse models of cancer.	The Journal of clinical investigation	2011	47
21726833	Cisplatin	Lee TK	CD24(+) liver tumor-initiating cells drive self-renewal and tumor initiation through STAT3-mediated NANOG regulation.	Cell stem cell	2011	148
21909139	Cisplatin	Yue P	Hyperactive EGF receptor, Jaks and Stat3 signaling promote enhanced colony-forming ability, motility and migration of cisplatin-resistant ovarian cancer cells.	Oncogene	2012	43
22431999	Cisplatin	Bruno S	Microvesicles derived from mesenchymal stem cells enhance survival in a lethal model of acute kidney injury.	PloS one	2012	135
22440905	Cisplatin	Zager RA	Plasma and urinary heme oxygenase-1 in AKI.	Journal of the American Society of Nephrology 	2012	33
22516258	Cisplatin	Nakasone ES	Imaging tumor-stroma interactions during chemotherapy reveals contributions of the microenvironment to resistance.	Cancer cell	2012	112
23251001	Cisplatin	Kimple RJ	Development and characterization of HPV-positive and HPV-negative head and neck squamous cell carcinoma tumorgrafts.	Clinical cancer research 	2013	31
23524583	Cisplatin	Zhang S	Generation of cancer stem-like cells through the formation of polyploid giant cancer cells.	Oncogene	2014	58
23537295	Cisplatin	Abubaker K	Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden.	Molecular cancer	2013	55
23818611	Cisplatin	Linkermann A	Two independent pathways of regulated necrosis mediate ischemia-reperfusion injury.	Proceedings of the National Academy of Sciences of the United States of America	2013	109
24025646	Cisplatin	Oh GS	Pharmacological activation of NQO1 increases NAD⁺ levels and attenuates cisplatin-mediated acute kidney injury in mice.	Kidney international	2014	23
24165223	Cisplatin	Sun XP	Up-regulation of survivin by AKT and hypoxia-inducible factor 1α contributes to cisplatin resistance in gastric cancer.	The FEBS journal	2014	20
24240701	Cisplatin	Shin DH	SIRT1 and AMPK mediate hypoxia-induced resistance of non-small cell lung cancers to cisplatin and doxorubicin.	Cancer research	2014	20
24502656	Cisplatin	Lu L	Combined PD-1 blockade and GITR triggering induce a potent antitumor immunity in murine cancer models and synergizes with chemotherapeutic drugs.	Journal of translational medicine	2014	25
24560445	Cisplatin	Topp MD	Molecular correlates of platinum response in human high-grade serous ovarian cancer patient-derived xenografts.	Molecular oncology	2014	30
24747074	Cisplatin	Chian S	Luteolin inhibits the Nrf2 signaling pathway and tumor growth in vivo.	Biochemical and biophysical research communications	2014	23
25483077	Cisplatin	Yano S	Tumor-targeting Salmonella typhimurium A1-R decoys quiescent cancer cells to cycle as visualized by FUCCI imaging and become sensitive to chemotherapy.	Cell cycle	2014	43
25537512	Cisplatin	Chiu WT	FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells.	Oncotarget	2015	35
25650716	Cisplatin	He J	Downregulation of ATG14 by EGR1-MIR152 sensitizes ovarian cancer cells to cisplatin-induced apoptosis by inhibiting cyto-protective autophagy.	Autophagy	2015	22
25658419	Cisplatin	Xu J	β-Catenin is required for the tumorigenic behavior of triple-negative breast cancer cells.	PloS one	2015	18
25871396	Cisplatin	Ma SR	Anterior gradient protein 2 expression in high grade head and neck squamous cell carcinoma correlated with cancer stem cell and epithelial mesenchymal transition.	Oncotarget	2015	20
25995442	Cisplatin	Liu G	Augmentation of response to chemotherapy by microRNA-506 through regulation of RAD51 in serous ovarian cancers.	Journal of the National Cancer Institute	2015	24
26020117	Cisplatin	Cioffi M	Identification of a distinct population of CD133(+)CXCR4(+) cancer stem cells in ovarian cancer.	Scientific reports	2015	22
26654944	Cisplatin	Choi EJ	FOXP1 functions as an oncogene in promoting cancer stem cell-like characteristics in ovarian cancer cells.	Oncotarget	2016	12
26859293	Cisplatin	Su YC	Galectin-1-Induced Autophagy Facilitates Cisplatin Resistance of Hepatocellular Carcinoma.	PloS one	2016	11
27381626	Cisplatin	Ter Brugge P	Mechanisms of Therapy Resistance in Patient-Derived Xenograft Models of BRCA1-Deficient Breast Cancer.	Journal of the National Cancer Institute	2016	11
28407783	Cisplatin	Zheng P	Exosomal transfer of tumor-associated macrophage-derived miR-21 confers cisplatin resistance in gastric cancer cells.	Journal of experimental & clinical cancer research 	2017	15
16697744	Ceruletide	van Westerloo DJ	The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in mice.	Gastroenterology	2006	95
18242220	Ceruletide	Siveke JT	Notch signaling is required for exocrine regeneration after acute pancreatitis.	Gastroenterology	2008	59
21684285	Ceruletide	Heid I	Early requirement of Rac1 in a mouse model of pancreatic cancer.	Gastroenterology	2011	39
22490516	Ceruletide	Sendler M	Tumour necrosis factor α secretion induces protease activation and acinar cell necrosis in acute experimental pancreatitis in mice.	Gut	2013	27
23041324	Ceruletide	Huang H	Activation of nuclear factor-κB in acinar cells increases the severity of pancreatitis in mice.	Gastroenterology	2013	47
23536075	Ceruletide	Schwartz ES	TRPV1 and TRPA1 antagonists prevent the transition of acute to chronic inflammation and pain in chronic pancreatitis.	The Journal of neuroscience 	2013	42
23598351	Ceruletide	Flandez M	Nr5a2 heterozygosity sensitises to, and cooperates with, inflammation in KRas(G12V)-driven pancreatic tumourigenesis.	Gut	2014	27
24361123	Ceruletide	Kang R	Intracellular Hmgb1 inhibits inflammatory nucleosome release and limits acute pancreatitis in mice.	Gastroenterology	2014	48
24657625	Ceruletide	Hoque R	Lactate reduces liver and pancreatic injury in Toll-like receptor- and inflammasome-mediated inflammation via GPR81-mediated suppression of innate immunity.	Gastroenterology	2014	40
1411543	Cholesterol	Zhang SH	Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E.	Science	1992	457
1423598	Cholesterol	Plump AS	Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells.	Cell	1992	435
7667279	Cholesterol	Smith JD	Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E.	Proceedings of the National Academy of Sciences of the United States of America	1995	132
8182121	Cholesterol	Ishibashi S	Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice.	The Journal of clinical investigation	1994	141
8274470	Cholesterol	Reddick RL	Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression.	Arteriosclerosis and thrombosis 	1994	140
8656070	Cholesterol	Tangirala RK	Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice.	Journal of lipid research	1995	123
8833906	Cholesterol	Shimano H	Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a.	The Journal of clinical investigation	1996	190
9062341	Cholesterol	Shimano H	Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells.	The Journal of clinical investigation	1997	184
9069289	Cholesterol	Suzuki H	A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection.	Nature	1997	217
9218423	Cholesterol	Sullivan PM	Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis.	The Journal of biological chemistry	1997	145
9598845	Cholesterol	Nakashima Y	Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse.	Arteriosclerosis, thrombosis, and vascular biology	1998	161
9734366	Cholesterol	Gu L	Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice.	Molecular cell	1998	281
10079097	Cholesterol	Gosling J	MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B.	The Journal of clinical investigation	1999	117
10359569	Cholesterol	Cyrus T	Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice.	The Journal of clinical investigation	1999	100
10430941	Cholesterol	Trigatti B	Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology.	Proceedings of the National Academy of Sciences of the United States of America	1999	114
10521365	Cholesterol	Huber SA	Interleukin-6 exacerbates early atherosclerosis in mice.	Arteriosclerosis, thrombosis, and vascular biology	1999	106
10639158	Cholesterol	Osuga J	Targeted disruption of hormone-sensitive lipase results in male sterility and adipocyte hypertrophy, but not in obesity.	Proceedings of the National Academy of Sciences of the United States of America	2000	121
10841519	Cholesterol	Daugherty A	Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice.	The Journal of clinical investigation	2000	312
11149950	Cholesterol	Laffitte BA	LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes.	Proceedings of the National Academy of Sciences of the United States of America	2001	139
11283668	Cholesterol	Celletti FL	Vascular endothelial growth factor enhances atherosclerotic plaque progression.	Nature medicine	2001	98
11375415	Cholesterol	Cybulsky MI	A major role for VCAM-1, but not ICAM-1, in early atherosclerosis.	The Journal of clinical investigation	2001	221
11375416	Cholesterol	Werstuck GH	Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways.	The Journal of clinical investigation	2001	156
11739396	Cholesterol	Razani B	Caveolin-1-deficient mice are lean, resistant to diet-induced obesity, and show hypertriglyceridemia with adipocyte abnormalities.	The Journal of biological chemistry	2002	159
11804981	Cholesterol	Navab M	Oral administration of an Apo A-I mimetic Peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol.	Circulation	2002	111
11861414	Cholesterol	Braun A	Loss of SR-BI expression leads to the early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in apolipoprotein E-deficient mice.	Circulation research	2002	106
11950702	Cholesterol	Aiello RJ	Increased atherosclerosis in hyperlipidemic mice with inactivation of ABCA1 in macrophages.	Arteriosclerosis, thrombosis, and vascular biology	2002	92
12032330	Cholesterol	Joseph SB	Synthetic LXR ligand inhibits the development of atherosclerosis in mice.	Proceedings of the National Academy of Sciences of the United States of America	2002	200
12145296	Cholesterol	Podrez EA	A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions.	The Journal of biological chemistry	2002	123
12639996	Cholesterol	Sukhova GK	Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice.	The Journal of clinical investigation	2003	94
12860902	Cholesterol	Rauscher FM	Aging, progenitor cell exhaustion, and atherosclerosis.	Circulation	2003	144
14993123	Cholesterol	Luttun A	Loss of matrix metalloproteinase-9 or matrix metalloproteinase-12 protects apolipoprotein E-deficient mice against atherosclerotic media destruction but differentially affects plaque growth.	Circulation	2004	71
15071184	Cholesterol	Sleat DE	Genetic evidence for nonredundant functional cooperativity between NPC1 and NPC2 in lipid transport.	Proceedings of the National Academy of Sciences of the United States of America	2004	93
15269217	Cholesterol	Wahrle SE	ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE.	The Journal of biological chemistry	2004	114
15269218	Cholesterol	Hirsch-Reinshagen V	Deficiency of ABCA1 impairs apolipoprotein E metabolism in brain.	The Journal of biological chemistry	2004	90
15479645	Cholesterol	Joseph SB	LXR-dependent gene expression is important for macrophage survival and the innate immune response.	Cell	2004	143
15578089	Cholesterol	Li AC	Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma.	The Journal of clinical investigation	2004	130
15809369	Cholesterol	Zhou J	Activation of the unfolded protein response occurs at all stages of atherosclerotic lesion development in apolipoprotein E-deficient mice.	Circulation	2005	96
15831805	Cholesterol	Schrijvers DM	Phagocytosis of apoptotic cells by macrophages is impaired in atherosclerosis.	Arteriosclerosis, thrombosis, and vascular biology	2005	93
16079201	Cholesterol	Malek G	Apolipoprotein E allele-dependent pathogenesis: a model for age-related retinal degeneration.	Proceedings of the National Academy of Sciences of the United States of America	2005	82
16127462	Cholesterol	Vikramadithyan RK	Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice.	The Journal of clinical investigation	2005	68
16207707	Cholesterol	Hirsch-Reinshagen V	The absence of ABCA1 decreases soluble ApoE levels but does not diminish amyloid deposition in two murine models of Alzheimer disease.	The Journal of biological chemistry	2005	77
16251441	Cholesterol	Valenza M	Dysfunction of the cholesterol biosynthetic pathway in Huntington's disease.	The Journal of neuroscience 	2005	72
16537455	Cholesterol	Trogan E	Gene expression changes in foam cells and the role of chemokine receptor CCR7 during atherosclerosis regression in ApoE-deficient mice.	Proceedings of the National Academy of Sciences of the United States of America	2006	129
16581003	Cholesterol	Han S	Macrophage insulin receptor deficiency increases ER stress-induced apoptosis and necrotic core formation in advanced atherosclerotic lesions.	Cell metabolism	2006	99
16801460	Cholesterol	Deguchi JO	Inflammation in atherosclerosis: visualizing matrix metalloproteinase action in macrophages in vivo.	Circulation	2006	99
16801531	Cholesterol	Swirski FK	Monocyte accumulation in mouse atherogenesis is progressive and proportional to extent of disease.	Proceedings of the National Academy of Sciences of the United States of America	2006	105
16936198	Cholesterol	Proctor G	Regulation of renal fatty acid and cholesterol metabolism, inflammation, and fibrosis in Akita and OVE26 mice with type 1 diabetes.	Diabetes	2006	65
17076584	Cholesterol	Mujawar Z	Human immunodeficiency virus impairs reverse cholesterol transport from macrophages.	PLoS biology	2006	117
17478727	Cholesterol	Mehta JL	Deletion of LOX-1 reduces atherogenesis in LDLR knockout mice fed high cholesterol diet.	Circulation research	2007	90
17563384	Cholesterol	Zelcer N	Attenuation of neuroinflammation and Alzheimer's disease pathology by liver x receptors.	Proceedings of the National Academy of Sciences of the United States of America	2007	87
17631520	Cholesterol	Liao G	Cholesterol accumulation is associated with lysosomal dysfunction and autophagic stress in Npc1 -/- mouse brain.	The American journal of pathology	2007	62
17657311	Cholesterol	Wang X	Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo.	The Journal of clinical investigation	2007	157
17657314	Cholesterol	Bradley MN	Ligand activation of LXR beta reverses atherosclerosis and cellular cholesterol overload in mice lacking LXR alpha and apoE.	The Journal of clinical investigation	2007	88
17940007	Cholesterol	DiFiglia M	Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits.	Proceedings of the National Academy of Sciences of the United States of America	2007	129
17992259	Cholesterol	Hanai J	The muscle-specific ubiquitin ligase atrogin-1/MAFbx mediates statin-induced muscle toxicity.	The Journal of clinical investigation	2007	72
17992262	Cholesterol	Yvan-Charvet L	Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice.	The Journal of clinical investigation	2007	153
18006857	Cholesterol	Out R	Combined deletion of macrophage ABCA1 and ABCG1 leads to massive lipid accumulation in tissue macrophages and distinct atherosclerosis at relatively low plasma cholesterol levels.	Arteriosclerosis, thrombosis, and vascular biology	2008	65
18309100	Cholesterol	Ryoo S	Endothelial arginase II: a novel target for the treatment of atherosclerosis.	Circulation research	2008	77
18410513	Cholesterol	Thirumangalakudi L	High cholesterol-induced neuroinflammation and amyloid precursor protein processing correlate with loss of working memory in mice.	Journal of neurochemistry	2008	68
18460335	Cholesterol	Iqbal J	IRE1beta inhibits chylomicron production by selectively degrading MTP mRNA.	Cell metabolism	2008	50
18614014	Cholesterol	Bensinger SJ	LXR signaling couples sterol metabolism to proliferation in the acquired immune response.	Cell	2008	172
18666258	Cholesterol	Zaid A	Proprotein convertase subtilisin/kexin type 9 (PCSK9): hepatocyte-specific low-density lipoprotein receptor degradation and critical role in mouse liver regeneration.	Hepatology	2008	69
18752326	Cholesterol	Ma KL	Inflammatory stress exacerbates lipid accumulation in hepatic cells and fatty livers of apolipoprotein E knockout mice.	Hepatology	2008	59
18997009	Cholesterol	Chiu IM	T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS.	Proceedings of the National Academy of Sciences of the United States of America	2008	109
19046569	Cholesterol	Gareus R	Endothelial cell-specific NF-kappaB inhibition protects mice from atherosclerosis.	Cell metabolism	2008	101
19221221	Cholesterol	McGillicuddy FC	Inflammation impairs reverse cholesterol transport in vivo.	Circulation	2009	118
19265037	Cholesterol	Stoletov K	Vascular lipid accumulation, lipoprotein oxidation, and macrophage lipid uptake in hypercholesterolemic zebrafish.	Circulation research	2009	67
19286630	Cholesterol	Wilhelm AJ	Apolipoprotein A-I and its role in lymphocyte cholesterol homeostasis and autoimmunity.	Arteriosclerosis, thrombosis, and vascular biology	2009	47
19520913	Cholesterol	Zelcer N	LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor.	Science	2009	204
19620499	Cholesterol	Lewis MJ	Immunoglobulin M is required for protection against atherosclerosis in low-density lipoprotein receptor-deficient mice.	Circulation	2009	65
19893012	Cholesterol	Paulson KE	Resident intimal dendritic cells accumulate lipid and contribute to the initiation of atherosclerosis.	Circulation research	2010	75
19897196	Cholesterol	Jun J	Effect of intermittent hypoxia on atherosclerosis in apolipoprotein E-deficient mice.	Atherosclerosis	2010	54
20047575	Cholesterol	Kanfi Y	SIRT6 protects against pathological damage caused by diet-induced obesity.	Aging cell	2010	74
20075422	Cholesterol	Bielicki JK	A new HDL mimetic peptide that stimulates cellular cholesterol efflux with high efficiency greatly reduces atherosclerosis in mice.	Journal of lipid research	2010	40
20088827	Cholesterol	Daugherty A	Angiotensin II infusion promotes ascending aortic aneurysms: attenuation by CCR2 deficiency in apoE-/- mice.	Clinical science	2010	61
20206286	Cholesterol	Ramkumar HL	Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD).	Progress in retinal and eye research	2010	49
20339025	Cholesterol	Xu F	Lack of SIRT1 (Mammalian Sirtuin 1) activity leads to liver steatosis in the SIRT1+/- mice: a role of lipid mobilization and inflammation.	Endocrinology	2010	67
20428172	Cholesterol	Duewell P	NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals.	Nature	2010	625
20484557	Cholesterol	Amar MJ	5A apolipoprotein mimetic peptide promotes cholesterol efflux and reduces atherosclerosis in mice.	The Journal of pharmacology and experimental therapeutics	2010	42
20543107	Cholesterol	McLaren JE	IL-33 reduces macrophage foam cell formation.	Journal of immunology	2010	41
20573727	Cholesterol	Jungheim ES	Diet-induced obesity model: abnormal oocytes and persistent growth abnormalities in the offspring.	Endocrinology	2010	72
20581737	Cholesterol	Ramirez CM	Weekly cyclodextrin administration normalizes cholesterol metabolism in nearly every organ of the Niemann-Pick type C1 mouse and markedly prolongs life.	Pediatric research	2010	52
20620999	Cholesterol	Temel RE	Biliary sterol secretion is not required for macrophage reverse cholesterol transport.	Cell metabolism	2010	43
20631254	Cholesterol	Yamamoto K	Induction of liver steatosis and lipid droplet formation in ATF6alpha-knockout mice burdened with pharmacological endoplasmic reticulum stress.	Molecular biology of the cell	2010	72
20650929	Cholesterol	Zhu X	Macrophage ABCA1 reduces MyD88-dependent Toll-like receptor trafficking to lipid rafts by reduction of lipid raft cholesterol.	Journal of lipid research	2010	84
20651282	Cholesterol	Tsukano H	The endoplasmic reticulum stress-C/EBP homologous protein pathway-mediated apoptosis in macrophages contributes to the instability of atherosclerotic plaques.	Arteriosclerosis, thrombosis, and vascular biology	2010	53
20847045	Cholesterol	Lewis TL	Overexpression of human apolipoprotein A-I preserves cognitive function and attenuates neuroinflammation and cerebral amyloid angiopathy in a mouse model of Alzheimer disease.	The Journal of biological chemistry	2010	46
20935201	Cholesterol	Chen S	IL-17A is proatherogenic in high-fat diet-induced and Chlamydia pneumoniae infection-accelerated atherosclerosis in mice.	Journal of immunology	2010	45
20959533	Cholesterol	Bjursell M	Improved glucose control and reduced body fat mass in free fatty acid receptor 2-deficient mice fed a high-fat diet.	American journal of physiology. Endocrinology and metabolism	2011	59
20978354	Cholesterol	Patrick DM	Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice.	The Journal of clinical investigation	2010	128
21273557	Cholesterol	Roubtsova A	Circulating proprotein convertase subtilisin/kexin 9 (PCSK9) regulates VLDLR protein and triglyceride accumulation in visceral adipose tissue.	Arteriosclerosis, thrombosis, and vascular biology	2011	43
21411092	Cholesterol	Sheehan AL	Role for Nox1 NADPH oxidase in atherosclerosis.	Atherosclerosis	2011	41
21484785	Cholesterol	Freigang S	Nrf2 is essential for cholesterol crystal-induced inflammasome activation and exacerbation of atherosclerosis.	European journal of immunology	2011	58
21505265	Cholesterol	Potteaux S	Suppressed monocyte recruitment drives macrophage removal from atherosclerotic plaques of Apoe-/- mice during disease regression.	The Journal of clinical investigation	2011	100
21646721	Cholesterol	Rayner KJ	Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis.	The Journal of clinical investigation	2011	209
21690377	Cholesterol	Ding JD	Anti-amyloid therapy protects against retinal pigmented epithelium damage and vision loss in a model of age-related macular degeneration.	Proceedings of the National Academy of Sciences of the United States of America	2011	64
21690490	Cholesterol	Maganto-García E	Dynamic changes in regulatory T cells are linked to levels of diet-induced hypercholesterolemia.	Circulation	2011	43
21885853	Cholesterol	Ramirez CM	MicroRNA-758 regulates cholesterol efflux through posttranscriptional repression of ATP-binding cassette transporter A1.	Arteriosclerosis, thrombosis, and vascular biology	2011	62
21968112	Cholesterol	Murphy AJ	ApoE regulates hematopoietic stem cell proliferation, monocytosis, and monocyte accumulation in atherosclerotic lesions in mice.	The Journal of clinical investigation	2011	116
22009537	Cholesterol	Park JK	miR-221 silencing blocks hepatocellular carcinoma and promotes survival.	Cancer research	2011	59
22048958	Cholesterol	Maue RA	A novel mouse model of Niemann-Pick type C disease carrying a D1005G-Npc1 mutation comparable to commonly observed human mutations.	Human molecular genetics	2012	32
22056881	Cholesterol	He XX	MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.	Oncogene	2012	84
22414386	Cholesterol	Lee JS	Pharmacologic ER stress induces non-alcoholic steatohepatitis in an animal model.	Toxicology letters	2012	34
22440612	Cholesterol	Razani B	Autophagy links inflammasomes to atherosclerotic progression.	Cell metabolism	2012	103
22511966	Cholesterol	Bobrowska A	SIRT2 ablation has no effect on tubulin acetylation in brain, cholesterol biosynthesis or the progression of Huntington's disease phenotypes in vivo.	PloS one	2012	35
22768840	Cholesterol	Le Guezennec X	Wip1-dependent regulation of autophagy, obesity, and atherosclerosis.	Cell metabolism	2012	35
22820288	Cholesterol	Hsu SH	Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver.	The Journal of clinical investigation	2012	184
22844426	Cholesterol	Gauffin Cano P	Bacteroides uniformis CECT 7771 ameliorates metabolic and immunological dysfunction in mice with high-fat-diet induced obesity.	PloS one	2012	45
22896587	Cholesterol	Sansbury BE	Overexpression of endothelial nitric oxide synthase prevents diet-induced obesity and regulates adipocyte phenotype.	Circulation research	2012	37
23027612	Cholesterol	Cardilo-Reis L	Interleukin-13 protects from atherosclerosis and modulates plaque composition by skewing the macrophage phenotype.	EMBO molecular medicine	2012	51
23238711	Cholesterol	Wang M	Cognitive deficits and delayed neuronal loss in a mouse model of multiple microinfarcts.	The Journal of neuroscience 	2012	35
23316322	Cholesterol	Horie T	MicroRNA-33 deficiency reduces the progression of atherosclerotic plaque in ApoE-/- mice.	Journal of the American Heart Association	2012	61
23409132	Cholesterol	Dixon LJ	Caspase-1 as a central regulator of high fat diet-induced non-alcoholic steatohepatitis.	PloS one	2013	34
23426179	Cholesterol	Klingenberg R	Depletion of FOXP3+ regulatory T cells promotes hypercholesterolemia and atherosclerosis.	The Journal of clinical investigation	2013	67
23500152	Cholesterol	Van Rooyen DM	Pharmacological cholesterol lowering reverses fibrotic NASH in obese, diabetic mice with metabolic syndrome.	Journal of hepatology	2013	28
23524964	Cholesterol	Martel C	Lymphatic vasculature mediates macrophage reverse cholesterol transport in mice.	The Journal of clinical investigation	2013	57
23555678	Cholesterol	Park DY	Supplementation of Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 in diet-induced obese mice is associated with gut microbial changes and reduction in obesity.	PloS one	2013	43
23562078	Cholesterol	Sene A	Impaired cholesterol efflux in senescent macrophages promotes age-related macular degeneration.	Cell metabolism	2013	56
23584088	Cholesterol	Murphy AJ	Cholesterol efflux in megakaryocyte progenitors suppresses platelet production and thrombocytosis.	Nature medicine	2013	33
23663738	Cholesterol	Nagareddy PR	Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis.	Cell metabolism	2013	71
23702658	Cholesterol	Rotllan N	Therapeutic silencing of microRNA-33 inhibits the progression of atherosclerosis in Ldlr-/- mice--brief report.	Arteriosclerosis, thrombosis, and vascular biology	2013	48
23812589	Cholesterol	Zeng H	mTORC1 couples immune signals and metabolic programming to establish T(reg)-cell function.	Nature	2013	150
23836106	Cholesterol	Giordano A	Obese adipocytes show ultrastructural features of stressed cells and die of pyroptosis.	Journal of lipid research	2013	28
23892605	Cholesterol	Buchovecky CM	A suppressor screen in Mecp2 mutant mice implicates cholesterol metabolism in Rett syndrome.	Nature genetics	2013	49
24290752	Cholesterol	Sarkar S	Impaired autophagy in the lipid-storage disorder Niemann-Pick type C1 disease.	Cell reports	2013	48
24407029	Cholesterol	Hewing B	Effects of native and myeloperoxidase-modified apolipoprotein a-I on reverse cholesterol transport and atherosclerosis in mice.	Arteriosclerosis, thrombosis, and vascular biology	2014	26
24488984	Cholesterol	Hilgendorf I	Innate response activator B cells aggravate atherosclerosis by stimulating T helper-1 adaptive immunity.	Circulation	2014	24
24504735	Cholesterol	Du F	MicroRNA-155 deficiency results in decreased macrophage inflammation and attenuated atherogenesis in apolipoprotein E-deficient mice.	Arteriosclerosis, thrombosis, and vascular biology	2014	31
24550188	Cholesterol	Youn JY	Role of vascular oxidative stress in obesity and metabolic syndrome.	Diabetes	2014	27
24551121	Cholesterol	Renaud HJ	Effect of diet on expression of genes involved in lipid metabolism, oxidative stress, and inflammation in mouse liver-insights into mechanisms of hepatic steatosis.	PloS one	2014	21
24606897	Cholesterol	Yue S	Cholesteryl ester accumulation induced by PTEN loss and PI3K/AKT activation underlies human prostate cancer aggressiveness.	Cell metabolism	2014	91
24795455	Cholesterol	Grailer JJ	Critical role for the NLRP3 inflammasome during acute lung injury.	Journal of immunology	2014	32
24849360	Cholesterol	Liao F	Anti-ApoE antibody given after plaque onset decreases Aβ accumulation and improves brain function in a mouse model of Aβ amyloidosis.	The Journal of neuroscience 	2014	23
25040043	Cholesterol	Csak T	microRNA-122 regulates hypoxia-inducible factor-1 and vimentin in hepatocytes and correlates with fibrosis in diet-induced steatohepatitis.	Liver international 	2015	20
25201911	Cholesterol	Zampetaki A	Role of miR-195 in aortic aneurysmal disease.	Circulation research	2014	24
25274309	Cholesterol	Lukens JR	Dietary modulation of the microbiome affects autoinflammatory disease.	Nature	2014	47
25341796	Cholesterol	Roche-Molina M	Induction of sustained hypercholesterolemia by single adeno-associated virus-mediated gene transfer of mutant hPCSK9.	Arteriosclerosis, thrombosis, and vascular biology	2015	22
25445398	Cholesterol	Idrissova L	TRAIL receptor deletion in mice suppresses the inflammation of nutrient excess.	Journal of hepatology	2015	20
25524771	Cholesterol	Meiler S	MicroRNA 302a is a novel modulator of cholesterol homeostasis and atherosclerosis.	Arteriosclerosis, thrombosis, and vascular biology	2015	19
25573853	Cholesterol	Vengrenyuk Y	Cholesterol loading reprograms the microRNA-143/145-myocardin axis to convert aortic smooth muscle cells to a dysfunctional macrophage-like phenotype.	Arteriosclerosis, thrombosis, and vascular biology	2015	37
25794851	Cholesterol	Lin Z	Fibroblast growth factor 21 prevents atherosclerosis by suppression of hepatic sterol regulatory element-binding protein-2 and induction of adiponectin in mice.	Circulation	2015	24
25985364	Cholesterol	Shankman LS	KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis.	Nature medicine	2015	99
25991857	Cholesterol	Toomey CB	Regulation of age-related macular degeneration-like pathology by complement factor H.	Proceedings of the National Academy of Sciences of the United States of America	2015	19
26077675	Cholesterol	Ganz M	Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.	Journal of translational medicine	2015	17
26501192	Cholesterol	Wagschal A	Genome-wide identification of microRNAs regulating cholesterol and triglyceride homeostasis.	Nature medicine	2015	36
27251289	Cholesterol	Sallam T	Feedback modulation of cholesterol metabolism by the lipid-responsive non-coding RNA LeXis.	Nature	2016	25
27342212	Cholesterol	Rahman K	Loss of Junctional Adhesion Molecule A Promotes Severe Steatohepatitis in Mice on a Diet High in Saturated Fat, Fructose, and Cholesterol.	Gastroenterology	2016	14
27806377	Cholesterol	Wei X	Fatty acid synthesis configures the plasma membrane for inflammation in diabetes.	Nature	2016	15
28188218	Cholesterol	Wang M	Focal Solute Trapping and Global Glymphatic Pathway Impairment in a Murine Model of Multiple Microinfarcts.	The Journal of neuroscience 	2017	11
11163183	Galactosamine	Dumitru CD	TNF-alpha induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway.	Cell	2000	233
16571730	Galactosamine	Wang Y	Tumor necrosis factor-induced toxic liver injury results from JNK2-dependent activation of caspase-8 and the mitochondrial death pathway.	The Journal of biological chemistry	2006	77
19119023	Galactosamine	Kaufmann T	Fatal hepatitis mediated by tumor necrosis factor TNFalpha requires caspase-8 and involves the BH3-only proteins Bid and Bim.	Immunity	2009	51
23519075	Galactosamine	Amir M	Inhibition of hepatocyte autophagy increases tumor necrosis factor-dependent liver injury by promoting caspase-8 activation.	Cell death and differentiation	2013	35
15082532	Diethylnitrosamine	Kalinichenko VV	Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor.	Genes & development	2004	143
15492232	Diethylnitrosamine	Yamamoto Y	The orphan nuclear receptor constitutive active/androstane receptor is essential for liver tumor promotion by phenobarbital in mice.	Cancer research	2004	84
15989949	Diethylnitrosamine	Maeda S	IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis.	Cell	2005	334
16807293	Diethylnitrosamine	Sakurai T	Loss of hepatic NF-kappa B activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation.	Proceedings of the National Academy of Sciences of the United States of America	2006	129
17615358	Diethylnitrosamine	Naugler WE	Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production.	Science	2007	486
20432254	Diethylnitrosamine	Nejak-Bowen KN	Accelerated liver regeneration and hepatocarcinogenesis in mice overexpressing serine-45 mutant beta-catenin.	Hepatology	2010	58
21440549	Diethylnitrosamine	Yang H	A mouse model of cholestasis-associated cholangiocarcinoma and transcription factors involved in progression.	Gastroenterology	2011	36
21465510	Diethylnitrosamine	Park O	In vivo consequences of liver-specific interleukin-22 expression in mice: Implications for human liver disease progression.	Hepatology	2011	65
21575863	Diethylnitrosamine	Bard-Chapeau EA	Ptpn11/Shp2 acts as a tumor suppressor in hepatocellular carcinogenesis.	Cancer cell	2011	87
21674558	Diethylnitrosamine	Jiang R	Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3.	Hepatology	2011	64
21778049	Diethylnitrosamine	Monnier J	CXCR7 is up-regulated in human and murine hepatocellular carcinoma and is specifically expressed by endothelial cells.	European journal of cancer	2012	33
22267597	Diethylnitrosamine	Schneider C	Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer.	Gut	2012	32
22473819	Diethylnitrosamine	Callegari E	Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model.	Hepatology	2012	50
22689379	Diethylnitrosamine	Srivastava J	Astrocyte elevated gene-1 promotes hepatocarcinogenesis: novel insights from a mouse model.	Hepatology	2012	36
22719066	Diethylnitrosamine	Wu J	The proinflammatory myeloid cell receptor TREM-1 controls Kupffer cell activation and development of hepatocellular carcinoma.	Cancer research	2012	44
22898879	Diethylnitrosamine	Wu K	Hepatic transforming growth factor beta gives rise to tumor-initiating cells and promotes liver cancer development.	Hepatology	2012	45
23391818	Diethylnitrosamine	Yang L	Transforming growth factor-β signaling in hepatocytes promotes hepatic fibrosis and carcinogenesis in mice with hepatocyte-specific deletion of TAK1.	Gastroenterology	2013	31
23813475	Diethylnitrosamine	Bertran E	Overactivation of the TGF-β pathway confers a mesenchymal-like phenotype and CXCR4-dependent migratory properties to liver tumor cells.	Hepatology	2013	31
24582836	Diethylnitrosamine	Lau CC	Viral-human chimeric transcript predisposes risk to liver cancer development and progression.	Cancer cell	2014	50
25010260	Diethylnitrosamine	Perra A	YAP activation is an early event and a potential therapeutic target in liver cancer development.	Journal of hepatology	2014	49
26028023	Diethylnitrosamine	Chen CC	The matricellular protein CCN1 suppresses hepatocarcinogenesis by inhibiting compensatory proliferation.	Oncogene	2016	14
11134556	Acetaminophen	Enomoto A	High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of ARE-regulated drug metabolizing enzymes and antioxidant genes.	Toxicological sciences 	2001	171
11245480	Acetaminophen	Jahr S	DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells.	Cancer research	2001	293
11287661	Acetaminophen	Chan K	An important function of Nrf2 in combating oxidative stress: detoxification of acetaminophen.	Proceedings of the National Academy of Sciences of the United States of America	2001	200
12011492	Acetaminophen	Gujral JS	Mode of cell death after acetaminophen overdose in mice: apoptosis or oncotic necrosis?	Toxicological sciences 	2002	102
15924568	Acetaminophen	Miller RA	Methionine-deficient diet extends mouse lifespan, slows immune and lens aging, alters glucose, T4, IGF-I and insulin levels, and increases hepatocyte MIF levels and stress resistance.	Aging cell	2005	181
16081675	Acetaminophen	Cover C	Peroxynitrite-induced mitochondrial and endonuclease-mediated nuclear DNA damage in acetaminophen hepatotoxicity.	The Journal of pharmacology and experimental therapeutics	2005	92
17185352	Acetaminophen	Henderson NC	Critical role of c-jun (NH2) terminal kinase in paracetamol- induced acute liver failure.	Gut	2007	68
17562481	Acetaminophen	Aleksunes LM	Emerging role of Nrf2 in protecting against hepatic and gastrointestinal disease.	Toxicologic pathology	2007	86
17584759	Acetaminophen	McConnachie LA	Glutamate cysteine ligase modifier subunit deficiency and gender as determinants of acetaminophen-induced hepatotoxicity in mice.	Toxicological sciences 	2007	56
17906064	Acetaminophen	Bajt ML	Mitochondrial bax translocation accelerates DNA fragmentation and cell necrosis in a murine model of acetaminophen hepatotoxicity.	The Journal of pharmacology and experimental therapeutics	2008	59
17935745	Acetaminophen	Aleksunes LM	Induction of Mrp3 and Mrp4 transporters during acetaminophen hepatotoxicity is dependent on Nrf2.	Toxicology and applied pharmacology	2008	55
18700144	Acetaminophen	Nakagawa H	Deletion of apoptosis signal-regulating kinase 1 attenuates acetaminophen-induced liver injury by inhibiting c-Jun N-terminal kinase activation.	Gastroenterology	2008	77
18713872	Acetaminophen	Holt MP	Identification and characterization of infiltrating macrophages in acetaminophen-induced liver injury.	Journal of leukocyte biology	2008	91
19164858	Acetaminophen	Imaeda AB	Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome.	The Journal of clinical investigation	2009	188
20234092	Acetaminophen	Si Y	CCR2 mediates hematopoietic stem and progenitor cell trafficking to sites of inflammation in mice.	The Journal of clinical investigation	2010	67
20404090	Acetaminophen	Taguchi K	Genetic analysis of cytoprotective functions supported by graded expression of Keap1.	Molecular and cellular biology	2010	42
20500806	Acetaminophen	Williams CD	Acetaminophen-induced hepatic neutrophil accumulation and inflammatory liver injury in CD18-deficient mice.	Liver international 	2010	43
20637792	Acetaminophen	Williams CD	Role of caspase-1 and interleukin-1beta in acetaminophen-induced hepatic inflammation and liver injury.	Toxicology and applied pharmacology	2010	43
20811657	Acetaminophen	Antoine DJ	Diet restriction inhibits apoptosis and HMGB1 oxidation and promotes inflammatory cell recruitment during acetaminophen hepatotoxicity.	Molecular medicine	2010	44
21784973	Acetaminophen	Xu J	Extracellular histones are mediators of death through TLR2 and TLR4 in mouse fatal liver injury.	Journal of immunology	2011	104
22378043	Acetaminophen	McGill MR	The mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation.	The Journal of clinical investigation	2012	139
22383490	Acetaminophen	Hoque R	P2X7 receptor-mediated purinergic signaling promotes liver injury in acetaminophen hepatotoxicity in mice.	American journal of physiology. Gastrointestinal and liver physiology	2012	34
22491424	Acetaminophen	Ni HM	Liver-specific loss of Atg5 causes persistent activation of Nrf2 and protects against acetaminophen-induced liver injury.	Toxicological sciences 	2012	49
22532075	Acetaminophen	Marques PE	Chemokines and mitochondrial products activate neutrophils to amplify organ injury during mouse acute liver failure.	Hepatology	2012	51
22684891	Acetaminophen	Bala S	Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases.	Hepatology	2012	152
22918968	Acetaminophen	Sharma M	Critical role for mixed-lineage kinase 3 in acetaminophen-induced hepatotoxicity.	Molecular pharmacology	2012	41
22986947	Acetaminophen	Xie Y	Purinergic receptor antagonist A438079 protects against acetaminophen-induced liver injury by inhibiting p450 isoenzymes, not by inflammasome activation.	Toxicological sciences 	2013	27
23665281	Acetaminophen	Uzi D	CHOP is a critical regulator of acetaminophen-induced hepatotoxicity.	Journal of hepatology	2013	28
23744808	Acetaminophen	Ramachandran A	Receptor interacting protein kinase 3 is a critical early mediator of acetaminophen-induced hepatocyte necrosis in mice.	Hepatology	2013	64
24440789	Acetaminophen	Williams CD	Neutrophil activation during acetaminophen hepatotoxicity and repair in mice and humans.	Toxicology and applied pharmacology	2014	40
24700364	Acetaminophen	Rodrigo-Torres D	The biliary epithelium gives rise to liver progenitor cells.	Hepatology	2014	38
24890723	Acetaminophen	Zigmond E	Infiltrating monocyte-derived macrophages and resident kupffer cells display different ontogeny and functions in acute liver injury.	Journal of immunology	2014	51
24915963	Acetaminophen	Tan CY	Mesenchymal stem cell-derived exosomes promote hepatic regeneration in drug-induced liver injury models.	Stem cell research & therapy	2014	65
25562324	Acetaminophen	Huebener P	The HMGB1/RAGE axis triggers neutrophil-mediated injury amplification following necrosis.	The Journal of clinical investigation	2015	55
25752611	Acetaminophen	Williams JA	Chronic Deletion and Acute Knockdown of Parkin Have Differential Responses to Acetaminophen-induced Mitophagy and Liver Injury in Mice.	The Journal of biological chemistry	2015	20
25950489	Acetaminophen	Deutsch M	Divergent effects of RIP1 or RIP3 blockade in murine models of acute liver injury.	Cell death & disease	2015	19
26708719	Acetaminophen	Cubero FJ	Combined Activities of JNK1 and JNK2 in Hepatocytes Protect Against Toxic Liver Injury.	Gastroenterology	2016	13
8550840	Bleomycin	Eitzman DT	Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene.	The Journal of clinical investigation	1996	130
11104787	Bleomycin	Hattori N	Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice.	The Journal of clinical investigation	2000	92
11413161	Bleomycin	Pittet JF	TGF-beta is a critical mediator of acute lung injury.	The Journal of clinical investigation	2001	133
11839555	Bleomycin	Zhao J	Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice.	American journal of physiology. Lung cellular and molecular physiology	2002	116
12759241	Bleomycin	McGuire JK	Matrilysin (matrix metalloproteinase-7) mediates E-cadherin ectodomain shedding in injured lung epithelium.	The American journal of pathology	2003	87
14722616	Bleomycin	Hashimoto N	Bone marrow-derived progenitor cells in pulmonary fibrosis.	The Journal of clinical investigation	2004	235
15205180	Bleomycin	Tager AM	Inhibition of pulmonary fibrosis by the chemokine IP-10/CXCL10.	American journal of respiratory cell and molecular biology	2004	79
15208274	Bleomycin	Cho HY	The transcription factor NRF2 protects against pulmonary fibrosis.	FASEB journal 	2004	97
15286810	Bleomycin	Phillips RJ	Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis.	The Journal of clinical investigation	2004	359
15520863	Bleomycin	Daniels CE	Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis.	The Journal of clinical investigation	2004	161
15618458	Bleomycin	Lawson WE	Characterization of fibroblast-specific protein 1 in pulmonary fibrosis.	American journal of respiratory and critical care medicine	2005	69
15891110	Bleomycin	Rojas M	Bone marrow-derived mesenchymal stem cells in repair of the injured lung.	American journal of respiratory cell and molecular biology	2005	232
16710477	Bleomycin	Jenkins RG	Ligation of protease-activated receptor 1 enhances alpha(v)beta6 integrin-dependent TGF-beta activation and promotes acute lung injury.	The Journal of clinical investigation	2006	107
17463394	Bleomycin	Xu J	Role of the SDF-1/CXCR4 axis in the pathogenesis of lung injury and fibrosis.	American journal of respiratory cell and molecular biology	2007	57
17485510	Bleomycin	Kang HR	Semaphorin 7A plays a critical role in TGF-beta1-induced pulmonary fibrosis.	The Journal of experimental medicine	2007	59
17569781	Bleomycin	Ortiz LA	Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury.	Proceedings of the National Academy of Sciences of the United States of America	2007	272
17785842	Bleomycin	Pilling D	Reduction of bleomycin-induced pulmonary fibrosis by serum amyloid P.	Journal of immunology	2007	73
17916809	Bleomycin	Horan GS	Partial inhibition of integrin alpha(v)beta6 prevents pulmonary fibrosis without exacerbating inflammation.	American journal of respiratory and critical care medicine	2008	98
17992263	Bleomycin	Gasse P	IL-1R1/MyD88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in mice.	The Journal of clinical investigation	2007	129
18165226	Bleomycin	Gao F	Extracellular superoxide dismutase inhibits inflammation by preventing oxidative fragmentation of hyaluronan.	The Journal of biological chemistry	2008	64
18203815	Bleomycin	Tourkina E	Antifibrotic properties of caveolin-1 scaffolding domain in vitro and in vivo.	American journal of physiology. Lung cellular and molecular physiology	2008	61
19073610	Bleomycin	Kliment CR	Oxidative stress alters syndecan-1 distribution in lungs with pulmonary fibrosis.	The Journal of biological chemistry	2009	53
19104148	Bleomycin	Kim KK	Epithelial cell alpha3beta1 integrin links beta-catenin and Smad signaling to promote myofibroblast formation and pulmonary fibrosis.	The Journal of clinical investigation	2009	158
19433312	Bleomycin	Mehrad B	Fibrocyte CXCR4 regulation as a therapeutic target in pulmonary fibrosis.	The international journal of biochemistry & cell biology	2009	63
19497992	Bleomycin	Moodley Y	Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury.	The American journal of pathology	2009	85
19565505	Bleomycin	Ponticos M	Pivotal role of connective tissue growth factor in lung fibrosis: MAPK-dependent transcriptional activation of type I collagen.	Arthritis and rheumatism	2009	61
19652365	Bleomycin	Scotton CJ	Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injury.	The Journal of clinical investigation	2009	84
19767450	Bleomycin	Hashimoto N	Endothelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis.	American journal of respiratory cell and molecular biology	2010	93
19884654	Bleomycin	Atabai K	Mfge8 diminishes the severity of tissue fibrosis in mice by binding and targeting collagen for uptake by macrophages.	The Journal of clinical investigation	2009	62
19933277	Bleomycin	Flozak AS	Beta-catenin/T-cell factor signaling is activated during lung injury and promotes the survival and migration of alveolar epithelial cells.	The Journal of biological chemistry	2010	41
20300636	Bleomycin	Murray LA	Serum amyloid P therapeutically attenuates murine bleomycin-induced pulmonary fibrosis via its effects on macrophages.	PloS one	2010	62
20484822	Bleomycin	Jiang D	Inhibition of pulmonary fibrosis in mice by CXCL10 requires glycosaminoglycan binding and syndecan-4.	The Journal of clinical investigation	2010	52
20498020	Bleomycin	Sonnenberg GF	Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A.	The Journal of experimental medicine	2010	108
20562227	Bleomycin	Degryse AL	Repetitive intratracheal bleomycin models several features of idiopathic pulmonary fibrosis.	American journal of physiology. Lung cellular and molecular physiology	2010	65
20643828	Bleomycin	Liu G	miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis.	The Journal of experimental medicine	2010	250
20733059	Bleomycin	Liu F	Feedback amplification of fibrosis through matrix stiffening and COX-2 suppression.	The Journal of cell biology	2010	171
20936632	Bleomycin	Liu S	CCN2 is required for bleomycin-induced skin fibrosis in mice.	Arthritis and rheumatism	2011	44
21044893	Bleomycin	Murray LA	TGF-beta driven lung fibrosis is macrophage dependent and blocked by Serum amyloid P.	The international journal of biochemistry & cell biology	2011	88
21135509	Bleomycin	Li M	Epithelium-specific deletion of TGF-β receptor type II protects mice from bleomycin-induced pulmonary fibrosis.	The Journal of clinical investigation	2011	65
21149612	Bleomycin	Zhou Y	Distinct roles for the A2B adenosine receptor in acute and chronic stages of bleomycin-induced lung injury.	Journal of immunology	2011	44
21169555	Bleomycin	Zhong Q	Role of endoplasmic reticulum stress in epithelial-mesenchymal transition of alveolar epithelial cells: effects of misfolded surfactant protein.	American journal of respiratory cell and molecular biology	2011	44
21370225	Bleomycin	Wei J	Canonical Wnt signaling induces skin fibrosis and subcutaneous lipoatrophy: a novel mouse model for scleroderma?	Arthritis and rheumatism	2011	45
21391892	Bleomycin	Carnesecchi S	A key role for NOX4 in epithelial cell death during development of lung fibrosis.	Antioxidants & redox signaling	2011	79
21670280	Bleomycin	Lawson WE	Endoplasmic reticulum stress enhances fibrotic remodeling in the lungs.	Proceedings of the National Academy of Sciences of the United States of America	2011	97
21680953	Bleomycin	Gibbons MA	Ly6Chi monocytes direct alternatively activated profibrotic macrophage regulation of lung fibrosis.	American journal of respiratory and critical care medicine	2011	107
21701069	Bleomycin	Chapman HA	Integrin α6β4 identifies an adult distal lung epithelial population with regenerative potential in mice.	The Journal of clinical investigation	2011	124
21708929	Bleomycin	Li Y	Severe lung fibrosis requires an invasive fibroblast phenotype regulated by hyaluronan and CD44.	The Journal of experimental medicine	2011	97
21858022	Bleomycin	Gasse P	IL-1 and IL-23 mediate early IL-17A production in pulmonary inflammation leading to late fibrosis.	PloS one	2011	42
21871427	Bleomycin	Yamashita CM	Matrix metalloproteinase 3 is a mediator of pulmonary fibrosis.	The American journal of pathology	2011	37
21990376	Bleomycin	Schneider DJ	Cadherin-11 contributes to pulmonary fibrosis: potential role in TGF-β production and epithelial to mesenchymal transition.	FASEB journal 	2012	40
22095546	Bleomycin	Mackinnon AC	Regulation of transforming growth factor-β1-driven lung fibrosis by galectin-3.	American journal of respiratory and critical care medicine	2012	52
22123957	Bleomycin	Rock JR	Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition.	Proceedings of the National Academy of Sciences of the United States of America	2011	234
22173045	Bleomycin	Sueblinvong V	Predisposition for disrepair in the aged lung.	The American journal of the medical sciences	2012	31
22287606	Bleomycin	Tanjore H	Emerging evidence for endoplasmic reticulum stress in the pathogenesis of idiopathic pulmonary fibrosis.	American journal of physiology. Lung cellular and molecular physiology	2012	54
22815997	Bleomycin	Patel AS	Autophagy in idiopathic pulmonary fibrosis.	PloS one	2012	74
23141927	Bleomycin	Bhattacharyya S	Toll-like receptor 4 signaling augments transforming growth factor-β responses: a novel mechanism for maintaining and amplifying fibrosis in scleroderma.	The American journal of pathology	2013	41
23371063	Bleomycin	Liu L	Hedgehog signaling in neonatal and adult lung.	American journal of respiratory cell and molecular biology	2013	27
23457217	Bleomycin	Yang S	miR-145 regulates myofibroblast differentiation and lung fibrosis.	FASEB journal 	2013	38
23459460	Bleomycin	Lino Cardenas CL	miR-199a-5p Is upregulated during fibrogenic response to tissue injury and mediates TGFbeta-induced lung fibroblast activation by targeting caveolin-1.	PLoS genetics	2013	62
23526221	Bleomycin	Aumiller V	WNT/β-catenin signaling induces IL-1β expression by alveolar epithelial cells in pulmonary fibrosis.	American journal of respiratory cell and molecular biology	2013	32
23759512	Bleomycin	Tang X	Assessment of Brd4 inhibition in idiopathic pulmonary fibrosis lung fibroblasts and in vivo models of lung fibrosis.	The American journal of pathology	2013	31
23924232	Bleomycin	Hung C	Role of lung pericytes and resident fibroblasts in the pathogenesis of pulmonary fibrosis.	American journal of respiratory and critical care medicine	2013	68
24070541	Bleomycin	O'Dwyer DN	The Toll-like receptor 3 L412F polymorphism and disease progression in idiopathic pulmonary fibrosis.	American journal of respiratory and critical care medicine	2013	37
24172847	Bleomycin	Suwara MI	IL-1α released from damaged epithelial cells is sufficient and essential to trigger inflammatory responses in human lung fibroblasts.	Mucosal immunology	2014	31
24279830	Bleomycin	Das S	MicroRNA-326 regulates profibrotic functions of transforming growth factor-β in pulmonary fibrosis.	American journal of respiratory cell and molecular biology	2014	36
24325577	Bleomycin	Redente EF	Tumor necrosis factor-α accelerates the resolution of established pulmonary fibrosis in mice by targeting profibrotic lung macrophages.	American journal of respiratory cell and molecular biology	2014	29
24613345	Bleomycin	Zucker SN	Nrf2 amplifies oxidative stress via induction of Klf9.	Molecular cell	2014	35
24920662	Bleomycin	Zhou Y	Chitinase 3-like 1 suppresses injury and promotes fibroproliferative responses in Mammalian lung fibrosis.	Science translational medicine	2014	29
24985397	Bleomycin	Li D	IL-33 promotes ST2-dependent lung fibrosis by the induction of alternatively activated macrophages and innate lymphoid cells in mice.	The Journal of allergy and clinical immunology	2014	55
25180292	Bleomycin	Zerr P	Sirt1 regulates canonical TGF-β signalling to control fibroblast activation and tissue fibrosis.	Annals of the rheumatic diseases	2016	20
25318478	Bleomycin	Karmouty-Quintana H	Deletion of ADORA2B from myeloid cells dampens lung fibrosis and pulmonary hypertension.	FASEB journal 	2015	18
25385603	Bleomycin	Lee RH	TSG-6 as a biomarker to predict efficacy of human mesenchymal stem/progenitor cells (hMSCs) in modulating sterile inflammation in vivo.	Proceedings of the National Academy of Sciences of the United States of America	2014	39
25504959	Bleomycin	Marangoni RG	Myofibroblasts in murine cutaneous fibrosis originate from adiponectin-positive intradermal progenitors.	Arthritis & rheumatology	2015	34
25533958	Bleomycin	Vaughan AE	Lineage-negative progenitors mobilize to regenerate lung epithelium after major injury.	Nature	2015	88
25584011	Bleomycin	Dong Y	Blocking follistatin-like 1 attenuates bleomycin-induced pulmonary fibrosis in mice.	The Journal of experimental medicine	2015	25
25762200	Bleomycin	dos Santos G	Vimentin regulates activation of the NLRP3 inflammasome.	Nature communications	2015	28
25785991	Bleomycin	Patel AS	Epithelial cell mitochondrial dysfunction and PINK1 are induced by transforming growth factor-beta1 in pulmonary fibrosis.	PloS one	2015	27
25986930	Bleomycin	Lan YW	Hypoxia-preconditioned mesenchymal stem cells attenuate bleomycin-induced pulmonary fibrosis.	Stem cell research & therapy	2015	22
25995225	Bleomycin	Reed NI	The αvβ1 integrin plays a critical in vivo role in tissue fibrosis.	Science translational medicine	2015	37
26059457	Bleomycin	Sosulski ML	Deregulation of selective autophagy during aging and pulmonary fibrosis: the role of TGFβ1.	Aging cell	2015	24
26370615	Bleomycin	Ji X	The Anti-fibrotic Effects and Mechanisms of MicroRNA-486-5p in Pulmonary Fibrosis.	Scientific reports	2015	19
26436920	Bleomycin	Su S	miR-142-5p and miR-130a-3p are regulated by IL-4 and IL-13 and control profibrogenic macrophage program.	Nature communications	2015	22
26763945	Bleomycin	Zhao XK	Focal Adhesion Kinase Regulates Fibroblast Migration via Integrin beta-1 and Plays a Central Role in Fibrosis.	Scientific reports	2016	12
26779814	Bleomycin	Cao Z	Targeting of the pulmonary capillary vascular niche promotes lung alveolar repair and ameliorates fibrosis.	Nature medicine	2016	29
26849959	Bleomycin	Spanjer AI	TGF-β-induced profibrotic signaling is regulated in part by the WNT receptor Frizzled-8.	FASEB journal 	2016	13
27668462	Bleomycin	Sennello JA	Lrp5/β-Catenin Signaling Controls Lung Macrophage Differentiation and Inhibits Resolution of Fibrosis.	American journal of respiratory cell and molecular biology	2017	6
28002407	Bleomycin	Satoh T	Identification of an atypical monocyte and committed progenitor involved in fibrosis.	Nature	2017	13
28062404	Bleomycin	Manetti M	Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis.	Annals of the rheumatic diseases	2017	6
18560594	irinotecan	Dylla SJ	Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy.	PloS one	2008	174
19470791	irinotecan	Piazza GA	A novel sulindac derivative that does not inhibit cyclooxygenases but potently inhibits colon tumor cell growth and induces apoptosis with antitumor activity.	Cancer prevention research	2009	45
20167811	irinotecan	de Groot JF	Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice.	Neuro-oncology	2010	166
20720216	irinotecan	Lam W	The four-herb Chinese medicine PHY906 reduces chemotherapy-induced gastrointestinal toxicity.	Science translational medicine	2010	71
21051639	irinotecan	Wallace BD	Alleviating cancer drug toxicity by inhibiting a bacterial enzyme.	Science	2010	122
23081779	irinotecan	Kobayashi S	LGR5-positive colon cancer stem cells interconvert with drug-resistant LGR5-negative cells and are capable of tumor reconstitution.	Stem cells	2012	38
15187022	Tamoxifen	Göthert JR	Genetically tagging endothelial cells in vivo: bone marrow-derived cells do not contribute to tumor endothelium.	Blood	2004	86
15662031	Tamoxifen	Kostetskii I	Induced deletion of the N-cadherin gene in the heart leads to dissolution of the intercalated disc structure.	Circulation research	2005	101
17803905	Tamoxifen	Nakamura T	Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts.	Cell	2007	225
17932118	Tamoxifen	Lantinga-van Leeuwen IS	Kidney-specific inactivation of the Pkd1 gene induces rapid cyst formation in developing kidneys and a slow onset of disease in adult mice.	Human molecular genetics	2007	63
18263895	Tamoxifen	Patel V	Acute kidney injury and aberrant planar cell polarity induce cyst formation in mice lacking renal cilia.	Human molecular genetics	2008	128
18635825	Tamoxifen	Raake PW	G protein-coupled receptor kinase 2 ablation in cardiac myocytes before or after myocardial infarction prevents heart failure.	Circulation research	2008	82
18684091	Tamoxifen	Kamiya N	Disruption of BMP signaling in osteoblasts through type IA receptor (BMPRIA) increases bone mass.	Journal of bone and mineral research 	2008	52
18809798	Tamoxifen	da Costa Martins PA	Conditional dicer gene deletion in the postnatal myocardium provokes spontaneous cardiac remodeling.	Circulation	2008	94
19324043	Tamoxifen	Snippert HJ	Prominin-1/CD133 marks stem cells and early progenitors in mouse small intestine.	Gastroenterology	2009	79
20578055	Tamoxifen	Li L	Focal cerebral ischemia induces a multilineage cytogenic response from adult subventricular zone that is predominantly gliogenic.	Glia	2010	45
20708594	Tamoxifen	Maes C	Osteoblast precursors, but not mature osteoblasts, move into developing and fractured bones along with invading blood vessels.	Developmental cell	2010	230
21368034	Tamoxifen	Fricker FR	Axonally derived neuregulin-1 is required for remyelination and regeneration after nerve injury in adulthood.	The Journal of neuroscience 	2011	42
21521783	Tamoxifen	Nguyen AT	DOT1L, the H3K79 methyltransferase, is required for MLL-AF9-mediated leukemogenesis.	Blood	2011	66
21526127	Tamoxifen	Albinsson S	Smooth muscle miRNAs are critical for post-natal regulation of blood pressure and vascular function.	PloS one	2011	44
21828094	Tamoxifen	McCarthy JJ	Effective fiber hypertrophy in satellite cell-depleted skeletal muscle.	Development	2011	151
22232212	Tamoxifen	Lapinski PE	RASA1 maintains the lymphatic vasculature in a quiescent functional state in mice.	The Journal of clinical investigation	2012	32
22685115	Tamoxifen	Dong F	Myocardial CXCR4 expression is required for mesenchymal stem cell mediated repair following acute myocardial infarction.	Circulation	2012	43
22996665	Tamoxifen	Lim KC	Conditional Gata2 inactivation results in HSC loss and lymphatic mispatterning.	The Journal of clinical investigation	2012	51
23143302	Tamoxifen	Nishio M	Cancer susceptibility and embryonic lethality in Mob1a/1b double-mutant mice.	The Journal of clinical investigation	2012	37
23298463	Tamoxifen	Wang M	MMP13 is a critical target gene during the progression of osteoarthritis.	Arthritis research & therapy	2013	46
23319657	Tamoxifen	Hosaka Y	Notch signaling in chondrocytes modulates endochondral ossification and osteoarthritis development.	Proceedings of the National Academy of Sciences of the United States of America	2013	32
23321074	Tamoxifen	Lee KY	Lessons on conditional gene targeting in mouse adipose tissue.	Diabetes	2013	102
23589310	Tamoxifen	Khurana SS	The hyaluronic acid receptor CD44 coordinates normal and metaplastic gastric epithelial progenitor cell proliferation.	The Journal of biological chemistry	2013	32
23615612	Tamoxifen	Benner EJ	Protective astrogenesis from the SVZ niche after injury is controlled by Notch modulator Thbs4.	Nature	2013	76
24360280	Tamoxifen	Parkhurst CN	Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor.	Cell	2013	268
24376025	Tamoxifen	Fry CS	Regulation of the muscle fiber microenvironment by activated satellite cells during hypertrophy.	FASEB journal 	2014	54
24520391	Tamoxifen	Choi EJ	Novel brain arteriovenous malformation mouse models for type 1 hereditary hemorrhagic telangiectasia.	PloS one	2014	25
24591619	Tamoxifen	Liu N	Requirement of MEF2A, C, and D for skeletal muscle regeneration.	Proceedings of the National Academy of Sciences of the United States of America	2014	37
24746818	Tamoxifen	Luo X	Isolation and molecular characterization of circulating melanoma cells.	Cell reports	2014	32
24805242	Tamoxifen	van Berlo JH	c-kit+ cells minimally contribute cardiomyocytes to the heart.	Nature	2014	180
25043421	Tamoxifen	Ohata S	Loss of Dishevelleds disrupts planar polarity in ependymal motile cilia and results in hydrocephalus.	Neuron	2014	25
25070003	Tamoxifen	Feil S	Transdifferentiation of vascular smooth muscle cells to macrophage-like cells during atherogenesis.	Circulation research	2014	68
25480918	Tamoxifen	López-Arribillaga E	Bmi1 regulates murine intestinal stem cell proliferation and self-renewal downstream of Notch.	Development	2015	19
25580734	Tamoxifen	Zhou W	Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth.	Nature cell biology	2015	88
26204899	Tamoxifen	Maarouf OH	Paracrine Wnt1 Drives Interstitial Fibrosis without Inflammation by Tubulointerstitial Cross-Talk.	Journal of the American Society of Nephrology 	2016	17
26523970	Tamoxifen	Miner JJ	The TAM receptor Mertk protects against neuroinvasive viral infection by maintaining blood-brain barrier integrity.	Nature medicine	2015	29
26538583	Tamoxifen	Tran KA	Endothelial β-Catenin Signaling Is Required for Maintaining Adult Blood-Brain Barrier Integrity and Central Nervous System Homeostasis.	Circulation	2016	11
26592447	Tamoxifen	Bailey JM	p53 mutations cooperate with oncogenic Kras to promote adenocarcinoma from pancreatic ductal cells.	Oncogene	2016	13
26619118	Tamoxifen	Storck SE	Endothelial LRP1 transports amyloid-β(1-42) across the blood-brain barrier.	The Journal of clinical investigation	2016	33
27049947	Tamoxifen	Fourgeaud L	TAM receptors regulate multiple features of microglial physiology.	Nature	2016	34
27140435	Tamoxifen	Kaur H	Targeted Ablation of Periostin-Expressing Activated Fibroblasts Prevents Adverse Cardiac Remodeling in Mice.	Circulation research	2016	24
27977766	Tamoxifen	Liu H	Knockdown of Long Non-Coding RNA UCA1 Increases the Tamoxifen Sensitivity of Breast Cancer Cells through Inhibition of Wnt/β-Catenin Pathway.	PloS one	2016	12
8917564	Nitric Oxide	Shesely EG	Elevated blood pressures in mice lacking endothelial nitric oxide synthase.	Proceedings of the National Academy of Sciences of the United States of America	1996	226
9104813	Nitric Oxide	Scharton-Kersten TM	Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondii.	The Journal of experimental medicine	1997	138
9364062	Nitric Oxide	Iadecola C	Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene.	The Journal of neuroscience 	1997	117
9784517	Nitric Oxide	Kullberg MC	Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12- and gamma interferon-dependent mechanism.	Infection and immunity	1998	137
9989990	Nitric Oxide	Murray HW	Macrophage microbicidal mechanisms in vivo: reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani.	The Journal of experimental medicine	1999	111
10092807	Nitric Oxide	Bean AG	Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin.	Journal of immunology	1999	178
10430608	Nitric Oxide	Frantz S	Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium.	The Journal of clinical investigation	1999	114
10562301	Nitric Oxide	Gracie JA	A proinflammatory role for IL-18 in rheumatoid arthritis.	The Journal of clinical investigation	1999	106
10934223	Nitric Oxide	Scanga CA	Depletion of CD4(+) T cells causes reactivation of murine persistent tuberculosis despite continued expression of interferon gamma and nitric oxide synthase 2.	The Journal of experimental medicine	2000	101
10952959	Nitric Oxide	Lee RJ	VEGF gene delivery to myocardium: deleterious effects of unregulated expression.	Circulation	2000	135
11157048	Nitric Oxide	Mogues T	The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice.	The Journal of experimental medicine	2001	177
11179363	Nitric Oxide	Mohan VP	Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: possible role for limiting pathology.	Infection and immunity	2001	105
11468208	Nitric Oxide	Kuhlencordt PJ	Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice.	Circulation	2001	130
11498544	Nitric Oxide	Drab M	Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice.	Science	2001	434
11714822	Nitric Oxide	Hesse M	Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism.	Journal of immunology	2001	206
12388077	Nitric Oxide	Cohen AW	Caveolin-1 null mice develop cardiac hypertrophy with hyperactivation of p42/44 MAP kinase in cardiac fibroblasts.	American journal of physiology. Cell physiology	2003	78
12506197	Nitric Oxide	Shi L	Expression of Th1-mediated immunity in mouse lungs induces a Mycobacterium tuberculosis transcription pattern characteristic of nonreplicating persistence.	Proceedings of the National Academy of Sciences of the United States of America	2003	109
12524534	Nitric Oxide	Joseph SB	Reciprocal regulation of inflammation and lipid metabolism by liver X receptors.	Nature medicine	2003	292
12850572	Nitric Oxide	Mizuno T	Production and neuroprotective functions of fractalkine in the central nervous system.	Brain research	2003	82
12892711	Nitric Oxide	Gratton JP	Selective inhibition of tumor microvascular permeability by cavtratin blocks tumor progression in mice.	Cancer cell	2003	77
15668244	Nitric Oxide	Das A	Phosphodiesterase-5 inhibitor sildenafil preconditions adult cardiac myocytes against necrosis and apoptosis. Essential role of nitric oxide signaling.	The Journal of biological chemistry	2005	80
16007254	Nitric Oxide	Peyssonnaux C	HIF-1alpha expression regulates the bactericidal capacity of phagocytes.	The Journal of clinical investigation	2005	194
16043715	Nitric Oxide	Yu J	Endothelial nitric oxide synthase is critical for ischemic remodeling, mural cell recruitment, and blood flow reserve.	Proceedings of the National Academy of Sciences of the United States of America	2005	112
16150726	Nitric Oxide	Isenberg JS	Thrombospondin-1 inhibits endothelial cell responses to nitric oxide in a cGMP-dependent manner.	Proceedings of the National Academy of Sciences of the United States of America	2005	94
16207887	Nitric Oxide	Cunningham C	Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration.	The Journal of neuroscience 	2005	189
16327800	Nitric Oxide	Yamamoto K	Impaired flow-dependent control of vascular tone and remodeling in P2X4-deficient mice.	Nature medicine	2006	79
16835222	Nitric Oxide	Isenberg JS	CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1.	The Journal of biological chemistry	2006	105
17082319	Nitric Oxide	Isenberg JS	Thrombospondin-1 limits ischemic tissue survival by inhibiting nitric oxide-mediated vascular smooth muscle relaxation.	Blood	2007	61
17098866	Nitric Oxide	Khan AA	Neuroglobin-overexpressing transgenic mice are resistant to cerebral and myocardial ischemia.	Proceedings of the National Academy of Sciences of the United States of America	2006	68
17101732	Nitric Oxide	Serafini P	Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function.	The Journal of experimental medicine	2006	198
17158223	Nitric Oxide	Hsu LL	Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailability.	Blood	2007	94
17209139	Nitric Oxide	Balasubramaniam V	Hyperoxia reduces bone marrow, circulating, and lung endothelial progenitor cells in the developing lung: implications for the pathogenesis of bronchopulmonary dysplasia.	American journal of physiology. Lung cellular and molecular physiology	2007	73
17339326	Nitric Oxide	Hamik A	Kruppel-like factor 4 regulates endothelial inflammation.	The Journal of biological chemistry	2007	129
17339545	Nitric Oxide	Tao L	Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress.	Circulation	2007	104
17355971	Nitric Oxide	Kim D	A critical role of toll-like receptor 2 in nerve injury-induced spinal cord glial cell activation and pain hypersensitivity.	The Journal of biological chemistry	2007	84
17372179	Nitric Oxide	Caso JR	Toll-like receptor 4 is involved in brain damage and inflammation after experimental stroke.	Circulation	2007	171
17452643	Nitric Oxide	Friebe A	Fatal gastrointestinal obstruction and hypertension in mice lacking nitric oxide-sensitive guanylyl cyclase.	Proceedings of the National Academy of Sciences of the United States of America	2007	66
17583794	Nitric Oxide	Zheng L	Critical role of inducible nitric oxide synthase in degeneration of retinal capillaries in mice with streptozotocin-induced diabetes.	Diabetologia	2007	85
17890448	Nitric Oxide	Isenberg JS	Thrombospondin-1 stimulates platelet aggregation by blocking the antithrombotic activity of nitric oxide/cGMP signaling.	Blood	2008	71
17893196	Nitric Oxide	Murata T	Reexpression of caveolin-1 in endothelium rescues the vascular, cardiac, and pulmonary defects in global caveolin-1 knockout mice.	The Journal of experimental medicine	2007	93
17913905	Nitric Oxide	Ponomarev ED	CNS-derived interleukin-4 is essential for the regulation of autoimmune inflammation and induces a state of alternative activation in microglial cells.	The Journal of neuroscience 	2007	123
17982277	Nitric Oxide	Walter S	Role of the toll-like receptor 4 in neuroinflammation in Alzheimer's disease.	Cellular physiology and biochemistry 	2007	103
18223185	Nitric Oxide	Salloum FN	Sildenafil (Viagra) attenuates ischemic cardiomyopathy and improves left ventricular function in mice.	American journal of physiology. Heart and circulatory physiology	2008	65
18283546	Nitric Oxide	ten Dijke P	Endoglin in angiogenesis and vascular diseases.	Angiogenesis	2008	82
18316027	Nitric Oxide	Halabi CM	Interference with PPAR gamma function in smooth muscle causes vascular dysfunction and hypertension.	Cell metabolism	2008	74
18322079	Nitric Oxide	Lehnardt S	A vicious cycle involving release of heat shock protein 60 from injured cells and activation of toll-like receptor 4 mediates neurodegeneration in the CNS.	The Journal of neuroscience 	2008	84
18632562	Nitric Oxide	Hendgen-Cotta UB	Nitrite reductase activity of myoglobin regulates respiration and cellular viability in myocardial ischemia-reperfusion injury.	Proceedings of the National Academy of Sciences of the United States of America	2008	100
18650345	Nitric Oxide	Gao HM	Neuroinflammation and oxidation/nitration of alpha-synuclein linked to dopaminergic neurodegeneration.	The Journal of neuroscience 	2008	112
18663129	Nitric Oxide	Takahashi N	IL-17 produced by Paneth cells drives TNF-induced shock.	The Journal of experimental medicine	2008	55
18674538	Nitric Oxide	Haile LA	Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway.	Gastroenterology	2008	93
18752470	Nitric Oxide	Mantena SK	High fat diet induces dysregulation of hepatic oxygen gradients and mitochondrial function in vivo.	The Biochemical journal	2009	64
18953332	Nitric Oxide	Kobayashi YM	Sarcolemma-localized nNOS is required to maintain activity after mild exercise.	Nature	2008	114
18972444	Nitric Oxide	Wang YD	Farnesoid X receptor antagonizes nuclear factor kappaB in hepatic inflammatory response.	Hepatology	2008	102
19004835	Nitric Oxide	Isenberg JS	Differential interactions of thrombospondin-1, -2, and -4 with CD47 and effects on cGMP signaling and ischemic injury responses.	The Journal of biological chemistry	2009	52
19047631	Nitric Oxide	Colussi C	HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment.	Proceedings of the National Academy of Sciences of the United States of America	2008	80
19103767	Nitric Oxide	Converse PJ	Role of the dosR-dosS two-component regulatory system in Mycobacterium tuberculosis virulence in three animal models.	Infection and immunity	2009	59
19164562	Nitric Oxide	Erdman SE	Nitric oxide and TNF-alpha trigger colonic inflammation and carcinogenesis in Helicobacter hepaticus-infected, Rag2-deficient mice.	Proceedings of the National Academy of Sciences of the United States of America	2009	75
19268668	Nitric Oxide	Yuan M	Sex differences in the response to activation of the poly (ADP-ribose) polymerase pathway after experimental stroke.	Experimental neurology	2009	58
19401296	Nitric Oxide	Li H	Matrix metalloproteinase-9 inhibition ameliorates pathogenesis and improves skeletal muscle regeneration in muscular dystrophy.	Human molecular genetics	2009	50
19440194	Nitric Oxide	Adamo L	Biomechanical forces promote embryonic haematopoiesis.	Nature	2009	135
19583953	Nitric Oxide	Fernández-Hernando C	Genetic evidence supporting a critical role of endothelial caveolin-1 during the progression of atherosclerosis.	Cell metabolism	2009	47
19837950	Nitric Oxide	Judkins CP	Direct evidence of a role for Nox2 in superoxide production, reduced nitric oxide bioavailability, and early atherosclerotic plaque formation in ApoE-/- mice.	American journal of physiology. Heart and circulatory physiology	2010	94
20144787	Nitric Oxide	Charles N	Perivascular nitric oxide activates notch signaling and promotes stem-like character in PDGF-induced glioma cells.	Cell stem cell	2010	140
20147609	Nitric Oxide	Crowley SD	Lymphocyte responses exacerbate angiotensin II-dependent hypertension.	American journal of physiology. Regulatory, integrative and comparative physiology	2010	69
20422004	Nitric Oxide	Oshikawa J	Extracellular SOD-derived H2O2 promotes VEGF signaling in caveolae/lipid rafts and post-ischemic angiogenesis in mice.	PloS one	2010	61
20489165	Nitric Oxide	Santhanam L	Decreased S-nitrosylation of tissue transglutaminase contributes to age-related increases in vascular stiffness.	Circulation research	2010	41
20689059	Nitric Oxide	Feinman R	HIF-1 mediates pathogenic inflammatory responses to intestinal ischemia-reperfusion injury.	American journal of physiology. Gastrointestinal and liver physiology	2010	43
20804550	Nitric Oxide	Veltman JD	COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function.	BMC cancer	2010	56
20814022	Nitric Oxide	Brinks H	Level of G protein-coupled receptor kinase-2 determines myocardial ischemia/reperfusion injury via pro- and anti-apoptotic mechanisms.	Circulation research	2010	51
21127294	Nitric Oxide	Austin SA	Endothelial nitric oxide modulates expression and processing of amyloid precursor protein.	Circulation research	2010	48
21256055	Nitric Oxide	Nairz M	Erythropoietin contrastingly affects bacterial infection and experimental colitis by inhibiting nuclear factor-κB-inducible immune pathways.	Immunity	2011	54
21383052	Nitric Oxide	Arora S	Effect of cytokine interplay on macrophage polarization during chronic pulmonary infection with Cryptococcus neoformans.	Infection and immunity	2011	53
21393577	Nitric Oxide	Egorova AD	Lack of primary cilia primes shear-induced endothelial-to-mesenchymal transition.	Circulation research	2011	48
21422926	Nitric Oxide	Alpers CE	Mouse models of diabetic nephropathy.	Current opinion in nephrology and hypertension	2011	38
21474820	Nitric Oxide	Madhur MS	Role of interleukin 17 in inflammation, atherosclerosis, and vascular function in apolipoprotein e-deficient mice.	Arteriosclerosis, thrombosis, and vascular biology	2011	60
21617137	Nitric Oxide	Faber JE	Aging causes collateral rarefaction and increased severity of ischemic injury in multiple tissues.	Arteriosclerosis, thrombosis, and vascular biology	2011	49
21933029	Nitric Oxide	Zhang Y	Novel mini-dystrophin gene dual adeno-associated virus vectors restore neuronal nitric oxide synthase expression at the sarcolemma.	Human gene therapy	2012	41
22000010	Nitric Oxide	Seimetz M	Inducible NOS inhibition reverses tobacco-smoke-induced emphysema and pulmonary hypertension in mice.	Cell	2011	73
22039240	Nitric Oxide	Stamer WD	eNOS, a pressure-dependent regulator of intraocular pressure.	Investigative ophthalmology & visual science	2011	52
22065738	Nitric Oxide	Liao S	Impaired lymphatic contraction associated with immunosuppression.	Proceedings of the National Academy of Sciences of the United States of America	2011	81
22158479	Nitric Oxide	Nguyen D	A new vicious cycle involving glutamate excitotoxicity, oxidative stress and mitochondrial dynamics.	Cell death & disease	2011	46
22194622	Nitric Oxide	Hanna RN	NR4A1 (Nur77) deletion polarizes macrophages toward an inflammatory phenotype and increases atherosclerosis.	Circulation research	2012	101
22215724	Nitric Oxide	Bauer PM	Activated CD47 promotes pulmonary arterial hypertension through targeting caveolin-1.	Cardiovascular research	2012	31
22266027	Nitric Oxide	Roberts DD	The matricellular protein thrombospondin-1 globally regulates cardiovascular function and responses to stress via CD47.	Matrix biology 	2012	48
22421969	Nitric Oxide	Li W	Mesenchymal stem cells: a double-edged sword in regulating immune responses.	Cell death and differentiation	2012	60
22529296	Nitric Oxide	Jayaraman P	Tumor-expressed inducible nitric oxide synthase controls induction of functional myeloid-derived suppressor cells through modulation of vascular endothelial growth factor release.	Journal of immunology	2012	35
22893683	Nitric Oxide	Shaked H	Chronic epithelial NF-κB activation accelerates APC loss and intestinal tumor initiation through iNOS up-regulation.	Proceedings of the National Academy of Sciences of the United States of America	2012	43
22936024	Nitric Oxide	Tamoutounour S	CD64 distinguishes macrophages from dendritic cells in the gut and reveals the Th1-inducing role of mesenteric lymph node macrophages during colitis.	European journal of immunology	2012	113
23197572	Nitric Oxide	Martin EA	Tadalafil alleviates muscle ischemia in patients with Becker muscular dystrophy.	Science translational medicine	2012	33
23328641	Nitric Oxide	Deroost K	Hemozoin induces lung inflammation and correlates with malaria-associated acute respiratory distress syndrome.	American journal of respiratory cell and molecular biology	2013	28
23349247	Nitric Oxide	Riwanto M	Altered activation of endothelial anti- and proapoptotic pathways by high-density lipoprotein from patients with coronary artery disease: role of high-density lipoprotein-proteome remodeling.	Circulation	2013	61
23401008	Nitric Oxide	He Y	The protein kinase PKR is critical for LPS-induced iNOS production but dispensable for inflammasome activation in macrophages.	European journal of immunology	2013	31
23681067	Nitric Oxide	Zhang Y	Dual AAV therapy ameliorates exercise-induced muscle injury and functional ischemia in murine models of Duchenne muscular dystrophy.	Human molecular genetics	2013	29
23733335	Nitric Oxide	Mussai F	Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenvironment.	Blood	2013	31
23745722	Nitric Oxide	Austin SA	Endothelial nitric oxide deficiency promotes Alzheimer's disease pathology.	Journal of neurochemistry	2013	28
23797094	Nitric Oxide	Jianjun Yang	T cell–derived inducible nitric oxide synthase switches off Th17 cell differentiation.	The Journal of experimental medicine	2013	25
23801246	Nitric Oxide	Lin AL	Chronic rapamycin restores brain vascular integrity and function through NO synthase activation and improves memory in symptomatic mice modeling Alzheimer's disease.	Journal of cerebral blood flow and metabolism 	2013	40
24009238	Nitric Oxide	Dessapt-Baradez C	Targeted glomerular angiopoietin-1 therapy for early diabetic kidney disease.	Journal of the American Society of Nephrology 	2014	26
24092752	Nitric Oxide	Ghorpade DS	NOD2-nitric oxide-responsive microRNA-146a activates Sonic hedgehog signaling to orchestrate inflammatory responses in murine model of inflammatory bowel disease.	The Journal of biological chemistry	2013	25
24284821	Nitric Oxide	Andrukhova O	Vitamin D is a regulator of endothelial nitric oxide synthase and arterial stiffness in mice.	Molecular endocrinology	2014	31
24301657	Nitric Oxide	Li B	IL-10 modulates DSS-induced colitis through a macrophage-ROS-NO axis.	Mucosal immunology	2014	26
24305053	Nitric Oxide	Whiteus C	Perturbed neural activity disrupts cerebral angiogenesis during a postnatal critical period.	Nature	2014	28
24526691	Nitric Oxide	Horio E	Role of endothelial cell-derived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression.	Arteriosclerosis, thrombosis, and vascular biology	2014	26
24733928	Nitric Oxide	Heinecke JL	Tumor microenvironment-based feed-forward regulation of NOS2 in breast cancer progression.	Proceedings of the National Academy of Sciences of the United States of America	2014	34
24959425	Nitric Oxide	Heimesaat MM	The role of serine protease HtrA in acute ulcerative enterocolitis and extra-intestinal immune responses during Campylobacter jejuni infection of gnotobiotic IL-10 deficient mice.	Frontiers in cellular and infection microbiology	2014	22
25038255	Nitric Oxide	Garcia-Bonilla L	Inducible nitric oxide synthase in neutrophils and endothelium contributes to ischemic brain injury in mice.	Journal of immunology	2014	21
25043204	Nitric Oxide	Colombo E	Fingolimod may support neuroprotection via blockade of astrocyte nitric oxide.	Annals of neurology	2014	23
25186836	Nitric Oxide	Godwin A	Blocking cold-inducible RNA-binding protein protects liver from ischemia-reperfusion injury.	Shock	2015	16
25186941	Nitric Oxide	Han JK	Direct conversion of adult skin fibroblasts to endothelial cells by defined factors.	Circulation	2014	24
25201986	Nitric Oxide	Duque-Correa MA	Macrophage arginase-1 controls bacterial growth and pathology in hypoxic tuberculosis granulomas.	Proceedings of the National Academy of Sciences of the United States of America	2014	29
25260583	Nitric Oxide	Ansari AA	Clinical features and pathobiology of Ebolavirus infection.	Journal of autoimmunity	2014	36
25331846	Nitric Oxide	Cifuentes D	Hypertension accelerates the progression of Alzheimer-like pathology in a mouse model of the disease.	Hypertension	2015	19
25341795	Nitric Oxide	Karbach S	Interleukin 17 drives vascular inflammation, endothelial dysfunction, and arterial hypertension in psoriasis-like skin disease.	Arteriosclerosis, thrombosis, and vascular biology	2014	27
25664851	Nitric Oxide	Saleh MA	Lymphocyte adaptor protein LNK deficiency exacerbates hypertension and end-organ inflammation.	The Journal of clinical investigation	2015	36
25710962	Nitric Oxide	Ager EI	Blockade of MMP14 activity in murine breast carcinomas: implications for macrophages, vessels, and radiotherapy.	Journal of the National Cancer Institute	2015	21
25786174	Nitric Oxide	Jha AK	Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization.	Immunity	2015	118
25849745	Nitric Oxide	Granados-Principal S	Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer.	Breast cancer research 	2015	30
25985180	Nitric Oxide	Finisguerra V	MET is required for the recruitment of anti-tumoural neutrophils.	Nature	2015	39
26009878	Nitric Oxide	Wang Y	Increases of M2a macrophages and fibrosis in aging muscle are influenced by bone marrow aging and negatively regulated by muscle-derived nitric oxide.	Aging cell	2015	16
26168216	Nitric Oxide	Wang S	P2Y₂ and Gq/G₁₁ control blood pressure by mediating endothelial mechanotransduction.	The Journal of clinical investigation	2015	21
26457757	Nitric Oxide	Gur-Cohen S	PAR1 signaling regulates the retention and recruitment of EPCR-expressing bone marrow hematopoietic stem cells.	Nature medicine	2015	21
26879229	Nitric Oxide	Jia G	Endothelial Mineralocorticoid Receptor Mediates Diet-Induced Aortic Stiffness in Females.	Circulation research	2016	25
26956697	Nitric Oxide	Wang J	Multiple myeloma exosomes establish a favourable bone marrow microenvironment with enhanced angiogenesis and immunosuppression.	The Journal of pathology	2016	17
28067899	Nitric Oxide	Oller J	Nitric oxide mediates aortic disease in mice deficient in the metalloprotease Adamts1 and in a mouse model of Marfan syndrome.	Nature medicine	2017	13
15895073	Oligonucleotides, Antisense	Chiarle R	Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target.	Nature medicine	2005	134
17554073	Oligonucleotides, Antisense	Guha M	Specific down-regulation of connective tissue growth factor attenuates progression of nephropathy in mouse models of type 1 and type 2 diabetes.	FASEB journal 	2007	59
18431520	Oligonucleotides, Antisense	Ernst M	STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice.	The Journal of clinical investigation	2008	93
19053047	Oligonucleotides, Antisense	Singh R	Differential effects of JNK1 and JNK2 inhibition on murine steatohepatitis and insulin resistance.	Hepatology	2009	71
19509158	Oligonucleotides, Antisense	Li J	MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor.	Clinical cancer research 	2009	102
19535574	Oligonucleotides, Antisense	Williams JH	Oligonucleotide-mediated survival of motor neuron protein expression in CNS improves phenotype in a mouse model of spinal muscular atrophy.	The Journal of neuroscience 	2009	54
21297615	Oligonucleotides, Antisense	Kaneko H	DICER1 deficit induces Alu RNA toxicity in age-related macular degeneration.	Nature	2011	213
21358643	Oligonucleotides, Antisense	Polymenidou M	Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43.	Nature neuroscience	2011	316
21368223	Oligonucleotides, Antisense	Passini MA	Antisense oligonucleotides delivered to the mouse CNS ameliorate symptoms of severe spinal muscular atrophy.	Science translational medicine	2011	115
21971427	Oligonucleotides, Antisense	Carroll JB	Potent and selective antisense oligonucleotides targeting single-nucleotide polymorphisms in the Huntington disease gene / allele-specific silencing of mutant huntingtin.	Molecular therapy 	2011	73
21979052	Oligonucleotides, Antisense	Hua Y	Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model.	Nature	2011	194
21979053	Oligonucleotides, Antisense	Taniguchi-Ikeda M	Pathogenic exon-trapping by SVA retrotransposon and rescue in Fukuyama muscular dystrophy.	Nature	2011	43
22116819	Oligonucleotides, Antisense	Merk DR	miR-29b participates in early aneurysm development in Marfan syndrome.	Circulation research	2012	47
22371589	Oligonucleotides, Antisense	Lee JE	RNase H-mediated degradation of toxic RNA in myotonic dystrophy type 1.	Proceedings of the National Academy of Sciences of the United States of America	2012	49
22859208	Oligonucleotides, Antisense	Wheeler TM	Targeting nuclear RNA for in vivo correction of myotonic dystrophy.	Nature	2012	130
23766514	Oligonucleotides, Antisense	Li J	Microvesicle-mediated transfer of microRNA-150 from monocytes to endothelial cells promotes angiogenesis.	The Journal of biological chemistry	2013	42
23929620	Oligonucleotides, Antisense	Nakamori M	Splicing biomarkers of disease severity in myotonic dystrophy.	Annals of neurology	2013	41
24170860	Oligonucleotides, Antisense	Lagier-Tourenne C	Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration.	Proceedings of the National Academy of Sciences of the United States of America	2013	126
25101598	Oligonucleotides, Antisense	Southwell AL	In vivo evaluation of candidate allele-specific mutant huntingtin gene silencing antisense oligonucleotides.	Molecular therapy 	2014	25
25223704	Oligonucleotides, Antisense	Yin Y	Tumor-secreted miR-214 induces regulatory T cells: a major link between immune evasion and tumor growth.	Cell research	2014	30
25639539	Oligonucleotides, Antisense	Zhao Y	Antisense inhibition of microRNA-21 and microRNA-221 in tumor-initiating stem-like cells modulates tumorigenesis, metastasis, and chemotherapy resistance in pancreatic cancer.	Targeted oncology	2015	23
25935000	Oligonucleotides, Antisense	Godfrey C	How much dystrophin is enough: the physiological consequences of different levels of dystrophin in the mdx mouse.	Human molecular genetics	2015	20
26282675	Oligonucleotides, Antisense	Wu H	MicroRNA-21 is a potential link between non-alcoholic fatty liver disease and hepatocellular carcinoma via modulation of the HBP1-p53-Srebp1c pathway.	Gut	2016	17
26733414	Oligonucleotides, Antisense	Arnold W	The neuromuscular impact of symptomatic SMN restoration in a mouse model of spinal muscular atrophy.	Neurobiology of disease	2016	10
27106101	Oligonucleotides, Antisense	Garanto A	In vitro and in vivo rescue of aberrant splicing in CEP290-associated LCA by antisense oligonucleotide delivery.	Human molecular genetics	2016	15
27281208	Oligonucleotides, Antisense	Fox RG	Image-based detection and targeting of therapy resistance in pancreatic adenocarcinoma.	Nature	2016	16
1680859	Phosphatidylinositols	Caughey B	The scrapie-associated form of PrP is made from a cell surface precursor that is both protease- and phospholipase-sensitive.	The Journal of biological chemistry	1991	157
10497129	Phosphatidylinositols	Di Cristofano A	Impaired Fas response and autoimmunity in Pten+/- mice.	Science	1999	117
10611246	Phosphatidylinositols	Lee RJ	Cyclin D1 is required for transformation by activated Neu and is induced through an E2F-dependent signaling pathway.	Molecular and cellular biology	2000	96
11470893	Phosphatidylinositols	Enari M	Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody.	Proceedings of the National Academy of Sciences of the United States of America	2001	106
11917000	Phosphatidylinositols	Fontaine V	Neurodegenerative and neuroprotective effects of tumor Necrosis factor (TNF) in retinal ischemia: opposite roles of TNF receptor 1 and TNF receptor 2.	The Journal of neuroscience 	2002	111
12124177	Phosphatidylinositols	Sattler M	Critical role for Gab2 in transformation by BCR/ABL.	Cancer cell	2002	93
12218133	Phosphatidylinositols	Abel B	Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice.	Journal of immunology	2002	84
12426564	Phosphatidylinositols	Gilfillan S	NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation.	Nature immunology	2002	97
12560330	Phosphatidylinositols	Senn JJ	Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes.	The Journal of biological chemistry	2003	107
12748302	Phosphatidylinositols	Hamilton TG	Evolutionary divergence of platelet-derived growth factor alpha receptor signaling mechanisms.	Molecular and cellular biology	2003	119
15033922	Phosphatidylinositols	Ho L	Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease.	FASEB journal 	2004	152
16091473	Phosphatidylinositols	Takeshita F	Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo.	Proceedings of the National Academy of Sciences of the United States of America	2005	91
16169464	Phosphatidylinositols	Stanger BZ	Pten constrains centroacinar cell expansion and malignant transformation in the pancreas.	Cancer cell	2005	112
16339315	Phosphatidylinositols	Zhao JJ	The oncogenic properties of mutant p110alpha and p110beta phosphatidylinositol 3-kinases in human mammary epithelial cells.	Proceedings of the National Academy of Sciences of the United States of America	2005	128
16489002	Phosphatidylinositols	Klos KS	ErbB2 increases vascular endothelial growth factor protein synthesis via activation of mammalian target of rapamycin/p70S6K leading to increased angiogenesis and spontaneous metastasis of human breast cancer cells.	Cancer research	2006	61
16818675	Phosphatidylinositols	Sutton C	A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis.	The Journal of experimental medicine	2006	315
17210696	Phosphatidylinositols	Maroulakou IG	Akt1 ablation inhibits, whereas Akt2 ablation accelerates, the development of mammary adenocarcinomas in mouse mammary tumor virus (MMTV)-ErbB2/neu and MMTV-polyoma middle T transgenic mice.	Cancer research	2007	108
17308108	Phosphatidylinositols	Sawada K	c-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion.	Cancer research	2007	92
18082964	Phosphatidylinositols	Fraser MM	Phosphatase and tensin homolog, deleted on chromosome 10 deficiency in brain causes defects in synaptic structure, transmission and plasticity, and myelination abnormalities.	Neuroscience	2008	64
18328427	Phosphatidylinositols	Kleber S	Yes and PI3K bind CD95 to signal invasion of glioblastoma.	Cancer cell	2008	88
19176381	Phosphatidylinositols	Almog N	Transcriptional switch of dormant tumors to fast-growing angiogenic phenotype.	Cancer research	2009	73
19351816	Phosphatidylinositols	Miller KA	Oncogenic Kras requires simultaneous PI3K signaling to induce ERK activation and transform thyroid epithelial cells in vivo.	Cancer research	2009	47
19491266	Phosphatidylinositols	Dillon RL	Akt1 and akt2 play distinct roles in the initiation and metastatic phases of mammary tumor progression.	Cancer research	2009	57
20010698	Phosphatidylinositols	Maes C	Increased skeletal VEGF enhances beta-catenin activity and results in excessively ossified bones.	The EMBO journal	2010	48
20081861	Phosphatidylinositols	Houghton AM	Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth.	Nature medicine	2010	120
20388916	Phosphatidylinositols	Poliseno L	Identification of the miR-106b~25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation.	Science signaling	2010	166
20424120	Phosphatidylinositols	Dillon RL	Distinct biological roles for the akt family in mammary tumor progression.	Cancer research	2010	60
20472933	Phosphatidylinositols	Garg P	Actin-depolymerizing factor cofilin-1 is necessary in maintaining mature podocyte architecture.	The Journal of biological chemistry	2010	43
20668162	Phosphatidylinositols	Goodman CA	A phosphatidylinositol 3-kinase/protein kinase B-independent activation of mammalian target of rapamycin signaling is sufficient to induce skeletal muscle hypertrophy.	Molecular biology of the cell	2010	42
20686178	Phosphatidylinositols	Andersen JN	Pathway-based identification of biomarkers for targeted therapeutics: personalized oncology with PI3K pathway inhibitors.	Science translational medicine	2010	57
21460223	Phosphatidylinositols	Jimenez S	Age-dependent accumulation of soluble amyloid beta (Abeta) oligomers reverses the neuroprotective effect of soluble amyloid precursor protein-alpha (sAPP(alpha)) by modulating phosphatidylinositol 3-kinase (PI3K)/Akt-GSK-3beta pathway in Alzheimer mouse model.	The Journal of biological chemistry	2011	41
21613208	Phosphatidylinositols	Suvasini R	Insulin growth factor-2 binding protein 3 (IGF2BP3) is a glioblastoma-specific marker that activates phosphatidylinositol 3-kinase/mitogen-activated protein kinase (PI3K/MAPK) pathways by modulating IGF-2.	The Journal of biological chemistry	2011	38
21628414	Phosphatidylinositols	Kuchenbauer F	Comprehensive analysis of mammalian miRNA* species and their role in myeloid cells.	Blood	2011	38
21666671	Phosphatidylinositols	La Marca R	TACE (ADAM17) inhibits Schwann cell myelination.	Nature neuroscience	2011	41
23487788	Phosphatidylinositols	Takeuchi K	Dysregulation of synaptic plasticity precedes appearance of morphological defects in a Pten conditional knockout mouse model of autism.	Proceedings of the National Academy of Sciences of the United States of America	2013	27
24162165	Phosphatidylinositols	Saijilafu	PI3K-GSK3 signalling regulates mammalian axon regeneration by inducing the expression of Smad1.	Nature communications	2013	34
24477292	Phosphatidylinositols	Tian L	p85α recruitment by the CD300f phosphatidylserine receptor mediates apoptotic cell clearance required for autoimmunity suppression.	Nature communications	2014	25
24569712	Phosphatidylinositols	Nakahata S	Loss of NDRG2 expression activates PI3K-AKT signalling via PTEN phosphorylation in ATLL and other cancers.	Nature communications	2014	28
24849286	Phosphatidylinositols	Lu J	NRBF2 regulates autophagy and prevents liver injury by modulating Atg14L-linked phosphatidylinositol-3 kinase III activity.	Nature communications	2014	25
25001183	Phosphatidylinositols	Hu J	microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C.	European journal of cancer	2014	33
25183785	Phosphatidylinositols	Rubashkin MG	Force engages vinculin and promotes tumor progression by enhancing PI3K activation of phosphatidylinositol (3,4,5)-triphosphate.	Cancer research	2014	41
25514767	Phosphatidylinositols	Hawkins PT	PI3K signalling in inflammation.	Biochimica et biophysica acta	2015	43
25534823	Phosphatidylinositols	Kaul A	Akt- or MEK-mediated mTOR inhibition suppresses Nf1 optic glioma growth.	Neuro-oncology	2015	17
25650317	Phosphatidylinositols	Ghosh JC	Adaptive mitochondrial reprogramming and resistance to PI3K therapy.	Journal of the National Cancer Institute	2015	27
25976245	Phosphatidylinositols	Crespo I	Molecular and Genomic Alterations in Glioblastoma Multiforme.	The American journal of pathology	2015	19
11875047	Sirolimus	Kwiatkowski DJ	A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells.	Human molecular genetics	2002	224
11909972	Sirolimus	Shioi T	Akt/protein kinase B promotes organ growth in transgenic mice.	Molecular and cellular biology	2002	129
12668503	Sirolimus	Shioi T	Rapamycin attenuates load-induced cardiac hypertrophy in mice.	Circulation	2003	122
15029198	Sirolimus	Wendel HG	Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy.	Nature	2004	282
15060135	Sirolimus	Pende M	S6K1(-/-)/S6K2(-/-) mice exhibit perinatal lethality and rapamycin-sensitive 5'-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway.	Molecular and cellular biology	2004	245
15156201	Sirolimus	Majumder PK	mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways.	Nature medicine	2004	282
15184287	Sirolimus	McMullen JR	Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload.	Circulation	2004	142
16075055	Sirolimus	Shiojima I	Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure.	The Journal of clinical investigation	2005	271
16203860	Sirolimus	Yu WH	Macroautophagy--a novel Beta-amyloid peptide-generating pathway activated in Alzheimer's disease.	The Journal of cell biology	2005	237
16567633	Sirolimus	Shillingford JM	The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease.	Proceedings of the National Academy of Sciences of the United States of America	2006	209
16598206	Sirolimus	Yilmaz OH	Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells.	Nature	2006	469
16714284	Sirolimus	Cao Y	Autophagy is disrupted in a knock-in mouse model of juvenile neuronal ceroid lipofuscinosis.	The Journal of biological chemistry	2006	79
16799564	Sirolimus	Androutsellis-Theotokis A	Notch signalling regulates stem cell numbers in vitro and in vivo.	Nature	2006	271
16904612	Sirolimus	Sodhi A	The TSC2/mTOR pathway drives endothelial cell transformation induced by the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor.	Cancer cell	2006	65
17082322	Sirolimus	Sin SH	Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signaling.	Blood	2007	67
17270455	Sirolimus	Erlich S	Rapamycin is a neuroprotective treatment for traumatic brain injury.	Neurobiology of disease	2007	85
17273556	Sirolimus	Le Bacquer O	Elevated sensitivity to diet-induced obesity and insulin resistance in mice lacking 4E-BP1 and 4E-BP2.	The Journal of clinical investigation	2007	97
17363557	Sirolimus	Mabuchi S	RAD001 (Everolimus) delays tumor onset and progression in a transgenic mouse model of ovarian cancer.	Cancer research	2007	59
17496901	Sirolimus	Hernando E	The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomas.	Nature medicine	2007	78
18354499	Sirolimus	Knutson SK	Liver-specific deletion of histone deacetylase 3 disrupts metabolic transcriptional networks.	The EMBO journal	2008	92
18474609	Sirolimus	Narayanan U	S6K1 phosphorylates and regulates fragile X mental retardation protein (FMRP) with the neuronal protein synthesis-dependent mammalian target of rapamycin (mTOR) signaling cascade.	The Journal of biological chemistry	2008	90
18495876	Sirolimus	Meikle L	Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function.	The Journal of neuroscience 	2008	168
18583310	Sirolimus	Yung HW	Evidence of placental translation inhibition and endoplasmic reticulum stress in the etiology of human intrauterine growth restriction.	The American journal of pathology	2008	96
18614690	Sirolimus	Cota D	The role of hypothalamic mammalian target of rapamycin complex 1 signaling in diet-induced obesity.	The Journal of neuroscience 	2008	57
18651560	Sirolimus	Yuan G	Induction of HIF-1alpha expression by intermittent hypoxia: involvement of NADPH oxidase, Ca2+ signaling, prolyl hydroxylases, and mTOR.	Journal of cellular physiology	2008	96
18684977	Sirolimus	Golovina TN	CD28 costimulation is essential for human T regulatory expansion and function.	Journal of immunology	2008	55
18713735	Sirolimus	Schieke SM	Mitochondrial metabolism modulates differentiation and teratoma formation capacity in mouse embryonic stem cells.	The Journal of biological chemistry	2008	56
18768809	Sirolimus	Fujishita T	Inhibition of the mTORC1 pathway suppresses intestinal polyp formation and reduces mortality in ApcDelta716 mice.	Proceedings of the National Academy of Sciences of the United States of America	2008	57
19185849	Sirolimus	Guertin DA	mTOR complex 2 is required for the development of prostate cancer induced by Pten loss in mice.	Cancer cell	2009	149
19211884	Sirolimus	Zhou J	Pharmacological inhibition of mTORC1 suppresses anatomical, cellular, and behavioral abnormalities in neural-specific Pten knock-out mice.	The Journal of neuroscience 	2009	149
19261747	Sirolimus	Puzio-Kuter AM	Inactivation of p53 and Pten promotes invasive bladder cancer.	Genes & development	2009	98
19282848	Sirolimus	Dankort D	Braf(V600E) cooperates with Pten loss to induce metastatic melanoma.	Nature genetics	2009	324
19356717	Sirolimus	Mori H	Critical role for hypothalamic mTOR activity in energy balance.	Cell metabolism	2009	68
19420259	Sirolimus	Di Nardo A	Tuberous sclerosis complex activity is required to control neuronal stress responses in an mTOR-dependent manner.	The Journal of neuroscience 	2009	63
19451225	Sirolimus	James MF	NF2/merlin is a novel negative regulator of mTOR complex 1, and activation of mTORC1 is associated with meningioma and schwannoma growth.	Molecular and cellular biology	2009	69
19470613	Sirolimus	Ljungberg MC	Rapamycin suppresses seizures and neuronal hypertrophy in a mouse model of cortical dysplasia.	Disease models & mechanisms	2009	68
19773376	Sirolimus	Kim KW	Combined Bcl-2/mammalian target of rapamycin inhibition leads to enhanced radiosensitization via induction of apoptosis and autophagy in non-small cell lung tumor xenograft model.	Clinical cancer research 	2009	47
20008787	Sirolimus	Kharas MG	Constitutively active AKT depletes hematopoietic stem cells and induces leukemia in mice.	Blood	2010	90
20008935	Sirolimus	Olive V	miR-19 is a key oncogenic component of mir-17-92.	Genes & development	2009	235
20042677	Sirolimus	Deng L	A novel mouse model of inflammatory bowel disease links mammalian target of rapamycin-dependent hyperproliferation of colonic epithelium to inflammation-associated tumorigenesis.	The American journal of pathology	2010	57
20071534	Sirolimus	Sharma A	Dysregulation of mTOR signaling in fragile X syndrome.	The Journal of neuroscience 	2010	185
20075061	Sirolimus	Shillingford JM	Rapamycin ameliorates PKD resulting from conditional inactivation of Pkd1.	Journal of the American Society of Nephrology 	2010	73
20080688	Sirolimus	Hung KE	Development of a mouse model for sporadic and metastatic colon tumors and its use in assessing drug treatment.	Proceedings of the National Academy of Sciences of the United States of America	2010	80
20174468	Sirolimus	Crews L	Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy.	PloS one	2010	92
20371474	Sirolimus	Amin DN	Resiliency and vulnerability in the HER2-HER3 tumorigenic driver.	Science translational medicine	2010	69
20453062	Sirolimus	Aguado C	Laforin, the most common protein mutated in Lafora disease, regulates autophagy.	Human molecular genetics	2010	54
20473305	Sirolimus	Yoshida T	Rtp801, a suppressor of mTOR signaling, is an essential mediator of cigarette smoke-induced pulmonary injury and emphysema.	Nature medicine	2010	61
20498714	Sirolimus	Squarize CH	Accelerated wound healing by mTOR activation in genetically defined mouse models.	PloS one	2010	40
20563248	Sirolimus	Molina JR	Invasive glioblastoma cells acquire stemness and increased Akt activation.	Neoplasia	2010	62
20644257	Sirolimus	Zhang D	MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice.	The Journal of clinical investigation	2010	101
20978191	Sirolimus	Zhang F	mTOR complex component Rictor interacts with PKCzeta and regulates cancer cell metastasis.	Cancer research	2010	49
21076392	Sirolimus	Balamurugan K	The tumour suppressor C/EBPδ inhibits FBXW7 expression and promotes mammary tumour metastasis.	The EMBO journal	2010	43
21084617	Sirolimus	Osterweil EK	Hypersensitivity to mGluR5 and ERK1/2 leads to excessive protein synthesis in the hippocampus of a mouse model of fragile X syndrome.	The Journal of neuroscience 	2010	128
21135502	Sirolimus	Zhao C	mTOR-mediated dedifferentiation of the retinal pigment epithelium initiates photoreceptor degeneration in mice.	The Journal of clinical investigation	2011	78
21147110	Sirolimus	Calvisi DF	Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma.	Gastroenterology	2011	98
21193837	Sirolimus	Zhang X	Rapamycin treatment augments motor neuron degeneration in SOD1(G93A) mouse model of amyotrophic lateral sclerosis.	Autophagy	2011	86
21289308	Sirolimus	Yoshimi A	Evi1 represses PTEN expression and activates PI3K/AKT/mTOR via interactions with polycomb proteins.	Blood	2011	35
21339483	Sirolimus	Grundmann S	MicroRNA-100 regulates neovascularization by suppression of mammalian target of rapamycin in endothelial and vascular smooth muscle cells.	Circulation	2011	48
21383697	Sirolimus	Oneyama C	MicroRNA-mediated downregulation of mTOR/FGFR3 controls tumor growth induced by Src-related oncogenic pathways.	Oncogene	2011	44
21403402	Sirolimus	Feliciano DM	Single-cell Tsc1 knockout during corticogenesis generates tuber-like lesions and reduces seizure threshold in mice.	The Journal of clinical investigation	2011	54
21737790	Sirolimus	Zhai P	Differential roles of GSK-3β during myocardial ischemia and ischemia/reperfusion.	Circulation research	2011	48
21746920	Sirolimus	Parkhitko A	Tumorigenesis in tuberous sclerosis complex is autophagy and p62/sequestosome 1 (SQSTM1)-dependent.	Proceedings of the National Academy of Sciences of the United States of America	2011	79
21779001	Sirolimus	Kato H	mTORC1 serves ER stress-triggered apoptosis via selective activation of the IRE1-JNK pathway.	Cell death and differentiation	2012	67
21907282	Sirolimus	Carson RP	Neuronal and glia abnormalities in Tsc1-deficient forebrain and partial rescue by rapamycin.	Neurobiology of disease	2012	57
21946849	Sirolimus	Goodman CA	The role of skeletal muscle mTOR in the regulation of mechanical load-induced growth.	The Journal of physiology	2011	63
21975930	Sirolimus	Patel V	Decreased lymphangiogenesis and lymph node metastasis by mTOR inhibition in head and neck cancer.	Cancer research	2011	52
21993994	Sirolimus	Ho C	AKT (v-akt murine thymoma viral oncogene homolog 1) and N-Ras (neuroblastoma ras viral oncogene homolog) coactivation in the mouse liver promotes rapid carcinogenesis by way of mTOR (mammalian target of rapamycin complex 1), FOXM1 (forkhead box M1)/SKP2, and c-Myc pathways.	Hepatology	2012	55
21997369	Sirolimus	Abdulrahman BA	Autophagy stimulation by rapamycin suppresses lung inflammation and infection by Burkholderia cenocepacia in a model of cystic fibrosis.	Autophagy	2011	62
22084394	Sirolimus	Caramés B	Autophagy activation by rapamycin reduces severity of experimental osteoarthritis.	Annals of the rheumatic diseases	2012	72
22193387	Sirolimus	Cinà DP	Inhibition of MTOR disrupts autophagic flux in podocytes.	Journal of the American Society of Nephrology 	2012	39
22234835	Sirolimus	Fang Y	MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma.	Hepatology	2012	103
22290600	Sirolimus	De Angel RE	The enhancing effects of obesity on mammary tumor growth and Akt/mTOR pathway activation persist after weight loss and are reversed by RAD001.	Molecular carcinogenesis	2013	26
22302821	Sirolimus	Sherman DL	Arrest of myelination and reduced axon growth when Schwann cells lack mTOR.	The Journal of neuroscience 	2012	53
22355189	Sirolimus	Sun Y	Inhibition of autophagy ameliorates acute lung injury caused by avian influenza A H5N1 infection.	Science signaling	2012	50
22361585	Sirolimus	Sheng R	Autophagy regulates endoplasmic reticulum stress in ischemic preconditioning.	Autophagy	2012	42
22409888	Sirolimus	Molinolo AA	mTOR as a molecular target in HPV-associated oral and cervical squamous carcinomas.	Clinical cancer research 	2012	38
22457330	Sirolimus	Menon S	Chronic activation of mTOR complex 1 is sufficient to cause hepatocellular carcinoma in mice.	Science signaling	2012	51
22552098	Sirolimus	Thoreen CC	A unifying model for mTORC1-mediated regulation of mRNA translation.	Nature	2012	370
22561297	Sirolimus	Aoyagi T	Cardiac mTOR protects the heart against ischemia-reperfusion injury.	American journal of physiology. Heart and circulatory physiology	2012	35
22698676	Sirolimus	Mercier I	Caveolin-1 and accelerated host aging in the breast tumor microenvironment: chemoprevention with rapamycin, an mTOR inhibitor and anti-aging drug.	The American journal of pathology	2012	68
22729283	Sirolimus	Xian L	Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells.	Nature medicine	2012	106
22763451	Sirolimus	Tsai PT	Autistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice.	Nature	2012	176
22826320	Sirolimus	Amiel E	Inhibition of mechanistic target of rapamycin promotes dendritic cell activation and enhances therapeutic autologous vaccination in mice.	Journal of immunology	2012	40
22826565	Sirolimus	Zeng Z	Targeting of mTORC1/2 by the mTOR kinase inhibitor PP242 induces apoptosis in AML cells under conditions mimicking the bone marrow microenvironment.	Blood	2012	38
22837538	Sirolimus	Ramos FJ	Rapamycin reverses elevated mTORC1 signaling in lamin A/C-deficient mice, rescues cardiac and skeletal muscle function, and extends survival.	Science translational medicine	2012	93
22859719	Sirolimus	Sun ZJ	Chemopreventive and chemotherapeutic actions of mTOR inhibitor in genetically defined head and neck squamous cell carcinoma mouse model.	Clinical cancer research 	2012	41
22907434	Sirolimus	Du W	ADAMTS9 is a functional tumor suppressor through inhibiting AKT/mTOR pathway and associated with poor survival in gastric cancer.	Oncogene	2013	27
22958934	Sirolimus	Kalaitzidis D	mTOR complex 1 plays critical roles in hematopoiesis and Pten-loss-evoked leukemogenesis.	Cell stem cell	2012	65
22981852	Sirolimus	Hinojosa CA	Enteric-delivered rapamycin enhances resistance of aged mice to pneumococcal pneumonia through reduced cellular senescence.	Experimental gerontology	2012	30
23123587	Sirolimus	Reith RM	Loss of Tsc2 in Purkinje cells is associated with autistic-like behavior in a mouse model of tuberous sclerosis complex.	Neurobiology of disease	2013	42
23152448	Sirolimus	Kaul A	Pediatric glioma-associated KIAA1549:BRAF expression regulates neuroglial cell growth in a cell type-specific and mTOR-dependent manner.	Genes & development	2012	33
23155049	Sirolimus	Avrahami L	Inhibition of glycogen synthase kinase-3 ameliorates β-amyloid pathology and restores lysosomal acidification and mammalian target of rapamycin activity in the Alzheimer disease mouse model: in vivo and in vitro studies.	The Journal of biological chemistry	2013	43
23173671	Sirolimus	Cui L	MicroRNA-99a induces G1-phase cell cycle arrest and suppresses tumorigenicity in renal cell carcinoma.	BMC cancer	2012	31
23274896	Sirolimus	Bachar-Wikstrom E	Stimulation of autophagy improves endoplasmic reticulum stress-induced diabetes.	Diabetes	2013	48
23562079	Sirolimus	Chaveroux C	Molecular and genetic crosstalks between mTOR and ERRα are key determinants of rapamycin-induced nonalcoholic fatty liver.	Cell metabolism	2013	27
23569215	Sirolimus	Thomanetz V	Ablation of the mTORC2 component rictor in brain or Purkinje cells affects size and neuron morphology.	The Journal of cell biology	2013	56
23637172	Sirolimus	Cloëtta D	Inactivation of mTORC1 in the developing brain causes microcephaly and affects gliogenesis.	The Journal of neuroscience 	2013	28
23667480	Sirolimus	Ozcelik S	Rapamycin attenuates the progression of tau pathology in P301S tau transgenic mice.	PloS one	2013	27
23682161	Sirolimus	Zhang Y	Rapamycin extends life and health in C57BL/6 mice.	The journals of gerontology. Series A, Biological sciences and medical sciences	2014	92
23686362	Sirolimus	Sandri M	Signalling pathways regulating muscle mass in ageing skeletal muscle: the role of the IGF1-Akt-mTOR-FoxO pathway.	Biogerontology	2013	55
23691153	Sirolimus	Guo D	Rapamycin attenuates the development of posttraumatic epilepsy in a mouse model of traumatic brain injury.	PloS one	2013	38
23729812	Sirolimus	Balu DT	Multiple risk pathways for schizophrenia converge in serine racemase knockout mice, a mouse model of NMDA receptor hypofunction.	Proceedings of the National Academy of Sciences of the United States of America	2013	53
23863708	Sirolimus	Neff F	Rapamycin extends murine lifespan but has limited effects on aging.	The Journal of clinical investigation	2013	113
23958952	Sirolimus	Lee K	Requirement for Rictor in homeostasis and function of mature B lymphoid cells.	Blood	2013	26
24008870	Sirolimus	Völkers M	Mechanistic target of rapamycin complex 2 protects the heart from ischemic damage.	Circulation	2013	31
24014241	Sirolimus	Willems L	Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemia.	Blood	2013	56
24052624	Sirolimus	Wang Q	Targeting amino acid transport in metastatic castration-resistant prostate cancer: effects on cell cycle, cell growth, and tumor development.	Journal of the National Cancer Institute	2013	31
24056770	Sirolimus	Canaud G	AKT2 is essential to maintain podocyte viability and function during chronic kidney disease.	Nature medicine	2013	46
24092929	Sirolimus	Yamahara K	Obesity-mediated autophagy insufficiency exacerbates proteinuria-induced tubulointerstitial lesions.	Journal of the American Society of Nephrology 	2013	43
24094105	Sirolimus	Saxena S	Neuroprotection through excitability and mTOR required in ALS motoneurons to delay disease and extend survival.	Neuron	2013	50
24231806	Sirolimus	Johnson SC	mTOR inhibition alleviates mitochondrial disease in a mouse model of Leigh syndrome.	Science	2013	86
24270418	Sirolimus	Liu SC	Leukemia inhibitory factor promotes nasopharyngeal carcinoma progression and radioresistance.	The Journal of clinical investigation	2013	29
24311635	Sirolimus	Kahn J	The mTORC1/mTORC2 inhibitor AZD2014 enhances the radiosensitivity of glioblastoma stem-like cells.	Neuro-oncology	2014	23
24341993	Sirolimus	Miller RA	Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction.	Aging cell	2014	126
24401272	Sirolimus	Li W	Tgfbr2 disruption in postnatal smooth muscle impairs aortic wall homeostasis.	The Journal of clinical investigation	2014	50
24469052	Sirolimus	Akeno N	p53 suppresses carcinoma progression by inhibiting mTOR pathway activation.	Oncogene	2015	15
24556924	Sirolimus	Popovich IG	Lifespan extension and cancer prevention in HER-2/neu transgenic mice treated with low intermittent doses of rapamycin.	Cancer biology & therapy	2014	25
24612461	Sirolimus	Dai DF	Altered proteome turnover and remodeling by short-term caloric restriction or rapamycin rejuvenate the aging heart.	Aging cell	2014	61
24651621	Sirolimus	Zhang Y	Cartilage-specific deletion of mTOR upregulates autophagy and protects mice from osteoarthritis.	Annals of the rheumatic diseases	2015	45
24728411	Sirolimus	Ota KT	REDD1 is essential for stress-induced synaptic loss and depressive behavior.	Nature medicine	2014	50
24899720	Sirolimus	Caccamo A	Genetic reduction of mammalian target of rapamycin ameliorates Alzheimer's disease-like cognitive and pathological deficits by restoring hippocampal gene expression signature.	The Journal of neuroscience 	2014	34
24910242	Sirolimus	Umemura A	Liver damage, inflammation, and enhanced tumorigenesis after persistent mTORC1 inhibition.	Cell metabolism	2014	27
24931163	Sirolimus	Dodd KM	mTORC1 drives HIF-1α and VEGF-A signalling via multiple mechanisms involving 4E-BP1, S6K1 and STAT3.	Oncogene	2015	24
24947615	Sirolimus	Park HW	Hepatoprotective role of Sestrin2 against chronic ER stress.	Nature communications	2014	26
24948603	Sirolimus	Chen J	mTORC1 signaling controls mammalian skeletal growth through stimulation of protein synthesis.	Development	2014	28
24948799	Sirolimus	Lebrun-Julien F	Balanced mTORC1 activity in oligodendrocytes is required for accurate CNS myelination.	The Journal of neuroscience 	2014	32
25057190	Sirolimus	Sidhu H	Genetic removal of matrix metalloproteinase 9 rescues the symptoms of fragile X syndrome in a mouse model.	The Journal of neuroscience 	2014	43
25082895	Sirolimus	Cornu M	Hepatic mTORC1 controls locomotor activity, body temperature, and lipid metabolism through FGF21.	Proceedings of the National Academy of Sciences of the United States of America	2014	34
25155956	Sirolimus	Tang G	Loss of mTOR-dependent macroautophagy causes autistic-like synaptic pruning deficits.	Neuron	2014	123
25175012	Sirolimus	Zhu L	TSC1 controls macrophage polarization to prevent inflammatory disease.	Nature communications	2014	40
25196701	Sirolimus	Chen J	mTORC2 signaling promotes skeletal growth and bone formation in mice.	Journal of bone and mineral research 	2015	20
25216585	Sirolimus	Ryu HH	Autophagy regulates amyotrophic lateral sclerosis-linked fused in sarcoma-positive stress granules in neurons.	Neurobiology of aging	2014	24
25311365	Sirolimus	Oguro-Ando A	Increased CYFIP1 dosage alters cellular and dendritic morphology and dysregulates mTOR.	Molecular psychiatry	2015	15
25383520	Sirolimus	Faller WJ	mTORC1-mediated translational elongation limits intestinal tumour initiation and growth.	Nature	2015	61
25403236	Sirolimus	Takayama K	Local intra-articular injection of rapamycin delays articular cartilage degeneration in a murine model of osteoarthritis.	Arthritis research & therapy	2014	25
25424641	Sirolimus	Goldberg EL	Lifespan-extending caloric restriction or mTOR inhibition impair adaptive immunity of old mice by distinct mechanisms.	Aging cell	2015	18
25450580	Sirolimus	Xu K	mTOR signaling in tumorigenesis.	Biochimica et biophysica acta	2014	34
25501597	Sirolimus	Rodríguez-Muela N	Lysosomal membrane permeabilization and autophagy blockade contribute to photoreceptor cell death in a mouse model of retinitis pigmentosa.	Cell death and differentiation	2015	17
25537496	Sirolimus	Martin SK	Brief report: the differential roles of mTORC1 and mTORC2 in mesenchymal stem cell differentiation.	Stem cells	2015	22
25562323	Sirolimus	Karner CM	Increased glutamine catabolism mediates bone anabolism in response to WNT signaling.	The Journal of clinical investigation	2015	24
25601637	Sirolimus	Kong B	A subset of metastatic pancreatic ductal adenocarcinomas depends quantitatively on oncogenic Kras/Mek/Erk-induced hyperactive mTOR signalling.	Gut	2016	14
25788687	Sirolimus	Sun J	Imbalanced mechanistic target of rapamycin C1 and C2 activity in the cerebellum of Angelman syndrome mice impairs motor function.	The Journal of neuroscience 	2015	18
25798620	Sirolimus	Tanaka K	Compensatory glutamine metabolism promotes glioblastoma resistance to mTOR inhibitor treatment.	The Journal of clinical investigation	2015	35
25799227	Sirolimus	Lim JS	Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy.	Nature medicine	2015	44
25813405	Sirolimus	Wang Y	CRNDE, a long-noncoding RNA, promotes glioma cell growth and invasion through mTOR signaling.	Cancer letters	2015	45
26134657	Sirolimus	Du K	Pten Deletion Promotes Regrowth of Corticospinal Tract Axons 1 Year after Spinal Cord Injury.	The Journal of neuroscience 	2015	21
26147250	Sirolimus	Laberge RM	MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation.	Nature cell biology	2015	103
26253609	Sirolimus	Feng ZC	c-Kit Receptor Signaling Regulates Islet Vasculature, β-Cell Survival, and Function In Vivo.	Diabetes	2015	15
26476289	Sirolimus	Li L	Inactivation of fatty acid synthase impairs hepatocarcinogenesis driven by AKT in mice and humans.	Journal of hepatology	2016	12
26565512	Sirolimus	Qiang L	Autophagy positively regulates DNA damage recognition by nucleotide excision repair.	Autophagy	2016	12
26721390	Sirolimus	Lin AL	Rapamycin rescues vascular, metabolic and learning deficits in apolipoprotein E4 transgenic mice with pre-symptomatic Alzheimer's disease.	Journal of cerebral blood flow and metabolism 	2017	12
26872208	Sirolimus	Chiao YA	Rapamycin transiently induces mitochondrial remodeling to reprogram energy metabolism in old hearts.	Aging	2016	14
26884601	Sirolimus	Viel S	TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway.	Science signaling	2016	24
8551223	Ovalbumin	Foster PS	Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model.	The Journal of experimental medicine	1996	229
9541491	Ovalbumin	Spergel JM	Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice.	The Journal of clinical investigation	1998	133
9916129	Ovalbumin	Hansen G	Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation.	The Journal of clinical investigation	1999	117
10720327	Ovalbumin	Matsuoka T	Prostaglandin D2 as a mediator of allergic asthma.	Science	2000	129
10953030	Ovalbumin	Lambrecht BN	Myeloid dendritic cells induce Th2 responses to inhaled antigen, leading to eosinophilic airway inflammation.	The Journal of clinical investigation	2000	100
14757645	Ovalbumin	Wan H	Foxa2 regulates alveolarization and goblet cell hyperplasia.	Development	2004	92
15527881	Ovalbumin	Campbell A	Particulate matter in polluted air may increase biomarkers of inflammation in mouse brain.	Neurotoxicology	2005	81
15618138	Ovalbumin	Noverr MC	Development of allergic airway disease in mice following antibiotic therapy and fungal microbiota increase: role of host genetics, antigen, and interleukin-13.	Infection and immunity	2005	72
15924144	Ovalbumin	Shakhar G	Stable T cell-dendritic cell interactions precede the development of both tolerance and immunity in vivo.	Nature immunology	2005	93
16815144	Ovalbumin	Takayama G	Periostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals.	The Journal of allergy and clinical immunology	2006	139
16951687	Ovalbumin	Bonasio R	Clonal deletion of thymocytes by circulating dendritic cells homing to the thymus.	Nature immunology	2006	121
18316417	Ovalbumin	Jacobsen EA	Allergic pulmonary inflammation in mice is dependent on eosinophil-induced recruitment of effector T cells.	The Journal of experimental medicine	2008	88
18711124	Ovalbumin	He R	TSLP acts on infiltrating effector T cells to drive allergic skin inflammation.	Proceedings of the National Academy of Sciences of the United States of America	2008	75
18787175	Ovalbumin	Ryman-Rasmussen JP	Inhaled multiwalled carbon nanotubes potentiate airway fibrosis in murine allergic asthma.	American journal of respiratory cell and molecular biology	2009	83
19168697	Ovalbumin	Medoff BD	Adiponectin deficiency increases allergic airway inflammation and pulmonary vascular remodeling.	American journal of respiratory cell and molecular biology	2009	64
19188585	Ovalbumin	Zhang Z	Thymic stromal lymphopoietin overproduced by keratinocytes in mouse skin aggravates experimental asthma.	Proceedings of the National Academy of Sciences of the United States of America	2009	51
19381017	Ovalbumin	Heymann F	Kidney dendritic cell activation is required for progression of renal disease in a mouse model of glomerular injury.	The Journal of clinical investigation	2009	58
19508862	Ovalbumin	Liu X	Anti-IL-33 antibody treatment inhibits airway inflammation in a murine model of allergic asthma.	Biochemical and biophysical research communications	2009	61
19665780	Ovalbumin	Oyoshi MK	Filaggrin-deficient mice exhibit TH17-dominated skin inflammation and permissiveness to epicutaneous sensitization with protein antigen.	The Journal of allergy and clinical immunology	2009	48
20167655	Ovalbumin	Klingenberg R	Intranasal immunization with an apolipoprotein B-100 fusion protein induces antigen-specific regulatory T cells and reduces atherosclerosis.	Arteriosclerosis, thrombosis, and vascular biology	2010	44
20817776	Ovalbumin	Bonfield TL	Human mesenchymal stem cells suppress chronic airway inflammation in the murine ovalbumin asthma model.	American journal of physiology. Lung cellular and molecular physiology	2010	50
20924102	Ovalbumin	Klages K	Selective depletion of Foxp3+ regulatory T cells improves effective therapeutic vaccination against established melanoma.	Cancer research	2010	73
20971830	Ovalbumin	Kearley J	IL-9 governs allergen-induced mast cell numbers in the lung and chronic remodeling of the airways.	American journal of respiratory and critical care medicine	2011	53
21072873	Ovalbumin	Vijay-Kumar M	TLR5 or NLRC4 is necessary and sufficient for promotion of humoral immunity by flagellin.	European journal of immunology	2010	42
21091718	Ovalbumin	Kavanagh H	Allogeneic mesenchymal stem cells prevent allergic airway inflammation by inducing murine regulatory T cells.	Allergy	2011	47
21215659	Ovalbumin	Stritesky GL	The transcription factor STAT3 is required for T helper 2 cell development.	Immunity	2011	77
21215831	Ovalbumin	Calabro S	Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes.	Vaccine	2011	71
21783420	Ovalbumin	Gregory LG	Orchestrating house dust mite-associated allergy in the lung.	Trends in immunology	2011	78
22012243	Ovalbumin	Nakano H	Pulmonary CD103(+) dendritic cells prime Th2 responses to inhaled allergens.	Mucosal immunology	2012	54
22114895	Ovalbumin	Dénes A	Systemic inflammatory challenges compromise survival after experimental stroke via augmenting brain inflammation, blood- brain barrier damage and brain oedema independently of infarct size.	Journal of neuroinflammation	2011	41
22292924	Ovalbumin	Ford AQ	Adoptive transfer of IL-4Rα+ macrophages is sufficient to enhance eosinophilic inflammation in a mouse model of allergic lung inflammation.	BMC immunology	2012	35
22388091	Ovalbumin	Kudo M	IL-17A produced by αβ T cells drives airway hyper-responsiveness in mice and enhances mouse and human airway smooth muscle contraction.	Nature medicine	2012	124
24939388	Ovalbumin	Drake LY	Group 2 innate lymphoid cells and CD4+ T cells cooperate to mediate type 2 immune response in mice.	Allergy	2014	35
25746972	Ovalbumin	Sehra S	TH9 cells are required for tissue mast cell accumulation during allergic inflammation.	The Journal of allergy and clinical immunology	2015	24
26323581	Ovalbumin	Vlcek KR	The contribution of Chlamydia-specific CD8⁺ T cells to upper genital tract pathology.	Immunology and cell biology	2016	12
27702671	Ovalbumin	Ewald DA	Major differences between human atopic dermatitis and murine models, as determined by using global transcriptomic profiling.	The Journal of allergy and clinical immunology	2017	8
11606625	Antioxidants	Lim GP	The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse.	The Journal of neuroscience 	2001	236
12891360	Antioxidants	Neumann CA	Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression.	Nature	2003	182
12968018	Antioxidants	Leung L	Deficiency of the Nrf1 and Nrf2 transcription factors results in early embryonic lethality and severe oxidative stress.	The Journal of biological chemistry	2003	84
15178682	Antioxidants	Ho YS	Mice lacking catalase develop normally but show differential sensitivity to oxidant tissue injury.	The Journal of biological chemistry	2004	76
15629862	Antioxidants	Cho HY	Gene expression profiling of NRF2-mediated protection against oxidative injury.	Free radical biology & medicine	2005	67
15680229	Antioxidants	Moskovitz J	Methionine sulfoxide reductases: ubiquitous enzymes involved in antioxidant defense, protein regulation, and prevention of aging-associated diseases.	Biochimica et biophysica acta	2005	75
15738389	Antioxidants	Xu Z	Liver-specific inactivation of the Nrf1 gene in adult mouse leads to nonalcoholic steatohepatitis and hepatic neoplasia.	Proceedings of the National Academy of Sciences of the United States of America	2005	77
15998787	Antioxidants	Rangasamy T	Disruption of Nrf2 enhances susceptibility to severe airway inflammation and asthma in mice.	The Journal of experimental medicine	2005	192
16849425	Antioxidants	Komeima K	Antioxidants reduce cone cell death in a model of retinitis pigmentosa.	Proceedings of the National Academy of Sciences of the United States of America	2006	112
17045908	Antioxidants	Cai L	Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy.	Journal of the American College of Cardiology	2006	94
17178711	Antioxidants	Cho S	A novel cell-permeable antioxidant peptide, SS31, attenuates ischemic brain injury by down-regulating CD36.	The Journal of biological chemistry	2007	64
17520694	Antioxidants	Komeima K	Antioxidants slow photoreceptor cell death in mouse models of retinitis pigmentosa.	Journal of cellular physiology	2007	71
17579710	Antioxidants	Melov S	Mitochondrial oxidative stress causes hyperphosphorylation of tau.	PloS one	2007	86
17916769	Antioxidants	Sukhanov S	IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice.	Arteriosclerosis, thrombosis, and vascular biology	2007	64
18202315	Antioxidants	Araujo JA	Ambient particulate pollutants in the ultrafine range promote early atherosclerosis and systemic oxidative stress.	Circulation research	2008	128
18567706	Antioxidants	Jha S	Hydrogen sulfide attenuates hepatic ischemia-reperfusion injury: role of antioxidant and antiapoptotic signaling.	American journal of physiology. Heart and circulatory physiology	2008	79
19005183	Antioxidants	Tang Y	CYP1B1 expression promotes the proangiogenic phenotype of endothelium through decreased intracellular oxidative stress and thrombospondin-2 expression.	Blood	2009	47
19129394	Antioxidants	Schwartz ES	Persistent pain is dependent on spinal mitochondrial antioxidant levels.	The Journal of neuroscience 	2009	47
19652361	Antioxidants	Sundaresan NR	Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice.	The Journal of clinical investigation	2009	256
19665035	Antioxidants	Biswas M	Role of Nrf1 in antioxidant response element-mediated gene expression and beyond.	Toxicology and applied pharmacology	2010	57
19901338	Antioxidants	Someya S	Age-related hearing loss in C57BL/6J mice is mediated by Bak-dependent mitochondrial apoptosis.	Proceedings of the National Academy of Sciences of the United States of America	2009	80
20382344	Antioxidants	Dai DF	Cardiac aging in mice and humans: the role of mitochondrial oxidative stress.	Trends in cardiovascular medicine	2009	64
20463406	Antioxidants	Manczak M	Mitochondria-targeted antioxidants protect against amyloid-beta toxicity in Alzheimer's disease neurons.	Journal of Alzheimer's disease 	2010	113
20812860	Antioxidants	Hariharan N	Oxidative stress stimulates autophagic flux during ischemia/reperfusion.	Antioxidants & redox signaling	2011	83
20947826	Antioxidants	Barajas B	NF-E2-related factor 2 promotes atherosclerosis by effects on plasma lipoproteins and cholesterol transport that overshadow antioxidant protection.	Arteriosclerosis, thrombosis, and vascular biology	2011	40
20978343	Antioxidants	Li W	CD36 participates in a signaling pathway that regulates ROS formation in murine VSMCs.	The Journal of clinical investigation	2010	48
21148108	Antioxidants	Lim J	Oxidative damage increases and antioxidant gene expression decreases with aging in the mouse ovary.	Biology of reproduction	2011	37
21159781	Antioxidants	Sengupta A	FoxO transcription factors promote cardiomyocyte survival upon induction of oxidative stress.	The Journal of biological chemistry	2011	100
21354971	Antioxidants	Linker RA	Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway.	Brain 	2011	174
21441382	Antioxidants	Lee SJ	Carbon monoxide activates autophagy via mitochondrial reactive oxygen species formation.	American journal of respiratory cell and molecular biology	2011	45
21559389	Antioxidants	Zhao Z	Age-related retinopathy in NRF2-deficient mice.	PloS one	2011	81
21605374	Antioxidants	Sotgia F	Mitochondrial oxidative stress drives tumor progression and metastasis: should we use antioxidants as a key component of cancer treatment and prevention?	BMC medicine	2011	36
21620606	Antioxidants	Dai DF	Mitochondrial targeted antioxidant Peptide ameliorates hypertensive cardiomyopathy.	Journal of the American College of Cardiology	2011	80
21734707	Antioxidants	DeNicola GM	Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis.	Nature	2011	434
22037588	Antioxidants	Reddy PH	Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: implications to mitochondria-targeted antioxidant therapeutics.	Biochimica et biophysica acta	2012	79
22210379	Antioxidants	Mercer JR	The mitochondria-targeted antioxidant MitoQ decreases features of the metabolic syndrome in ATM+/-/ApoE-/- mice.	Free radical biology & medicine	2012	34
22366763	Antioxidants	Miller CJ	Disruption of Nrf2/ARE signaling impairs antioxidant mechanisms and promotes cell degradation pathways in aged skeletal muscle.	Biochimica et biophysica acta	2012	35
22383093	Antioxidants	Schäfer M	Nrf2 links epidermal barrier function with antioxidant defense.	EMBO molecular medicine	2012	34
22492997	Antioxidants	Im JY	DJ-1 induces thioredoxin 1 expression through the Nrf2 pathway.	Human molecular genetics	2012	41
22628578	Antioxidants	Zhang D	Severe hyperhomocysteinemia promotes bone marrow-derived and resident inflammatory monocyte differentiation and atherosclerosis in LDLr/CBS-deficient mice.	Circulation research	2012	31
22706306	Antioxidants	Leal SM Jr	Fungal antioxidant pathways promote survival against neutrophils during infection.	The Journal of clinical investigation	2012	36
23507145	Antioxidants	Du H	Cyclophilin D deficiency rescues Aβ-impaired PKA/CREB signaling and alleviates synaptic degeneration.	Biochimica et biophysica acta	2014	28
23547261	Antioxidants	Lee J	Bmal1 and β-cell clock are required for adaptation to circadian disruption, and their loss of function leads to oxidative stress-induced β-cell failure in mice.	Molecular and cellular biology	2013	47
23726973	Antioxidants	Cheung EC	TIGAR is required for efficient intestinal regeneration and tumorigenesis.	Developmental cell	2013	45
23857982	Antioxidants	Gorrini C	BRCA1 interacts with Nrf2 to regulate antioxidant signaling and cell survival.	The Journal of experimental medicine	2013	41
23915129	Antioxidants	Dashdorj A	Mitochondria-targeted antioxidant MitoQ ameliorates experimental mouse colitis by suppressing NLRP3 inflammasome-mediated inflammatory cytokines.	BMC medicine	2013	37
24718857	Antioxidants	Hecker L	Reversal of persistent fibrosis in aging by targeting Nox4-Nrf2 redox imbalance.	Science translational medicine	2014	111
24928512	Antioxidants	Ge X	High mobility group box-1 (HMGB1) participates in the pathogenesis of alcoholic liver disease (ALD).	The Journal of biological chemistry	2014	31
24953182	Antioxidants	Paul MK	Dynamic changes in intracellular ROS levels regulate airway basal stem cell homeostasis through Nrf2-dependent Notch signaling.	Cell stem cell	2014	52
25288763	Antioxidants	Umanskaya A	Genetically enhancing mitochondrial antioxidant activity improves muscle function in aging.	Proceedings of the National Academy of Sciences of the United States of America	2014	48
25590811	Antioxidants	Singer E	Reactive oxygen species-mediated therapeutic response and resistance in glioblastoma.	Cell death & disease	2015	18
25792665	Antioxidants	Ahmad T	Impaired mitophagy leads to cigarette smoke stress-induced cellular senescence: implications for chronic obstructive pulmonary disease.	FASEB journal 	2015	26
25828268	Antioxidants	Wiegman CH	Oxidative stress-induced mitochondrial dysfunction drives inflammation and airway smooth muscle remodeling in patients with chronic obstructive pulmonary disease.	The Journal of allergy and clinical immunology	2015	41
25909888	Antioxidants	Oettinghaus B	Synaptic dysfunction, memory deficits and hippocampal atrophy due to ablation of mitochondrial fission in adult forebrain neurons.	Cell death and differentiation	2016	10
26466563	Antioxidants	Piskounova E	Oxidative stress inhibits distant metastasis by human melanoma cells.	Nature	2015	126
26700816	Antioxidants	Liao L	TNF-α Inhibits FoxO1 by Upregulating miR-705 to Aggravate Oxidative Damage in Bone Marrow-Derived Mesenchymal Stem Cells during Osteoporosis.	Stem cells	2016	12
27127201	Antioxidants	Li X	Mitochondrial Reactive Oxygen Species Mediate Lysophosphatidylcholine-Induced Endothelial Cell Activation.	Arteriosclerosis, thrombosis, and vascular biology	2016	14
27251288	Antioxidants	Tao G	Pitx2 promotes heart repair by activating the antioxidant response after cardiac injury.	Nature	2016	25
27312235	Antioxidants	Strong R	Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α-glucosidase inhibitor or a Nrf2-inducer.	Aging cell	2016	21
12451010	Streptozocin	Bucciarelli LG	RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice.	Circulation	2002	117
15326158	Streptozocin	Martin PM	Death of retinal neurons in streptozotocin-induced diabetic mice.	Investigative ophthalmology & visual science	2004	129
16249509	Streptozocin	Feit-Leichman RA	Vascular damage in a mouse model of diabetic retinopathy: relation to neuronal and glial changes.	Investigative ophthalmology & visual science	2005	77
17053023	Streptozocin	Botolin S	Bone loss and increased bone adiposity in spontaneous and pharmacologically induced diabetic mice.	Endocrinology	2007	68
17360381	Streptozocin	Camici GG	Genetic deletion of p66(Shc) adaptor protein prevents hyperglycemia-induced endothelial dysfunction and oxidative stress.	Proceedings of the National Academy of Sciences of the United States of America	2007	69
18987304	Streptozocin	Zeisberg EM	Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition.	Journal of the American Society of Nephrology 	2008	243
19729486	Streptozocin	Li J	Endothelial-myofibroblast transition contributes to the early development of diabetic renal interstitial fibrosis in streptozotocin-induced diabetic mice.	The American journal of pathology	2009	79
19966057	Streptozocin	Williamson CL	Enhanced apoptotic propensity in diabetic cardiac mitochondria: influence of subcellular spatial location.	American journal of physiology. Heart and circulatory physiology	2010	41
20023661	Streptozocin	Gur C	The activating receptor NKp46 is essential for the development of type 1 diabetes.	Nature immunology	2010	54
20682692	Streptozocin	Li J	Blockade of endothelial-mesenchymal transition by a Smad3 inhibitor delays the early development of streptozotocin-induced diabetic nephropathy.	Diabetes	2010	57
20937871	Streptozocin	Oboki K	IL-33 is a crucial amplifier of innate rather than acquired immunity.	Proceedings of the National Academy of Sciences of the United States of America	2010	149
21212173	Streptozocin	Huang H	TNFalpha is required for late BRB breakdown in diabetic retinopathy, and its inhibition prevents leukostasis and protects vessels and neurons from apoptosis.	Investigative ophthalmology & visual science	2011	58
21730150	Streptozocin	Ruan Q	The microRNA-21-PDCD4 axis prevents type 1 diabetes by blocking pancreatic beta cell death.	Proceedings of the National Academy of Sciences of the United States of America	2011	51
21926276	Streptozocin	Morris SM Jr	Arginase-2 mediates diabetic renal injury.	Diabetes	2011	35
23093658	Streptozocin	Sivaskandarajah GA	Vegfa protects the glomerular microvasculature in diabetes.	Diabetes	2012	34
23139354	Streptozocin	Hodgin JB	Identification of cross-species shared transcriptional networks of diabetic nephropathy in human and mouse glomeruli.	Diabetes	2013	44
23321698	Streptozocin	Erener S	Circulating miR-375 as a biomarker of β-cell death and diabetes in mice.	Endocrinology	2013	38
23426181	Streptozocin	Luo M	Diabetes increases mortality after myocardial infarction by oxidizing CaMKII.	The Journal of clinical investigation	2013	70
24428157	Streptozocin	Chen S	Cardiac miR-133a overexpression prevents early cardiac fibrosis in diabetes.	Journal of cellular and molecular medicine	2014	31
24574044	Streptozocin	Kanasaki K	Linagliptin-mediated DPP-4 inhibition ameliorates kidney fibrosis in streptozotocin-induced diabetic mice by inhibiting endothelial-to-mesenchymal transition in a therapeutic regimen.	Diabetes	2014	56
24722437	Streptozocin	Lenoir O	Direct action of endothelin-1 on podocytes promotes diabetic glomerulosclerosis.	Journal of the American Society of Nephrology 	2014	22
25311234	Streptozocin	Hou X	Sirt3 is essential for apelin-induced angiogenesis in post-myocardial infarction of diabetes.	Journal of cellular and molecular medicine	2015	21
25830763	Streptozocin	Shi S	Interactions of DPP-4 and integrin β1 influences endothelial-to-mesenchymal transition.	Kidney international	2015	18
26508318	Streptozocin	Jha JC	Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.	Diabetologia	2016	13
27318147	Streptozocin	Teufel A	Comparison of Gene Expression Patterns Between Mouse Models of Nonalcoholic Fatty Liver Disease and Liver Tissues From Patients.	Gastroenterology	2016	18
16166452	gemcitabine	Suzuki E	Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity.	Clinical cancer research 	2005	255
17332349	gemcitabine	Feldmann G	Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers.	Cancer research	2007	242
17404099	gemcitabine	Nomi T	Clinical significance and therapeutic potential of the programmed death-1 ligand/programmed death-1 pathway in human pancreatic cancer.	Clinical cancer research 	2007	211
17440100	gemcitabine	Kunnumakkara AB	Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products.	Cancer research	2007	145
18413796	gemcitabine	Melisi D	LY2109761, a novel transforming growth factor beta receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis.	Molecular cancer therapeutics	2008	93
18772115	gemcitabine	Shaked Y	Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: implications for antiangiogenic drugs as chemosensitizing agents.	Cancer cell	2008	130
19336265	gemcitabine	Le HK	Gemcitabine directly inhibits myeloid derived suppressor cells in BALB/c mice bearing 4T1 mammary carcinoma and augments expansion of T cells from tumor-bearing mice.	International immunopharmacology	2009	89
19501590	gemcitabine	Mueller MT	Combined targeted treatment to eliminate tumorigenic cancer stem cells in human pancreatic cancer.	Gastroenterology	2009	81
19908231	gemcitabine	Harikumar KB	Resveratrol, a multitargeted agent, can enhance antitumor activity of gemcitabine in vitro and in orthotopic mouse model of human pancreatic cancer.	International journal of cancer	2010	52
20072652	gemcitabine	Lin L	A novel small molecule, LLL12, inhibits STAT3 phosphorylation and activities and exhibits potent growth-suppressive activity in human cancer cells.	Neoplasia	2010	54
20683663	gemcitabine	Du Z	Pancreatic cancer cells resistant to chemoradiotherapy rich in "stem-cell-like" tumor cells.	Digestive diseases and sciences	2011	54
21148071	gemcitabine	Dangi-Garimella S	Three-dimensional collagen I promotes gemcitabine resistance in pancreatic cancer through MT1-MMP-mediated expression of HMGA2.	Cancer research	2011	37
21408027	gemcitabine	Bao B	Anti-tumor activity of a novel compound-CDF is mediated by regulating miR-21, miR-200, and PTEN in pancreatic cancer.	PloS one	2011	73
21436454	gemcitabine	Beatty GL	CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans.	Science	2011	405
21525939	gemcitabine	Donadelli M	Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism.	Cell death & disease	2011	45
21680779	gemcitabine	Mundy-Bosse BL	Myeloid-derived suppressor cell inhibition of the IFN response in tumor-bearing mice.	Cancer research	2011	48
21864475	gemcitabine	Li C	c-Met is a marker of pancreatic cancer stem cells and therapeutic target.	Gastroenterology	2011	119
21969517	gemcitabine	Von Hoff DD	Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial.	Journal of clinical oncology 	2011	260
22585996	gemcitabine	Frese KK	nab-Paclitaxel potentiates gemcitabine activity by reducing cytidine deaminase levels in a mouse model of pancreatic cancer.	Cancer discovery	2012	93
23034169	gemcitabine	Yi H	Mouse CD11b+Gr-1+ myeloid cells can promote Th17 cell differentiation and experimental autoimmune encephalomyelitis.	Journal of immunology	2012	36
23348422	gemcitabine	Kozono S	Pirfenidone inhibits pancreatic cancer desmoplasia by regulating stellate cells.	Cancer research	2013	26
23402593	gemcitabine	Lee GY	Theranostic nanoparticles with controlled release of gemcitabine for targeted therapy and MRI of pancreatic cancer.	ACS nano	2013	47
23520471	gemcitabine	Kreahling JM	Wee1 inhibition by MK-1775 leads to tumor inhibition and enhances efficacy of gemcitabine in human sarcomas.	PloS one	2013	26
23593991	gemcitabine	Thompson R	The cancer therapeutic potential of Chk1 inhibitors: how mechanistic studies impact on clinical trial design.	British journal of clinical pharmacology	2013	35
23626745	gemcitabine	Lesterhuis WJ	Synergistic effect of CTLA-4 blockade and cancer chemotherapy in the induction of anti-tumor immunity.	PloS one	2013	31
23836645	gemcitabine	Neesse A	CTGF antagonism with mAb FG-3019 enhances chemotherapy response without increasing drug delivery in murine ductal pancreas cancer.	Proceedings of the National Academy of Sciences of the United States of America	2013	48
23995783	gemcitabine	Weizman N	Macrophages mediate gemcitabine resistance of pancreatic adenocarcinoma by upregulating cytidine deaminase.	Oncogene	2014	45
24148817	gemcitabine	Reid G	Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma.	Annals of oncology 	2013	33
24856586	gemcitabine	Özdemir BC	Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival.	Cancer cell	2014	307
24859161	gemcitabine	Li L	Down-regulation of microRNA-494 via loss of SMAD4 increases FOXM1 and β-catenin signaling in pancreatic ductal adenocarcinoma cells.	Gastroenterology	2014	29
24919854	gemcitabine	Gelbert LM	Preclinical characterization of the CDK4/6 inhibitor LY2835219: in-vivo cell cycle-dependent/independent anti-tumor activities alone/in combination with gemcitabine.	Investigational new drugs	2014	57
25277192	gemcitabine	Khan S	MicroRNA-145 targets MUC13 and suppresses growth and invasion of pancreatic cancer.	Oncotarget	2014	33
25544770	gemcitabine	Zhao T	Inhibition of HIF-1α by PX-478 enhances the anti-tumor effect of gemcitabine by inducing immunogenic cell death in pancreatic ductal adenocarcinoma.	Oncotarget	2015	22
25548227	gemcitabine	Tebartz C	A major role for myeloid-derived suppressor cells and a minor role for regulatory T cells in immunosuppression during Staphylococcus aureus infection.	Journal of immunology	2015	18
25776964	gemcitabine	Meng H	Use of a lipid-coated mesoporous silica nanoparticle platform for synergistic gemcitabine and paclitaxel delivery to human pancreatic cancer in mice.	ACS nano	2015	26
25834145	gemcitabine	Duluc C	Pharmacological targeting of the protein synthesis mTOR/4E-BP1 pathway in cancer-associated fibroblasts abrogates pancreatic tumour chemoresistance.	EMBO molecular medicine	2015	20
25840985	gemcitabine	Khan S	Ormeloxifene suppresses desmoplasia and enhances sensitivity of gemcitabine in pancreatic cancer.	Cancer research	2015	19
25889214	gemcitabine	Li Z	The long non-coding RNA HOTTIP promotes progression and gemcitabine resistance by regulating HOXA13 in pancreatic cancer.	Journal of translational medicine	2015	45
26036346	gemcitabine	Tréhoux S	Micro-RNAs miR-29a and miR-330-5p function as tumor suppressors by targeting the MUC1 mucin in pancreatic cancer cells.	Biochimica et biophysica acta	2015	20
26077591	gemcitabine	Miller BW	Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacy.	EMBO molecular medicine	2015	33
26169969	gemcitabine	Hidalgo M	SPARC Expression Did Not Predict Efficacy of nab-Paclitaxel plus Gemcitabine or Gemcitabine Alone for Metastatic Pancreatic Cancer in an Exploratory Analysis of the Phase III MPACT Trial.	Clinical cancer research 	2015	30
26255562	gemcitabine	Nagathihalli NS	Signal Transducer and Activator of Transcription 3, Mediated Remodeling of the Tumor Microenvironment Results in Enhanced Tumor Drug Delivery in a Mouse Model of Pancreatic Cancer.	Gastroenterology	2015	16
26517239	gemcitabine	Vendetti FP	The orally active and bioavailable ATR kinase inhibitor AZD6738 potentiates the anti-tumor effects of cisplatin to resolve ATM-deficient non-small cell lung cancer in vivo.	Oncotarget	2015	26
26560028	gemcitabine	Zheng X	Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer.	Nature	2015	289
27003603	gemcitabine	Wörmann SM	Loss of P53 Function Activates JAK2-STAT3 Signaling to Promote Pancreatic Tumor Growth, Stroma Modification, and Gemcitabine Resistance in Mice and Is Associated With Patient Survival.	Gastroenterology	2016	17
27049944	gemcitabine	Seifert L	The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression.	Nature	2016	29
27216178	gemcitabine	Schultz MJ	The Tumor-Associated Glycosyltransferase ST6Gal-I Regulates Stem Cell Transcription Factors and Confers a Cancer Stem Cell Phenotype.	Cancer research	2016	12
9633809	Reactive Oxygen Species	Hall ED	Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS.	Glia	1998	124
11249877	Reactive Oxygen Species	Ide T	Mitochondrial DNA damage and dysfunction associated with oxidative stress in failing hearts after myocardial infarction.	Circulation research	2001	134
11714743	Reactive Oxygen Species	Barry-Lane PA	p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice.	The Journal of clinical investigation	2001	123
14707072	Reactive Oxygen Species	Kusmartsev S	Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species.	Journal of immunology	2004	220
15165233	Reactive Oxygen Species	Ng VH	Role of KatG catalase-peroxidase in mycobacterial pathogenesis: countering the phagocyte oxidative burst.	Molecular microbiology	2004	91
15310853	Reactive Oxygen Species	Hultqvist M	Enhanced autoimmunity, arthritis, and encephalomyelitis in mice with a reduced oxidative burst due to a mutation in the Ncf1 gene.	Proceedings of the National Academy of Sciences of the United States of America	2004	94
15647368	Reactive Oxygen Species	Petros JA	mtDNA mutations increase tumorigenicity in prostate cancer.	Proceedings of the National Academy of Sciences of the United States of America	2005	249
15800626	Reactive Oxygen Species	Nakagawa T	Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death.	Nature	2005	435
15867174	Reactive Oxygen Species	Tojo T	Role of gp91phox (Nox2)-containing NAD(P)H oxidase in angiogenesis in response to hindlimb ischemia.	Circulation	2005	97
16109921	Reactive Oxygen Species	Castier Y	p47phox-dependent NADPH oxidase regulates flow-induced vascular remodeling.	Circulation research	2005	70
16505246	Reactive Oxygen Species	Shen X	Protection of cardiac mitochondria by overexpression of MnSOD reduces diabetic cardiomyopathy.	Diabetes	2006	101
16789936	Reactive Oxygen Species	Whitehead NP	Muscle damage in mdx (dystrophic) mice: role of calcium and reactive oxygen species.	Clinical and experimental pharmacology & physiology	2006	74
16847346	Reactive Oxygen Species	Kondratov RV	Early aging and age-related pathologies in mice deficient in BMAL1, the core componentof the circadian clock.	Genes & development	2006	272
17034877	Reactive Oxygen Species	Schrader M	Peroxisomes and oxidative stress.	Biochimica et biophysica acta	2006	124
17055439	Reactive Oxygen Species	St-Pierre J	Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators.	Cell	2006	567
17116235	Reactive Oxygen Species	Lambert MP	Monoclonal antibodies that target pathological assemblies of Abeta.	Journal of neurochemistry	2007	109
17584954	Reactive Oxygen Species	Muller FL	Denervation-induced skeletal muscle atrophy is associated with increased mitochondrial ROS production.	American journal of physiology. Regulatory, integrative and comparative physiology	2007	78
17602956	Reactive Oxygen Species	Wang J	Role of Nrf2 in protection against intracerebral hemorrhage injury in mice.	Free radical biology & medicine	2007	68
17977949	Reactive Oxygen Species	Brezniceanu ML	Attenuation of interstitial fibrosis and tubular apoptosis in db/db transgenic mice overexpressing catalase in renal proximal tubular cells.	Diabetes	2008	56
18074631	Reactive Oxygen Species	Spiegelman BM	Transcriptional control of mitochondrial energy metabolism through the PGC1 coactivators.	Novartis Foundation symposium	2007	59
18216297	Reactive Oxygen Species	Wernig G	The Jak2V617F oncogene associated with myeloproliferative diseases requires a functional FERM domain for transformation and for expression of the Myc and Pim proto-oncogenes.	Blood	2008	50
18372916	Reactive Oxygen Species	Frohlich DA	The role of Nrf2 in increased reactive oxygen species and DNA damage in prostate tumorigenesis.	Oncogene	2008	58
18394557	Reactive Oxygen Species	Duran A	The signaling adaptor p62 is an important NF-kappaB mediator in tumorigenesis.	Cancer cell	2008	181
18583711	Reactive Oxygen Species	Urao N	Role of nox2-based NADPH oxidase in bone marrow and progenitor cell function involved in neovascularization induced by hindlimb ischemia.	Circulation research	2008	74
18832739	Reactive Oxygen Species	Youn JI	Subsets of myeloid-derived suppressor cells in tumor-bearing mice.	Journal of immunology	2008	503
19023330	Reactive Oxygen Species	Moisoi N	Mitochondrial dysfunction triggered by loss of HtrA2 results in the activation of a brain-specific transcriptional stress response.	Cell death and differentiation	2009	47
19047182	Reactive Oxygen Species	Sung SY	Coevolution of prostate cancer and bone stroma in three-dimensional coculture: implications for cancer growth and metastasis.	Cancer research	2008	56
19190247	Reactive Oxygen Species	Lucas DM	The novel plant-derived agent silvestrol has B-cell selective activity in chronic lymphocytic leukemia and acute lymphoblastic leukemia in vitro and in vivo.	Blood	2009	55
19380816	Reactive Oxygen Species	Corzo CA	Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells.	Journal of immunology	2009	166
19413947	Reactive Oxygen Species	Lebedeva MA	Loss of p53 causes mitochondrial DNA depletion and altered mitochondrial reactive oxygen species homeostasis.	Biochimica et biophysica acta	2009	62
19430489	Reactive Oxygen Species	Satoh K	Cyclophilin A enhances vascular oxidative stress and the development of angiotensin II-induced aortic aneurysms.	Nature medicine	2009	78
19451351	Reactive Oxygen Species	Dai DF	Overexpression of catalase targeted to mitochondria attenuates murine cardiac aging.	Circulation	2009	151
19592468	Reactive Oxygen Species	Li J	Nrf2 protects against maladaptive cardiac responses to hemodynamic stress.	Arteriosclerosis, thrombosis, and vascular biology	2009	63
19592621	Reactive Oxygen Species	Shen E	Rac1 is required for cardiomyocyte apoptosis during hyperglycemia.	Diabetes	2009	50
19633237	Reactive Oxygen Species	Jang YC	Overexpression of Mn superoxide dismutase does not increase life span in mice.	The journals of gerontology. Series A, Biological sciences and medical sciences	2009	85
19661248	Reactive Oxygen Species	Carnesecchi S	NADPH oxidase-1 plays a crucial role in hyperoxia-induced acute lung injury in mice.	American journal of respiratory and critical care medicine	2009	52
19801454	Reactive Oxygen Species	Zhou G	Hypoxia-induced alveolar epithelial-mesenchymal transition requires mitochondrial ROS and hypoxia-inducible factor 1.	American journal of physiology. Lung cellular and molecular physiology	2009	62
19908287	Reactive Oxygen Species	Rojo AI	Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson's disease.	Glia	2010	65
20162412	Reactive Oxygen Species	Sasaki M	Neurodegenerative influence of oxidative stress in the retina of a murine model of diabetes.	Diabetologia	2010	55
20186336	Reactive Oxygen Species	Krebiehl G	Reduced basal autophagy and impaired mitochondrial dynamics due to loss of Parkinson's disease-associated protein DJ-1.	PloS one	2010	88
20421486	Reactive Oxygen Species	Weinberg F	Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity.	Proceedings of the National Academy of Sciences of the United States of America	2010	375
20463404	Reactive Oxygen Species	Dragicevic N	Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice.	Journal of Alzheimer's disease 	2010	52
20511556	Reactive Oxygen Species	Kong X	NADPH oxidase-dependent reactive oxygen species mediate amplified TLR4 signaling and sepsis-induced mortality in Nrf2-deficient mice.	Journal of immunology	2010	46
20628647	Reactive Oxygen Species	Hiona A	Mitochondrial DNA mutations induce mitochondrial dysfunction, apoptosis and sarcopenia in skeletal muscle of mitochondrial DNA mutator mice.	PloS one	2010	69
20639397	Reactive Oxygen Species	Irrcher I	Loss of the Parkinson's disease-linked gene DJ-1 perturbs mitochondrial dynamics.	Human molecular genetics	2010	115
21029048	Reactive Oxygen Species	Mandal CC	Reactive oxygen species derived from Nox4 mediate BMP2 gene transcription and osteoblast differentiation.	The Biochemical journal	2011	38
21245373	Reactive Oxygen Species	Papanicolaou KN	Mitofusin-2 maintains mitochondrial structure and contributes to stress-induced permeability transition in cardiac myocytes.	Molecular and cellular biology	2011	109
21300795	Reactive Oxygen Species	Kim MJ	Involvement of autophagy in oncogenic K-Ras-induced malignant cell transformation.	The Journal of biological chemistry	2011	76
21304882	Reactive Oxygen Species	Vlahos R	Inhibition of Nox2 oxidase activity ameliorates influenza A virus-induced lung inflammation.	PLoS pathogens	2011	55
21307849	Reactive Oxygen Species	Sahin E	Telomere dysfunction induces metabolic and mitochondrial compromise.	Nature	2011	324
21358671	Reactive Oxygen Species	Bell EL	SirT3 suppresses hypoxia inducible factor 1α and tumor growth by inhibiting mitochondrial ROS production.	Oncogene	2011	130
21528437	Reactive Oxygen Species	Murdoch CE	Role of endothelial Nox2 NADPH oxidase in angiotensin II-induced hypertension and vasomotor dysfunction.	Basic research in cardiology	2011	39
21555567	Reactive Oxygen Species	Shaw AT	Selective killing of K-ras mutant cancer cells by small molecule inducers of oxidative stress.	Proceedings of the National Academy of Sciences of the United States of America	2011	56
21715323	Reactive Oxygen Species	Szczepanek K	Mitochondrial-targeted Signal transducer and activator of transcription 3 (STAT3) protects against ischemia-induced changes in the electron transport chain and the generation of reactive oxygen species.	The Journal of biological chemistry	2011	54
21803290	Reactive Oxygen Species	Andersson DC	Ryanodine receptor oxidation causes intracellular calcium leak and muscle weakness in aging.	Cell metabolism	2011	100
21853114	Reactive Oxygen Species	Hahm ER	Withaferin A-induced apoptosis in human breast cancer cells is mediated by reactive oxygen species.	PloS one	2011	52
21983037	Reactive Oxygen Species	Suh YA	Multiple stress signals activate mutant p53 in vivo.	Cancer research	2011	35
22056359	Reactive Oxygen Species	Woo DK	Mitochondrial genome instability and ROS enhance intestinal tumorigenesis in APC(Min/+) mice.	The American journal of pathology	2012	37
22079466	Reactive Oxygen Species	Piao LS	CD133+ liver cancer stem cells modulate radioresistance in human hepatocellular carcinoma.	Cancer letters	2012	53
22101731	Reactive Oxygen Species	Di A	The redox-sensitive cation channel TRPM2 modulates phagocyte ROS production and inflammation.	Nature immunology	2011	55
22123964	Reactive Oxygen Species	He S	Toll-like receptors activate programmed necrosis in macrophages through a receptor-interacting kinase-3-mediated pathway.	Proceedings of the National Academy of Sciences of the United States of America	2011	139
22337127	Reactive Oxygen Species	Weissmann N	Activation of TRPC6 channels is essential for lung ischaemia-reperfusion induced oedema in mice.	Nature communications	2012	47
22341444	Reactive Oxygen Species	Raimundo N	Mitochondrial stress engages E2F1 apoptotic signaling to cause deafness.	Cell	2012	58
22388960	Reactive Oxygen Species	Wu LJ	The voltage-gated proton channel Hv1 enhances brain damage from ischemic stroke.	Nature neuroscience	2012	60
22567104	Reactive Oxygen Species	Kim DY	Inflammation-mediated memory dysfunction and effects of a ketogenic diet in a murine model of multiple sclerosis.	PloS one	2012	39
22592897	Reactive Oxygen Species	Ma X	Impaired autophagosome clearance contributes to cardiomyocyte death in ischemia/reperfusion injury.	Circulation	2012	100
22747566	Reactive Oxygen Species	Zhang M	NADPH oxidases in heart failure: poachers or gamekeepers?	Antioxidants & redox signaling	2013	42
22797809	Reactive Oxygen Species	Okuno Y	Pathological neoangiogenesis depends on oxidative stress regulation by ATM.	Nature medicine	2012	44
22882466	Reactive Oxygen Species	Jurk D	Postmitotic neurons develop a p21-dependent senescence-like phenotype driven by a DNA damage response.	Aging cell	2012	60
22897481	Reactive Oxygen Species	Sheng SL	Knockdown of lactate dehydrogenase A suppresses tumor growth and metastasis of human hepatocellular carcinoma.	The FEBS journal	2012	42
22917578	Reactive Oxygen Species	Frank M	Mitophagy is triggered by mild oxidative stress in a mitochondrial fission dependent manner.	Biochimica et biophysica acta	2012	90
23159440	Reactive Oxygen Species	Sakai J	Reactive oxygen species-induced actin glutathionylation controls actin dynamics in neutrophils.	Immunity	2012	41
23248151	Reactive Oxygen Species	Sun B	Bone morphogenetic protein-4 mediates cardiac hypertrophy, apoptosis, and fibrosis in experimentally pathological cardiac hypertrophy.	Hypertension	2013	28
23311871	Reactive Oxygen Species	Parada E	The microglial α7-acetylcholine nicotinic receptor is a key element in promoting neuroprotection by inducing heme oxygenase-1 via nuclear factor erythroid-2-related factor 2.	Antioxidants & redox signaling	2013	29
23564668	Reactive Oxygen Species	Gray SP	NADPH oxidase 1 plays a key role in diabetes mellitus-accelerated atherosclerosis.	Circulation	2013	86
23645674	Reactive Oxygen Species	Onal M	Suppression of autophagy in osteocytes mimics skeletal aging.	The Journal of biological chemistry	2013	34
23828498	Reactive Oxygen Species	Markowitz J	Myeloid-derived suppressor cells in breast cancer.	Breast cancer research and treatment	2013	32
23841983	Reactive Oxygen Species	Yu E	Mitochondrial DNA damage can promote atherosclerosis independently of reactive oxygen species through effects on smooth muscle cells and monocytes and correlates with higher-risk plaques in humans.	Circulation	2013	34
23996730	Reactive Oxygen Species	Yang L	Transforming growth factor beta signaling in hepatocytes participates in steatohepatitis through regulation of cell death and lipid metabolism in mice.	Hepatology	2014	30
24019511	Reactive Oxygen Species	Zhang Q	Mitochondrial localized Stat3 promotes breast cancer growth via phosphorylation of serine 727.	The Journal of biological chemistry	2013	38
24053718	Reactive Oxygen Species	Wilkinson-Berka JL	NADPH oxidase, NOX1, mediates vascular injury in ischemic retinopathy.	Antioxidants & redox signaling	2014	22
24141879	Reactive Oxygen Species	Jones RM	Symbiotic lactobacilli stimulate gut epithelial proliferation via Nox-mediated generation of reactive oxygen species.	The EMBO journal	2013	63
24186494	Reactive Oxygen Species	Xu Z	NRF2 plays a protective role in diabetic retinopathy in mice.	Diabetologia	2014	31
24206089	Reactive Oxygen Species	Nayernia Z	New insights on NOX enzymes in the central nervous system.	Antioxidants & redox signaling	2014	52
24490760	Reactive Oxygen Species	Tang Z	CX3CR1 deficiency suppresses activation and neurotoxicity of microglia/macrophage in experimental ischemic stroke.	Journal of neuroinflammation	2014	34
24509161	Reactive Oxygen Species	Crosas-Molist E	The NADPH oxidase NOX4 inhibits hepatocyte proliferation and liver cancer progression.	Free radical biology & medicine	2014	20
24525732	Reactive Oxygen Species	Kang SU	Nonthermal plasma induces head and neck cancer cell death: the potential involvement of mitogen-activated protein kinase-dependent mitochondrial reactive oxygen species.	Cell death & disease	2014	33
24583638	Reactive Oxygen Species	Ogrunc M	Oncogene-induced reactive oxygen species fuel hyperproliferation and DNA damage response activation.	Cell death and differentiation	2014	46
24675724	Reactive Oxygen Species	Tian FJ	Elevated microRNA-155 promotes foam cell formation by targeting HBP1 in atherogenesis.	Cardiovascular research	2014	24
24739962	Reactive Oxygen Species	Noubade R	NRROS negatively regulates reactive oxygen species during host defence and autoimmunity.	Nature	2014	40
24781012	Reactive Oxygen Species	Bartell SM	FoxO proteins restrain osteoclastogenesis and bone resorption by attenuating H2O2 accumulation.	Nature communications	2014	37
24811539	Reactive Oxygen Species	Cichon MA	ROS-induced epithelial-mesenchymal transition in mammary epithelial cells is mediated by NF-kB-dependent activation of Snail.	Oncotarget	2014	40
24836575	Reactive Oxygen Species	Schwab L	Neutrophil granulocytes recruited upon translocation of intestinal bacteria enhance graft-versus-host disease via tissue damage.	Nature medicine	2014	30
24841199	Reactive Oxygen Species	Bracey NA	Mitochondrial NLRP3 protein induces reactive oxygen species to promote Smad protein signaling and fibrosis independent from the inflammasome.	The Journal of biological chemistry	2014	27
24874428	Reactive Oxygen Species	Song M	Super-suppression of mitochondrial reactive oxygen species signaling impairs compensatory autophagy in primary mitophagic cardiomyopathy.	Circulation research	2014	47
24916152	Reactive Oxygen Species	Deffert C	Phagocyte NADPH oxidase, chronic granulomatous disease and mycobacterial infections.	Cellular microbiology	2014	26
24920296	Reactive Oxygen Species	Luedde M	RIP3, a kinase promoting necroptotic cell death, mediates adverse remodelling after myocardial infarction.	Cardiovascular research	2014	42
25028121	Reactive Oxygen Species	Pal R	Src-dependent impairment of autophagy by oxidative stress in a mouse model of Duchenne muscular dystrophy.	Nature communications	2014	44
25079327	Reactive Oxygen Species	Santos MA	DNA-damage-induced differentiation of leukaemic cells as an anti-cancer barrier.	Nature	2014	40
25160818	Reactive Oxygen Species	Sommer F	The gut microbiota engages different signaling pathways to induce Duox2 expression in the ileum and colon epithelium.	Mucosal immunology	2015	17
25254654	Reactive Oxygen Species	Lupfer CR	Reactive oxygen species regulate caspase-11 expression and activation of the non-canonical NLRP3 inflammasome during enteric pathogen infection.	PLoS pathogens	2014	20
25270067	Reactive Oxygen Species	Zhan M	Disruption of renal tubular mitochondrial quality control by Myo-inositol oxygenase in diabetic kidney disease.	Journal of the American Society of Nephrology 	2015	25
25356867	Reactive Oxygen Species	Kim SR	NLRP3 inflammasome activation by mitochondrial ROS in bronchial epithelial cells is required for allergic inflammation.	Cell death & disease	2014	21
25378412	Reactive Oxygen Species	Usui F	Inflammasome activation by mitochondrial oxidative stress in macrophages leads to the development of angiotensin II-induced aortic aneurysm.	Arteriosclerosis, thrombosis, and vascular biology	2015	20
25406339	Reactive Oxygen Species	Kawakami T	Deficient Autophagy Results in Mitochondrial Dysfunction and FSGS.	Journal of the American Society of Nephrology 	2015	27
25594180	Reactive Oxygen Species	Liu L	Glial lipid droplets and ROS induced by mitochondrial defects promote neurodegeneration.	Cell	2015	53
25628390	Reactive Oxygen Species	Huang Q	Thioredoxin-2 inhibits mitochondrial reactive oxygen species generation and apoptosis stress kinase-1 activity to maintain cardiac function.	Circulation	2015	28
25656366	Reactive Oxygen Species	Gorin Y	Targeting NADPH oxidase with a novel dual Nox1/Nox4 inhibitor attenuates renal pathology in type 1 diabetes.	American journal of physiology. Renal physiology	2015	32
25705917	Reactive Oxygen Species	Yin Y	Early hyperlipidemia promotes endothelial activation via a caspase-1-sirtuin 1 pathway.	Arteriosclerosis, thrombosis, and vascular biology	2015	25
25782072	Reactive Oxygen Species	Zeng H	High-fat diet induces cardiac remodelling and dysfunction: assessment of the role played by SIRT3 loss.	Journal of cellular and molecular medicine	2015	17
25833396	Reactive Oxygen Species	Schlie K	Survival of effector CD8+ T cells during influenza infection is dependent on autophagy.	Journal of immunology	2015	17
26039448	Reactive Oxygen Species	Varanita T	The OPA1-dependent mitochondrial cristae remodeling pathway controls atrophic, apoptotic, and ischemic tissue damage.	Cell metabolism	2015	39
26099526	Reactive Oxygen Species	Xu MJ	Fat-Specific Protein 27/CIDEC Promotes Development of Alcoholic Steatohepatitis in Mice and Humans.	Gastroenterology	2015	23
26217001	Reactive Oxygen Species	Santulli G	Mitochondrial calcium overload is a key determinant in heart failure.	Proceedings of the National Academy of Sciences of the United States of America	2015	55
26222337	Reactive Oxygen Species	Lan T	Deficiency of NOX1 or NOX4 Prevents Liver Inflammation and Fibrosis in Mice through Inhibition of Hepatic Stellate Cell Activation.	PloS one	2015	26
26308771	Reactive Oxygen Species	Jayavelu AK	NOX4-driven ROS formation mediates PTP inactivation and cell transformation in FLT3ITD-positive AML cells.	Leukemia	2016	11
26463424	Reactive Oxygen Species	Canli Ö	Glutathione peroxidase 4 prevents necroptosis in mouse erythroid precursors.	Blood	2016	13
26582950	Reactive Oxygen Species	Moriwaki K	The Mitochondrial Phosphatase PGAM5 Is Dispensable for Necroptosis but Promotes Inflammasome Activation in Macrophages.	Journal of immunology	2016	14
26659062	Reactive Oxygen Species	González-Juarbe N	Pore-Forming Toxins Induce Macrophage Necroptosis during Acute Bacterial Pneumonia.	PLoS pathogens	2015	25
26675351	Reactive Oxygen Species	Vinchi F	Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.	Blood	2016	27
26921108	Reactive Oxygen Species	Larson-Casey JL	Macrophage Akt1 Kinase-Mediated Mitophagy Modulates Apoptosis Resistance and Pulmonary Fibrosis.	Immunity	2016	27
26934227	Reactive Oxygen Species	Ma C	NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis.	Nature	2016	37
26982722	Reactive Oxygen Species	Ravindran R	The amino acid sensor GCN2 controls gut inflammation by inhibiting inflammasome activation.	Nature	2016	27
27157131	Reactive Oxygen Species	Chan TK	House dust mite-induced asthma causes oxidative damage and DNA double-strand breaks in the lungs.	The Journal of allergy and clinical immunology	2016	11
28273069	Reactive Oxygen Species	Rodríguez-Colman MJ	Interplay between metabolic identities in the intestinal crypt supports stem cell function.	Nature	2017	13
9108112	Kainic Acid	Schauwecker PE	Genetic determinants of susceptibility to excitotoxic cell death: implications for gene targeting approaches.	Proceedings of the National Academy of Sciences of the United States of America	1997	118
9349820	Kainic Acid	Yang DD	Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene.	Nature	1997	221
10080190	Kainic Acid	Behrens A	Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation.	Nature genetics	1999	147
16525056	Kainic Acid	Cunningham MO	Region-specific reduction in entorhinal gamma oscillations and parvalbumin-immunoreactive neurons in animal models of psychiatric illness.	The Journal of neuroscience 	2006	62
16908411	Kainic Acid	Monory K	The endocannabinoid system controls key epileptogenic circuits in the hippocampus.	Neuron	2006	171
18386786	Kainic Acid	Bulloch K	CD11c/EYFP transgene illuminates a discrete network of dendritic cells within the embryonic, neonatal, adult, and injured mouse brain.	The Journal of comparative neurology	2008	74
18784294	Kainic Acid	Avignone E	Status epilepticus induces a particular microglial activation state characterized by enhanced purinergic signaling.	The Journal of neuroscience 	2008	59
19474323	Kainic Acid	Zeng LH	The mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy.	The Journal of neuroscience 	2009	166
21411646	Kainic Acid	Zattoni M	Brain infiltration of leukocytes contributes to the pathophysiology of temporal lobe epilepsy.	The Journal of neuroscience 	2011	48
23296467	Kainic Acid	Luo J	Colony-stimulating factor 1 receptor (CSF1R) signaling in injured neurons facilitates protection and survival.	The Journal of experimental medicine	2013	39
23523633	Kainic Acid	Iori V	Receptor for Advanced Glycation Endproducts is upregulated in temporal lobe epilepsy and contributes to experimental seizures.	Neurobiology of disease	2013	28
24452334	Kainic Acid	Duran J	Glycogen accumulation underlies neurodegeneration and autophagy impairment in Lafora disease.	Human molecular genetics	2014	27
25636686	Kainic Acid	Kuzniewska B	Adult Deletion of SRF Increases Epileptogenesis and Decreases Activity-Induced Gene Expression.	Molecular neurobiology	2016	10
25706475	Kainic Acid	Haines JD	Nuclear export inhibitors avert progression in preclinical models of inflammatory demyelination.	Nature neuroscience	2015	18
27155358	Kainic Acid	Hubbard JA	Regulation of astrocyte glutamate transporter-1 (GLT1) and aquaporin-4 (AQP4) expression in a model of epilepsy.	Experimental neurology	2016	13
15122762	Carbon Tetrachloride	Radaeva S	Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation.	Hepatology	2004	170
15565662	Carbon Tetrachloride	Sakaida I	Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice.	Hepatology	2004	121
15630444	Carbon Tetrachloride	Duffield JS	Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair.	The Journal of clinical investigation	2005	431
15765409	Carbon Tetrachloride	Julien B	Antifibrogenic role of the cannabinoid receptor CB2 in the liver.	Gastroenterology	2005	94
17133483	Carbon Tetrachloride	Jeong WI	STAT1 inhibits liver fibrosis in mice by inhibiting stellate cell proliferation and stimulating NK cell cytotoxicity.	Hepatology	2006	71
17187438	Carbon Tetrachloride	Higashiyama R	Bone marrow-derived cells express matrix metalloproteinases and contribute to regression of liver fibrosis in mice.	Hepatology	2007	63
17404313	Carbon Tetrachloride	Fallowfield JA	Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis.	Journal of immunology	2007	119
18823985	Carbon Tetrachloride	Taura K	Hepatic stellate cells secrete angiopoietin 1 that induces angiogenesis in liver fibrosis.	Gastroenterology	2008	67
20052656	Carbon Tetrachloride	Taura K	Hepatocytes do not undergo epithelial-mesenchymal transition in liver fibrosis in mice.	Hepatology	2010	113
20489162	Carbon Tetrachloride	Wiesner P	Low doses of lipopolysaccharide and minimally oxidized low-density lipoprotein cooperatively activate macrophages via nuclear factor kappa B and activator protein-1: possible mechanism for acceleration of atherosclerosis by subclinical endotoxemia.	Circulation research	2010	59
20546735	Carbon Tetrachloride	Scholten D	Genetic labeling does not detect epithelial-to-mesenchymal transition of cholangiocytes in liver fibrosis in mice.	Gastroenterology	2010	83
20618941	Carbon Tetrachloride	Fujii T	Mouse model of carbon tetrachloride induced liver fibrosis: Histopathological changes and expression of CD133 and epidermal growth factor.	BMC gastroenterology	2010	44
20683935	Carbon Tetrachloride	Aoyama T	CX3CL1-CX3CR1 interaction prevents carbon tetrachloride-induced liver inflammation and fibrosis in mice.	Hepatology	2010	48
20978355	Carbon Tetrachloride	Berres ML	Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice.	The Journal of clinical investigation	2010	46
21433043	Carbon Tetrachloride	Thomas JA	Macrophage therapy for murine liver fibrosis recruits host effector cells improving fibrosis, regeneration, and function.	Hepatology	2011	65
21813474	Carbon Tetrachloride	Baeck C	Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury.	Gut	2012	94
21898476	Carbon Tetrachloride	Jiao J	Dendritic cell regulation of carbon tetrachloride-induced murine liver fibrosis regression.	Hepatology	2012	36
22031018	Carbon Tetrachloride	Heymann F	Hepatic macrophage migration and differentiation critical for liver fibrosis is mediated by the chemokine receptor C-C motif chemokine receptor 8 in mice.	Hepatology	2012	41
22750464	Carbon Tetrachloride	Troeger JS	Deactivation of hepatic stellate cells during liver fibrosis resolution in mice.	Gastroenterology	2012	105
22922013	Carbon Tetrachloride	Español-Suñer R	Liver progenitor cells yield functional hepatocytes in response to chronic liver injury in mice.	Gastroenterology	2012	91
23100531	Carbon Tetrachloride	Ramachandran P	Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis.	Proceedings of the National Academy of Sciences of the United States of America	2012	158
23508104	Carbon Tetrachloride	Kim KH	Matricellular protein CCN1 promotes regression of liver fibrosis through induction of cellular senescence in hepatic myofibroblasts.	Molecular and cellular biology	2013	59
23680654	Carbon Tetrachloride	Kuramitsu K	Failure of fibrotic liver regeneration in mice is linked to a severe fibrogenic response driven by hepatic progenitor cell activation.	The American journal of pathology	2013	27
23838178	Carbon Tetrachloride	Fuchs BC	Molecular MRI of collagen to diagnose and stage liver fibrosis.	Journal of hepatology	2013	26
23842754	Carbon Tetrachloride	Tan Z	IL-17A plays a critical role in the pathogenesis of liver fibrosis through hepatic stellate cell activation.	Journal of immunology	2013	45
24196965	Carbon Tetrachloride	Zhang Z	The autoregulatory feedback loop of microRNA-21/programmed cell death protein 4/activation protein-1 (MiR-21/PDCD4/AP-1) as a driving force for hepatic fibrosis development.	The Journal of biological chemistry	2013	26
24216753	Carbon Tetrachloride	Henderson NC	Targeting of αv integrin identifies a core molecular pathway that regulates fibrosis in several organs.	Nature medicine	2013	142
24256728	Carbon Tetrachloride	Ding BS	Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis.	Nature	2014	108
24561613	Carbon Tetrachloride	Ehling J	CCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis.	Gut	2014	39
24677197	Carbon Tetrachloride	Fuchs BC	Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma.	Hepatology	2014	68
24728410	Carbon Tetrachloride	O'Brien AJ	Immunosuppression in acutely decompensated cirrhosis is mediated by prostaglandin E2.	Nature medicine	2014	21
24817606	Carbon Tetrachloride	Tu X	MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway.	The Journal of pathology	2014	26
25074909	Carbon Tetrachloride	Iwaisako K	Origin of myofibroblasts in the fibrotic liver in mice.	Proceedings of the National Academy of Sciences of the United States of America	2014	73
26061908	Carbon Tetrachloride	Lodder J	Macrophage autophagy protects against liver fibrosis in mice.	Autophagy	2015	23
26806818	Carbon Tetrachloride	Lua I	Characterization of hepatic stellate cells, portal fibroblasts, and mesothelial cells in normal and fibrotic livers.	Journal of hepatology	2016	19
26944089	Carbon Tetrachloride	Sun KH	α-Smooth muscle actin is an inconsistent marker of fibroblasts responsible for force-dependent TGFβ activation or collagen production across multiple models of organ fibrosis.	American journal of physiology. Lung cellular and molecular physiology	2016	14
27001906	Carbon Tetrachloride	Hyun J	MicroRNA-378 limits activation of hepatic stellate cells and liver fibrosis by suppressing Gli3 expression.	Nature communications	2016	20
28336518	Carbon Tetrachloride	Breitkopf-Heinlein K	BMP-9 interferes with liver regeneration and promotes liver fibrosis.	Gut	2017	6
11751631	Doxycycline	Fisher GH	Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes.	Genes & development	2001	193
12498714	Doxycycline	Moody SE	Conditional activation of Neu in the mammary epithelium of transgenic mice results in reversible pulmonary metastasis.	Cancer cell	2002	114
14726475	Doxycycline	Russell LK	Cardiac-specific induction of the transcriptional coactivator peroxisome proliferator-activated receptor gamma coactivator-1alpha promotes mitochondrial biogenesis and reversible cardiomyopathy in a developmental stage-dependent manner.	Circulation research	2004	117
15668323	Doxycycline	Lappalainen U	Interleukin-1beta causes pulmonary inflammation, emphysema, and airway remodeling in the adult murine lung.	American journal of respiratory cell and molecular biology	2005	99
15882627	Doxycycline	Hochedlinger K	Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues.	Cell	2005	292
16291936	Doxycycline	Ramsden M	Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L).	The Journal of neuroscience 	2005	163
17450133	Doxycycline	Sarkisian CJ	Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis.	Nature cell biology	2007	153
17475880	Doxycycline	Cheng DS	Airway epithelium controls lung inflammation and injury through the NF-kappa B pathway.	Journal of immunology	2007	74
18374910	Doxycycline	Gontan C	Sox2 is important for two crucial processes in lung development: branching morphogenesis and epithelial cell differentiation.	Developmental biology	2008	83
18723761	Doxycycline	West J	Mice expressing BMPR2R899X transgene in smooth muscle develop pulmonary vascular lesions.	American journal of physiology. Lung cellular and molecular physiology	2008	60
20375978	Doxycycline	Veron D	Overexpression of VEGF-A in podocytes of adult mice causes glomerular disease.	Kidney international	2010	56
20603324	Doxycycline	Ward AJ	CUGBP1 overexpression in mouse skeletal muscle reproduces features of myotonic dystrophy type 1.	Human molecular genetics	2010	56
21293062	Doxycycline	Hiramatsu K	Generation of hyaline cartilaginous tissue from mouse adult dermal fibroblast culture by defined factors.	The Journal of clinical investigation	2011	44
21750654	Doxycycline	Yori JL	Krüppel-like factor 4 inhibits tumorigenic progression and metastasis in a mouse model of breast cancer.	Neoplasia	2011	46
21804090	Doxycycline	Zhu L	Activation of RhoA in podocytes induces focal segmental glomerulosclerosis.	Journal of the American Society of Nephrology 	2011	40
21854751	Doxycycline	Kopeikina KJ	Tau accumulation causes mitochondrial distribution deficits in neurons in a mouse model of tauopathy and in human Alzheimer's disease brain.	The American journal of pathology	2011	56
22105174	Doxycycline	Chakravarty D	Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation.	The Journal of clinical investigation	2011	67
22158040	Doxycycline	Hsu TI	Sp1 expression regulates lung tumor progression.	Oncogene	2012	37
22278020	Doxycycline	Wang L	Mechanisms of the proteinuria induced by Rho GTPases.	Kidney international	2012	40
22908324	Doxycycline	Reis M	Endothelial Wnt/β-catenin signaling inhibits glioma angiogenesis and normalizes tumor blood vessels by inducing PDGF-B expression.	The Journal of experimental medicine	2012	35
23218253	Doxycycline	Fitting S	Synaptic dysfunction in the hippocampus accompanies learning and memory deficits in human immunodeficiency virus type-1 Tat transgenic mice.	Biological psychiatry	2013	54
23312284	Doxycycline	Sung HK	Adipose vascular endothelial growth factor regulates metabolic homeostasis through angiogenesis.	Cell metabolism	2013	61
24474779	Doxycycline	Berger K	Origin of regenerating tubular cells after acute kidney injury.	Proceedings of the National Academy of Sciences of the United States of America	2014	34
24985474	Doxycycline	Mao H	Mitochondrial oxidative stress in the retinal pigment epithelium leads to localized retinal degeneration.	Investigative ophthalmology & visual science	2014	23
25176645	Doxycycline	Dandapat A	Dominant lethal pathologies in male mice engineered to contain an X-linked DUX4 transgene.	Cell reports	2014	25
25965570	Doxycycline	Shirai CL	Mutant U2AF1 Expression Alters Hematopoiesis and Pre-mRNA Splicing In Vivo.	Cancer cell	2015	34
26091037	Doxycycline	Dow LE	Apc Restoration Promotes Cellular Differentiation and Reestablishes Crypt Homeostasis in Colorectal Cancer.	Cell	2015	80
26197969	Doxycycline	Walker AK	Functional recovery in new mouse models of ALS/FTLD after clearance of pathological cytoplasmic TDP-43.	Acta neuropathologica	2015	24
21259015	perlecan	Hawkes CA	Perivascular drainage of solutes is impaired in the ageing mouse brain and in the presence of cerebral amyloid angiopathy.	Acta neuropathologica	2011	67
21747167	perlecan	Lee B	Perlecan domain V is neuroprotective and proangiogenic following ischemic stroke in rodents.	The Journal of clinical investigation	2011	38
10200307	trichostatin A	Saito A	A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors.	Proceedings of the National Academy of Sciences of the United States of America	1999	111
19553350	trichostatin A	Noh H	Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury.	American journal of physiology. Renal physiology	2009	60
19640900	trichostatin A	Pang M	Inhibition of histone deacetylase activity attenuates renal fibroblast activation and interstitial fibrosis in obstructive nephropathy.	American journal of physiology. Renal physiology	2009	63
20036643	trichostatin A	Benny Klimek ME	Acute inhibition of myostatin-family proteins preserves skeletal muscle in mouse models of cancer cachexia.	Biochemical and biophysical research communications	2010	57
22038994	trichostatin A	Landreville S	Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.	Clinical cancer research 	2012	66
22116937	trichostatin A	Giralt A	Long-term memory deficits in Huntington's disease are associated with reduced CBP histone acetylase activity.	Human molecular genetics	2012	32
22226832	trichostatin A	Wang B	Histone deacetylase inhibition activates transcription factor Nrf2 and protects against cerebral ischemic damage.	Free radical biology & medicine	2012	36
22419664	trichostatin A	Coulouarn C	Hepatocyte-stellate cell cross-talk in the liver engenders a permissive inflammatory microenvironment that drives progression in hepatocellular carcinoma.	Cancer research	2012	46
22641068	trichostatin A	Buurman R	Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells.	Gastroenterology	2012	52
22699621	trichostatin A	Pérez-Mancera PA	The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma.	Nature	2012	101
23379261	trichostatin A	Li Y	Epigenetic reactivation of estrogen receptor-α (ERα) by genistein enhances hormonal therapy sensitivity in ERα-negative breast cancer.	Molecular cancer	2013	37
23979134	trichostatin A	Yang Z	MicroRNA-433 inhibits liver cancer cell migration by repressing the protein expression and function of cAMP response element-binding protein.	The Journal of biological chemistry	2013	29
26408027	trichostatin A	Cai D	Histone deacetylase inhibition activates Nrf2 and protects against osteoarthritis.	Arthritis research & therapy	2015	16
10395330	9,10-Dimethyl-1,2-benzanthracene	Moore RJ	Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis.	Nature medicine	1999	181
12075356	9,10-Dimethyl-1,2-benzanthracene	Malliri A	Mice deficient in the Rac activator Tiam1 are resistant to Ras-induced skin tumours.	Nature	2002	94
16024603	9,10-Dimethyl-1,2-benzanthracene	Jansen AP	Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis.	Cancer research	2005	68
18208974	9,10-Dimethyl-1,2-benzanthracene	Gebhardt C	RAGE signaling sustains inflammation and promotes tumor development.	The Journal of experimental medicine	2008	113
21646541	9,10-Dimethyl-1,2-benzanthracene	Ma X	Loss of the miR-21 allele elevates the expression of its target genes and reduces tumorigenesis.	Proceedings of the National Academy of Sciences of the United States of America	2011	65
21779166	9,10-Dimethyl-1,2-benzanthracene	Viarisio D	E6 and E7 from beta HPV38 cooperate with ultraviolet light in the development of actinic keratosis-like lesions and squamous cell carcinoma in mice.	PLoS pathogens	2011	39
23699408	9,10-Dimethyl-1,2-benzanthracene	Inoue S	Mule/Huwe1/Arf-BP1 suppresses Ras-driven tumorigenesis by preventing c-Myc/Miz1-mediated down-regulation of p21 and p15.	Genes & development	2013	35
26168291	9,10-Dimethyl-1,2-benzanthracene	Nassar D	Genomic landscape of carcinogen-induced and genetically induced mouse skin squamous cell carcinoma.	Nature medicine	2015	34
9267034	polyglutamine	Scherzinger E	Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo.	Cell	1997	301
9398841	polyglutamine	White JK	Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion.	Nature genetics	1997	132
9620770	polyglutamine	Cummings CJ	Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1.	Nature genetics	1998	178
9778246	polyglutamine	Klement IA	Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice.	Cell	1998	196
10942430	polyglutamine	Jana NR	Polyglutamine length-dependent interaction of Hsp40 and Hsp70 family chaperones with truncated N-terminal huntingtin: their role in suppression of aggregation and cellular toxicity.	Human molecular genetics	2000	94
11007884	polyglutamine	Kegel KB	Huntingtin expression stimulates endosomal-lysosomal activity, endosome tubulation, and autophagy.	The Journal of neuroscience 	2000	108
11279522	polyglutamine	Kovtun IV	Trinucleotide expansion in haploid germ cells by gap repair.	Nature genetics	2001	100
11394998	polyglutamine	Hara J	Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity.	Neuron	2001	282
11448943	polyglutamine	Cummings CJ	Over-expression of inducible HSP70 chaperone suppresses neuropathology and improves motor function in SCA1 mice.	Human molecular genetics	2001	99
11967539	polyglutamine	Mantamadiotis T	Disruption of CREB function in brain leads to neurodegeneration.	Nature genetics	2002	174
12165554	polyglutamine	Luthi-Carter R	Dysregulation of gene expression in the R6/2 model of polyglutamine disease: parallel changes in muscle and brain.	Human molecular genetics	2002	89
12223539	polyglutamine	Wellington CL	Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease.	The Journal of neuroscience 	2002	85
12554681	polyglutamine	Wheeler VC	Mismatch repair gene Msh2 modifies the timing of early disease in Hdh(Q111) striatum.	Human molecular genetics	2003	77
12741986	polyglutamine	Emamian ES	Serine 776 of ataxin-1 is critical for polyglutamine-induced disease in SCA1 transgenic mice.	Neuron	2003	84
14981075	polyglutamine	Gafni J	Inhibition of calpain cleavage of huntingtin reduces toxicity: accumulation of calpain/caspase fragments in the nucleus.	The Journal of biological chemistry	2004	76
15152038	polyglutamine	Chevalier-Larsen ES	Castration restores function and neurofilament alterations of aged symptomatic males in a transgenic mouse model of spinal and bulbar muscular atrophy.	The Journal of neuroscience 	2004	72
15235598	polyglutamine	Xia H	RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia.	Nature medicine	2004	151
15470152	polyglutamine	Zu T	Recovery from polyglutamine-induced neurodegeneration in conditional SCA1 transgenic mice.	The Journal of neuroscience 	2004	80
15695335	polyglutamine	Tang TS	Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington's disease.	Proceedings of the National Academy of Sciences of the United States of America	2005	99
15811941	polyglutamine	Harper SQ	RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model.	Proceedings of the National Academy of Sciences of the United States of America	2005	195
15882643	polyglutamine	Gu X	Pathological cell-cell interactions elicited by a neuropathogenic form of mutant Huntingtin contribute to cortical pathogenesis in HD mice.	Neuron	2005	87
15983371	polyglutamine	Shu W	Altered ultrasonic vocalization in mice with a disruption in the Foxp2 gene.	Proceedings of the National Academy of Sciences of the United States of America	2005	115
16076956	polyglutamine	Slow EJ	Absence of behavioral abnormalities and neurodegeneration in vivo despite widespread neuronal huntingtin inclusions.	Proceedings of the National Academy of Sciences of the United States of America	2005	76
16155577	polyglutamine	Waza M	17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration.	Nature medicine	2005	120
16804541	polyglutamine	Moseley ML	Bidirectional expression of CUG and CAG expansion transcripts and intranuclear polyglutamine inclusions in spinocerebellar ataxia type 8.	Nature genetics	2006	132
16936724	polyglutamine	Custer SK	Bergmann glia expression of polyglutamine-expanded ataxin-7 produces neurodegeneration by impairing glutamate transport.	Nature neuroscience	2006	86
17110330	polyglutamine	Serra HG	RORalpha-mediated Purkinje cell development determines disease severity in adult SCA1 mice.	Cell	2006	85
17334372	polyglutamine	Yang Z	ASC-J9 ameliorates spinal and bulbar muscular atrophy phenotype via degradation of androgen receptor.	Nature medicine	2007	57
17352931	polyglutamine	Woodman B	The Hdh(Q150/Q150) knock-in mouse model of HD and the R6/2 exon 1 model develop comparable and widespread molecular phenotypes.	Brain research bulletin	2007	73
17687326	polyglutamine	Bennett EJ	Global changes to the ubiquitin system in Huntington's disease.	Nature	2007	184
17986219	polyglutamine	Weiss A	Sensitive biochemical aggregate detection reveals aggregation onset before symptom development in cellular and murine models of Huntington's disease.	Journal of neurochemistry	2008	51
18337408	polyglutamine	Orr AL	N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking.	The Journal of neuroscience 	2008	107
18362179	polyglutamine	Wang J	Impaired ubiquitin-proteasome system activity in the synapses of Huntington's disease mice.	The Journal of cell biology	2008	54
18550760	polyglutamine	Gray M	Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice.	The Journal of neuroscience 	2008	194
18638556	polyglutamine	Heng MY	Rodent genetic models of Huntington disease.	Neurobiology of disease	2008	62
18687887	polyglutamine	Watase K	Spinocerebellar ataxia type 6 knockin mice develop a progressive neuronal dysfunction with age-dependent accumulation of mutant CaV2.1 channels.	Proceedings of the National Academy of Sciences of the United States of America	2008	52
18805465	polyglutamine	Hickey MA	Extensive early motor and non-motor behavioral deficits are followed by striatal neuronal loss in knock-in Huntington's disease mice.	Neuroscience	2008	79
19052220	polyglutamine	Tydlacka S	Differential activities of the ubiquitin-proteasome system in neurons versus glia may account for the preferential accumulation of misfolded proteins in neurons.	The Journal of neuroscience 	2008	57
19487684	polyglutamine	Nekooki-Machida Y	Distinct conformations of in vitro and in vivo amyloids of huntingtin-exon1 show different cytotoxicity.	Proceedings of the National Academy of Sciences of the United States of America	2009	81
19525941	polyglutamine	Morfini GA	Pathogenic huntingtin inhibits fast axonal transport by activating JNK3 and phosphorylating kinesin.	Nature neuroscience	2009	87
19679072	polyglutamine	Palazzolo I	Overexpression of IGF-1 in muscle attenuates disease in a mouse model of spinal and bulbar muscular atrophy.	Neuron	2009	67
19825844	polyglutamine	Sathasivam K	Identical oligomeric and fibrillar structures captured from the brains of R6/2 and knock-in mouse models of Huntington's disease.	Human molecular genetics	2010	68
20018729	polyglutamine	Bradford J	Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms.	Proceedings of the National Academy of Sciences of the United States of America	2009	84
20190739	polyglutamine	Bauer PO	Harnessing chaperone-mediated autophagy for the selective degradation of mutant huntingtin protein.	Nature biotechnology	2010	52
20383138	polyglutamine	Martinez-Vicente M	Cargo recognition failure is responsible for inefficient autophagy in Huntington's disease.	Nature neuroscience	2010	194
20494921	polyglutamine	Faideau M	In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington's disease subjects.	Human molecular genetics	2010	59
20670829	polyglutamine	Miller JP	Matrix metalloproteinases are modifiers of huntingtin proteolysis and toxicity in Huntington's disease.	Neuron	2010	54
21048129	polyglutamine	Xie Y	BDNF overexpression in the forebrain rescues Huntington's disease phenotypes in YAC128 mice.	The Journal of neuroscience 	2010	65
21555070	polyglutamine	Wilburn B	An antisense CAG repeat transcript at JPH3 locus mediates expanded polyglutamine protein toxicity in Huntington's disease-like 2 mice.	Neuron	2011	62
21689595	polyglutamine	Sopher BL	CTCF regulates ataxin-7 expression through promotion of a convergently transcribed, antisense noncoding RNA.	Neuron	2011	52
21900579	polyglutamine	Shakkottai VG	Early changes in cerebellar physiology accompany motor dysfunction in the polyglutamine disease spinocerebellar ataxia type 3.	The Journal of neuroscience 	2011	55
22179319	polyglutamine	Jiang M	Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets.	Nature medicine	2011	91
22337954	polyglutamine	Vidal RL	Targeting the UPR transcription factor XBP1 protects against Huntington's disease through the regulation of FoxO1 and autophagy.	Human molecular genetics	2012	70
22590724	polyglutamine	Jia H	Histone deacetylase (HDAC) inhibitors targeting HDAC3 and HDAC1 ameliorate polyglutamine-elicited phenotypes in model systems of Huntington's disease.	Neurobiology of disease	2012	40
22613578	polyglutamine	Juopperi TA	Astrocytes generated from patient induced pluripotent stem cells recapitulate features of Huntington's disease patient cells.	Molecular brain	2012	72
22660636	polyglutamine	Miyazaki Y	Viral delivery of miR-196a ameliorates the SBMA phenotype via the silencing of CELF2.	Nature medicine	2012	49
22726834	polyglutamine	Kordasiewicz HB	Sustained therapeutic reversal of Huntington's disease by transient repression of huntingtin synthesis.	Neuron	2012	165
22786682	polyglutamine	Tsunemi T	PGC-1α rescues Huntington's disease proteotoxicity by preventing oxidative stress and promoting TFEB function.	Science translational medicine	2012	109
23087021	polyglutamine	Hansen ST	Changes in Purkinje cell firing and gene expression precede behavioral pathology in a mouse model of SCA2.	Human molecular genetics	2013	32
23160193	polyglutamine	Kwan W	Mutant huntingtin impairs immune cell migration in Huntington disease.	The Journal of clinical investigation	2012	37
23719381	polyglutamine	Park J	RAS-MAPK-MSK1 pathway modulates ataxin 1 protein levels and toxicity in SCA1.	Nature	2013	33
24302884	polyglutamine	Mielcarek M	HDAC4 reduction: a novel therapeutic strategy to target cytoplasmic huntingtin and ameliorate neurodegeneration.	PLoS biology	2013	40
24462098	polyglutamine	Yang S	Age-dependent decrease in chaperone activity impairs MANF expression, leading to Purkinje cell degeneration in inducible SCA17 mice.	Neuron	2014	23
24484067	polyglutamine	Stanek LM	Silencing mutant huntingtin by adeno-associated virus-mediated RNA interference ameliorates disease manifestations in the YAC128 mouse model of Huntington's disease.	Human gene therapy	2014	21
24584051	polyglutamine	Crotti A	Mutant Huntingtin promotes autonomous microglia activation via myeloid lineage-determining factors.	Nature neuroscience	2014	57
24742458	polyglutamine	Cortes CJ	Muscle expression of mutant androgen receptor accounts for systemic and motor neuron disease phenotypes in spinal and bulbar muscular atrophy.	Neuron	2014	38
24784230	polyglutamine	Wang N	Neuronal targets for reducing mutant huntingtin expression to ameliorate disease in a mouse model of Huntington's disease.	Nature medicine	2014	28
24836077	polyglutamine	Yano H	Inhibition of mitochondrial protein import by mutant huntingtin.	Nature neuroscience	2014	29
24882209	polyglutamine	Guo L	A cellular system that degrades misfolded proteins and protects against neurodegeneration.	Molecular cell	2014	27
25101683	polyglutamine	Mielcarek M	Dysfunction of the CNS-heart axis in mouse models of Huntington's disease.	PLoS genetics	2014	24
25108912	polyglutamine	Cortes CJ	Polyglutamine-expanded androgen receptor interferes with TFEB to elicit autophagy defects in SBMA.	Nature neuroscience	2014	27
25556834	polyglutamine	Lee JH	Reinstating aberrant mTORC1 activity in Huntington's disease mice improves disease phenotypes.	Neuron	2015	24
27140644	polyglutamine	Molero AE	Selective expression of mutant huntingtin during development recapitulates characteristic features of Huntington's disease.	Proceedings of the National Academy of Sciences of the United States of America	2016	13
12682289	Cancer Vaccines	Hodi FS	Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients.	Proceedings of the National Academy of Sciences of the United States of America	2003	194
12907617	Cancer Vaccines	Kusmartsev S	All-trans-retinoic acid eliminates immature myeloid cells from tumor-bearing mice and improves the effect of vaccination.	Cancer research	2003	126
21908423	Cancer Vaccines	Pere H	A CCR4 antagonist combined with vaccines induces antigen-specific CD8+ T cells and tumor immunity against self antigens.	Blood	2011	48
23633484	Cancer Vaccines	Duraiswamy J	Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors.	Cancer research	2013	152
26669718	Cancer Vaccines	Ali OA	Vaccines Combined with Immune Checkpoint Antibodies Promote Cytotoxic T-cell Activity and Tumor Eradication.	Cancer immunology research	2016	13
27020860	Cancer Vaccines	Ahrends T	CD27 Agonism Plus PD-1 Blockade Recapitulates CD4+ T-cell Help in Therapeutic Anticancer Vaccination.	Cancer research	2016	13
19029980	arsenic trioxide	Nasr R	Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation.	Nature medicine	2008	87
20624968	arsenic trioxide	Kim J	Arsenic antagonizes the Hedgehog pathway by preventing ciliary accumulation and reducing stability of the Gli2 transcriptional effector.	Proceedings of the National Academy of Sciences of the United States of America	2010	80
21183792	arsenic trioxide	Beauchamp EM	Arsenic trioxide inhibits human cancer cell growth and tumor development in mice by blocking Hedgehog/GLI pathway.	The Journal of clinical investigation	2011	74
23291299	arsenic trioxide	Kim J	Itraconazole and arsenic trioxide inhibit Hedgehog pathway activation and tumor growth associated with acquired resistance to smoothened antagonists.	Cancer cell	2013	82
21606592	Oxazolone	Yan F	Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism.	The Journal of clinical investigation	2011	79
24908389	Oxazolone	Gerlach K	TH9 cells that express the transcription factor PU.1 drive T cell-mediated colitis via IL-9 receptor signaling in intestinal epithelial cells.	Nature immunology	2014	52
25209655	Oxazolone	Masterson JC	Eosinophil-mediated signalling attenuates inflammatory responses in experimental colitis.	Gut	2015	20
16606824	docetaxel	Farokhzad OC	Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo.	Proceedings of the National Academy of Sciences of the United States of America	2006	334
17606733	docetaxel	Marangoni E	A new model of patient tumor-derived breast cancer xenografts for preclinical assays.	Clinical cancer research 	2007	119
17626183	docetaxel	Rottenberg S	Selective induction of chemotherapy resistance of mammary tumors in a conditional mouse model for hereditary breast cancer.	Proceedings of the National Academy of Sciences of the United States of America	2007	71
17909051	docetaxel	Loberg RD	Targeting CCL2 with systemic delivery of neutralizing antibodies induces prostate cancer tumor regression in vivo.	Cancer research	2007	91
18645028	docetaxel	Meng Y	Natural BH3 mimetic (-)-gossypol chemosensitizes human prostate cancer via Bcl-xL inhibition accompanied by increase of Puma and Noxa.	Molecular cancer therapeutics	2008	60
19147587	docetaxel	Kim RH	Arginine deiminase as a novel therapy for prostate cancer induces autophagy and caspase-independent apoptosis.	Cancer research	2009	73
19826044	docetaxel	Gan L	Inhibition of the androgen receptor as a novel mechanism of taxol chemotherapy in prostate cancer.	Cancer research	2009	52
21768359	docetaxel	Oakes SR	Sensitization of BCL-2-expressing breast tumors to chemotherapy by the BH3 mimetic ABT-737.	Proceedings of the National Academy of Sciences of the United States of America	2012	50
22359577	docetaxel	Dubrovska A	CXCR4 expression in prostate cancer progenitor cells.	PloS one	2012	38
23100512	docetaxel	Kodumudi KN	Blockade of myeloid-derived suppressor cells after induction of lymphopenia improves adoptive T cell therapy in a murine model of melanoma.	Journal of immunology	2012	33
23340294	docetaxel	Schott AF	Preclinical and clinical studies of gamma secretase inhibitors with docetaxel on human breast tumors.	Clinical cancer research 	2013	44
23589177	docetaxel	Vrignaud P	Preclinical antitumor activity of cabazitaxel, a semisynthetic taxane active in taxane-resistant tumors.	Clinical cancer research 	2013	26
24985346	docetaxel	Ono M	Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells.	Science signaling	2014	105
24996221	docetaxel	Pan B	HMGB1-mediated autophagy promotes docetaxel resistance in human lung adenocarcinoma.	Molecular cancer	2014	24
25156255	docetaxel	Di Mitri D	Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer.	Nature	2014	42
25484141	docetaxel	van Soest RJ	Targeting the Androgen Receptor Confers In Vivo Cross-resistance Between Enzalutamide and Docetaxel, But Not Cabazitaxel, in Castration-resistant Prostate Cancer.	European urology	2015	22
26153498	docetaxel	Maia AR	Inhibition of the spindle assembly checkpoint kinase TTK enhances the efficacy of docetaxel in a triple-negative breast cancer model.	Annals of oncology 	2015	17
22549931	tartaric acid	Tang SY	Matrix metalloproteinase-13 is required for osteocytic perilacunar remodeling and maintains bone fracture resistance.	Journal of bone and mineral research 	2012	34
24733914	tartaric acid	Chen W	Arthritogenic alphaviral infection perturbs osteoblast function and triggers pathologic bone loss.	Proceedings of the National Academy of Sciences of the United States of America	2014	22
25503693	tartaric acid	Xu W	The systemic delivery of an oncolytic adenovirus expressing decorin inhibits bone metastasis in a mouse model of human prostate cancer.	Gene therapy	2015	18
7845465	Amyloid beta-Peptides	Games D	Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein.	Nature	1995	321
8816718	Amyloid beta-Peptides	Paresce DM	Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor.	Neuron	1996	141
8986743	Amyloid beta-Peptides	Citron M	Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice.	Nature medicine	1997	183
9037091	Amyloid beta-Peptides	Johnson-Wood K	Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease.	Proceedings of the National Academy of Sciences of the United States of America	1997	175
10077666	Amyloid beta-Peptides	Hsia AY	Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models.	Proceedings of the National Academy of Sciences of the United States of America	1999	283
10932230	Amyloid beta-Peptides	Bard F	Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease.	Nature medicine	2000	454
11941374	Amyloid beta-Peptides	Dodart JC	Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer's disease model.	Nature neuroscience	2002	233
12415125	Amyloid beta-Peptides	Selkoe DJ	Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics.	Annual review of pharmacology and toxicology	2003	176
13678674	Amyloid beta-Peptides	Sheng JG	Lipopolysaccharide-induced-neuroinflammation increases intracellular accumulation of amyloid precursor protein and amyloid beta peptide in APPswe transgenic mice.	Neurobiology of disease	2003	81
13679422	Amyloid beta-Peptides	Das P	Amyloid-beta immunization effectively reduces amyloid deposition in FcRgamma-/- knock-out mice.	The Journal of neuroscience 	2003	77
14687544	Amyloid beta-Peptides	Leissring MA	Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death.	Neuron	2003	200
14742275	Amyloid beta-Peptides	Fukumoto H	Beta-secretase activity increases with aging in human, monkey, and mouse brain.	The American journal of pathology	2004	77
15084661	Amyloid beta-Peptides	Kawarabayashi T	Dimeric amyloid beta protein rapidly accumulates in lipid rafts followed by apolipoprotein E and phosphorylated tau accumulation in the Tg2576 mouse model of Alzheimer's disease.	The Journal of neuroscience 	2004	90
15708439	Amyloid beta-Peptides	Caccamo A	Age- and region-dependent alterations in Abeta-degrading enzymes: implications for Abeta-induced disorders.	Neurobiology of aging	2005	79
16207708	Amyloid beta-Peptides	Wahrle SE	Deletion of Abca1 increases Abeta deposition in the PDAPP transgenic mouse model of Alzheimer disease.	The Journal of biological chemistry	2005	88
17187063	Amyloid beta-Peptides	Fulga TA	Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo.	Nature cell biology	2007	121
17314396	Amyloid beta-Peptides	Majumdar A	Activation of microglia acidifies lysosomes and leads to degradation of Alzheimer amyloid fibrils.	Molecular biology of the cell	2007	66
17694066	Amyloid beta-Peptides	Sagare A	Clearance of amyloid-beta by circulating lipoprotein receptors.	Nature medicine	2007	119
17724122	Amyloid beta-Peptides	He P	Deletion of tumor necrosis factor death receptor inhibits amyloid beta generation and prevents learning and memory deficits in Alzheimer's mice.	The Journal of cell biology	2007	93
19553447	Amyloid beta-Peptides	Puzzo D	Phosphodiesterase 5 inhibition improves synaptic function, memory, and amyloid-beta load in an Alzheimer's disease mouse model.	The Journal of neuroscience 	2009	59
25351177	Amyloid beta-Peptides	Khan MB	Remote ischemic postconditioning: harnessing endogenous protection in a murine model of vascular cognitive impairment.	Translational stroke research	2015	19
25744023	Amyloid beta-Peptides	Kaushal V	Neuronal NLRP1 inflammasome activation of Caspase-1 coordinately regulates inflammatory interleukin-1-beta production and axonal degeneration-associated Caspase-6 activation.	Cell death and differentiation	2015	22
26202697	Amyloid beta-Peptides	Baranger K	MT5-MMP is a new pro-amyloidogenic proteinase that promotes amyloid pathology and cognitive decline in a transgenic mouse model of Alzheimer's disease.	Cellular and molecular life sciences 	2016	12
14611673	Azoxymethane	Tanaka T	A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate.	Cancer science	2003	179
16880406	Azoxymethane	Myung SJ	15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis.	Proceedings of the National Academy of Sciences of the United States of America	2006	89
17398123	Azoxymethane	Xiao H	The Toll-interleukin-1 receptor member SIGIRR regulates colonic epithelial homeostasis, inflammation, and tumorigenesis.	Immunity	2007	103
17408638	Azoxymethane	Yoshida Y	The forkhead box M1 transcription factor contributes to the development and growth of mouse colorectal cancer.	Gastroenterology	2007	68
17631644	Azoxymethane	Osburn WO	Increased colonic inflammatory injury and formation of aberrant crypt foci in Nrf2-deficient mice upon dextran sulfate treatment.	International journal of cancer	2007	65
17681179	Azoxymethane	Li P	Guanylyl cyclase C suppresses intestinal tumorigenesis by restricting proliferation and maintaining genomic integrity.	Gastroenterology	2007	59
18219394	Azoxymethane	Popivanova BK	Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis.	The Journal of clinical investigation	2008	261
18981289	Azoxymethane	Maran RR	Farnesoid X receptor deficiency in mice leads to increased intestinal epithelial cell proliferation and tumor development.	The Journal of pharmacology and experimental therapeutics	2009	59
19229991	Azoxymethane	Fukata M	Innate immune signaling by Toll-like receptor-4 (TLR4) shapes the inflammatory microenvironment in colitis-associated tumors.	Inflammatory bowel diseases	2009	50
19328876	Azoxymethane	Lin S	The absence of LPA2 attenuates tumor formation in an experimental model of colitis-associated cancer.	Gastroenterology	2009	48
20226691	Azoxymethane	Dupaul-Chicoine J	Control of intestinal homeostasis, colitis, and colitis-associated colorectal cancer by the inflammatory caspases.	Immunity	2010	150
20385749	Azoxymethane	Allen IC	The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer.	The Journal of experimental medicine	2010	180
20564343	Azoxymethane	Hosono K	Metformin suppresses azoxymethane-induced colorectal aberrant crypt foci by activating AMP-activated protein kinase.	Molecular carcinogenesis	2010	59
20624890	Azoxymethane	Salcedo R	MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18.	The Journal of experimental medicine	2010	122
21674704	Azoxymethane	Fukata M	Constitutive activation of epithelial TLR4 augments inflammatory responses to mucosal injury and drives colitis-associated tumorigenesis.	Inflammatory bowel diseases	2011	48
21987656	Azoxymethane	Stolfi C	Involvement of interleukin-21 in the regulation of colitis-associated colon cancer.	The Journal of experimental medicine	2011	36
22677195	Azoxymethane	Flores MBS	RETRACTED: Obesity-induced increase in tumor necrosis factor-α leads to development of colon cancer in mice.	Gastroenterology	2012	35
23027128	Azoxymethane	Zheng Y	Protein tyrosine kinase 6 protects cells from anoikis by directly phosphorylating focal adhesion kinase and activating AKT.	Oncogene	2013	25
23041326	Azoxymethane	Asfaha S	Mice that express human interleukin-8 have increased mobilization of immature myeloid cells, which exacerbates inflammation and accelerates colon carcinogenesis.	Gastroenterology	2013	37
23272179	Azoxymethane	Shang K	Crucial involvement of tumor-associated neutrophils in the regulation of chronic colitis-associated carcinogenesis in mice.	PloS one	2012	36
23878224	Azoxymethane	Bosurgi L	Paradoxical role of the proto-oncogene Axl and Mer receptor tyrosine kinases in colon cancer.	Proceedings of the National Academy of Sciences of the United States of America	2013	38
25994220	Azoxymethane	Shi C	Novel evidence for an oncogenic role of microRNA-21 in colitis-associated colorectal cancer.	Gut	2016	20
26055138	Azoxymethane	Polytarchou C	MicroRNA214 Is Associated With Progression of Ulcerative Colitis, and Inhibition Reduces Development of Colitis and Colitis-Associated Cancer in Mice.	Gastroenterology	2015	23
27876571	Azoxymethane	Yang Y	Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.	Gastroenterology	2017	18
12097494	Neuroprotective Agents	Cao G	In Vivo Delivery of a Bcl-xL Fusion Protein Containing the TAT Protein Transduction Domain Protects against Ischemic Brain Injury and Neuronal Apoptosis.	The Journal of neuroscience 	2002	90
15494404	Neuroprotective Agents	Gardian G	Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease.	The Journal of biological chemistry	2005	122
17901380	Neuroprotective Agents	Li J	Neuroprotective effects of adenosine monophosphate-activated protein kinase inhibition and gene deletion in stroke.	Stroke	2007	70
21555578	Neuroprotective Agents	Spence RD	Neuroprotection mediated through estrogen receptor-alpha in astrocytes.	Proceedings of the National Academy of Sciences of the United States of America	2011	59
21806471	Neuroprotective Agents	Sekiguchi A	Rapamycin promotes autophagy and reduces neural tissue damage and locomotor impairment after spinal cord injury in mice.	Journal of neurotrauma	2012	32
21895523	Neuroprotective Agents	Yu F	Lithium ameliorates neurodegeneration, suppresses neuroinflammation, and improves behavioral performance in a mouse model of traumatic brain injury.	Journal of neurotrauma	2012	34
23199080	Neuroprotective Agents	Loane DJ	Activation of mGluR5 and inhibition of NADPH oxidase improves functional recovery after traumatic brain injury.	Journal of neurotrauma	2013	29
24149893	Neuroprotective Agents	Shin JY	Mesenchymal stem cells enhance autophagy and increase β-amyloid clearance in Alzheimer disease models.	Autophagy	2014	34
25607368	Neuroprotective Agents	Peretti D	RBM3 mediates structural plasticity and protective effects of cooling in neurodegeneration.	Nature	2015	22
26708289	Neuroprotective Agents	Bonafede R	Exosome derived from murine adipose-derived stromal cells: Neuroprotective effect on in vitro model of amyotrophic lateral sclerosis.	Experimental cell research	2016	13
27009601	Neuroprotective Agents	Lastres-Becker I	Repurposing the NRF2 Activator Dimethyl Fumarate as Therapy Against Synucleinopathy in Parkinson's Disease.	Antioxidants & redox signaling	2016	15
7958674	Dextran Sulfate	Dieleman LA	Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice.	Gastroenterology	1994	170
8824194	Dextran Sulfate	Mashimo H	Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor.	Science	1996	129
10958782	Dextran Sulfate	Steidler L	Treatment of murine colitis by Lactococcus lactis secreting interleukin-10.	Science	2000	224
15692785	Dextran Sulfate	Araki A	MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis.	Journal of gastroenterology	2005	80
16157881	Dextran Sulfate	Rhee SH	Pathophysiological role of Toll-like receptor 5 engagement by bacterial flagellin in colonic inflammation.	Proceedings of the National Academy of Sciences of the United States of America	2005	75
16831596	Dextran Sulfate	Van der Sluis M	Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection.	Gastroenterology	2006	305
16888083	Dextran Sulfate	Qualls JE	Suppression of experimental colitis by intestinal mononuclear phagocytes.	Journal of leukocyte biology	2006	79
16952555	Dextran Sulfate	Fukata M	Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: Role in proliferation and apoptosis in the intestine.	Gastroenterology	2006	119
17178849	Dextran Sulfate	Khor TO	Nrf2-deficient mice have an increased susceptibility to dextran sulfate sodium-induced colitis.	Cancer research	2006	117
18058233	Dextran Sulfate	Maines LW	Suppression of ulcerative colitis in mice by orally available inhibitors of sphingosine kinase.	Digestive diseases and sciences	2008	57
18395085	Dextran Sulfate	Fina D	Regulation of gut inflammation and th17 cell response by interleukin-21.	Gastroenterology	2008	66
18439915	Dextran Sulfate	Shah YM	Hypoxia-inducible factor augments experimental colitis through an MIF-dependent inflammatory signaling cascade.	Gastroenterology	2008	64
18521188	Dextran Sulfate	Meira LB	DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice.	The Journal of clinical investigation	2008	152
18598698	Dextran Sulfate	Takedatsu H	TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation.	Gastroenterology	2008	80
18601927	Dextran Sulfate	Kolachala VL	A2B adenosine receptor gene deletion attenuates murine colitis.	Gastroenterology	2008	53
19234201	Dextran Sulfate	Ismail AS	Reciprocal interactions between commensal bacteria and gamma delta intraepithelial lymphocytes during mucosal injury.	Journal of immunology	2009	49
19303021	Dextran Sulfate	Podolsky DK	Colitis-associated variant of TLR2 causes impaired mucosal repair because of TFF3 deficiency.	Gastroenterology	2009	57
19342675	Dextran Sulfate	Frick JS	Contribution of adenosine A2B receptors to inflammatory parameters of experimental colitis.	Journal of immunology	2009	73
19562033	Dextran Sulfate	Yan Y	Temporal and spatial analysis of clinical and molecular parameters in dextran sodium sulfate induced colitis.	PloS one	2009	83
20303296	Dextran Sulfate	Zaki MH	The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis.	Immunity	2010	224
20602997	Dextran Sulfate	Cadwell K	Virus-plus-susceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine.	Cell	2010	265
20603312	Dextran Sulfate	Chalaris A	Critical role of the disintegrin metalloprotease ADAM17 for intestinal inflammation and regeneration in mice.	The Journal of experimental medicine	2010	65
20805871	Dextran Sulfate	Johansson ME	Bacteria penetrate the inner mucus layer before inflammation in the dextran sulfate colitis model.	PloS one	2010	82
21281806	Dextran Sulfate	Yanaba K	IL-10-producing regulatory B10 cells inhibit intestinal injury in a mouse model.	The American journal of pathology	2011	38
21391286	Dextran Sulfate	Nagalingam NA	Microbial ecology of the murine gut associated with the development of dextran sodium sulfate-induced colitis.	Inflammatory bowel diseases	2011	46
21440550	Dextran Sulfate	Koch S	The Wnt antagonist Dkk1 regulates intestinal epithelial homeostasis and wound repair.	Gastroenterology	2011	40
21703208	Dextran Sulfate	Gäbele E	DSS induced colitis increases portal LPS levels and enhances hepatic inflammation and fibrogenesis in experimental NASH.	Journal of hepatology	2011	38
21873195	Dextran Sulfate	McNamee EN	Interleukin 37 expression protects mice from colitis.	Proceedings of the National Academy of Sciences of the United States of America	2011	76
22069308	Dextran Sulfate	Diegelmann J	A novel role for interleukin-27 (IL-27) as mediator of intestinal epithelial barrier protection mediated via differential signal transducer and activator of transcription (STAT) protein signaling and induction of antibacterial and anti-inflammatory proteins.	The Journal of biological chemistry	2012	37
22089030	Dextran Sulfate	Cox JH	Opposing consequences of IL-23 signaling mediated by innate and adaptive cells in chemically induced colitis in mice.	Mucosal immunology	2012	32
22993206	Dextran Sulfate	Cao AT	Th17 cells upregulate polymeric Ig receptor and intestinal IgA and contribute to intestinal homeostasis.	Journal of immunology	2012	54
23680148	Dextran Sulfate	Cooks T	Mutant p53 prolongs NF-κB activation and promotes chronic inflammation and inflammation-associated colorectal cancer.	Cancer cell	2013	95
23732773	Dextran Sulfate	Sokol H	Card9 mediates intestinal epithelial cell restitution, T-helper 17 responses, and control of bacterial infection in mice.	Gastroenterology	2013	36
23860500	Dextran Sulfate	Xue X	Endothelial PAS domain protein 1 activates the inflammatory response in the intestinal epithelium to promote colitis in mice.	Gastroenterology	2013	48
23994200	Dextran Sulfate	Brun P	Toll-like receptor 2 regulates intestinal inflammation by controlling integrity of the enteric nervous system.	Gastroenterology	2013	44
24414342	Dextran Sulfate	Håkansson Å	Immunological alteration and changes of gut microbiota after dextran sulfate sodium (DSS) administration in mice.	Clinical and experimental medicine	2015	21
25790743	Dextran Sulfate	Sala E	Mesenchymal Stem Cells Reduce Colitis in Mice via Release of TSG6, Independently of Their Localization to the Intestine.	Gastroenterology	2015	30
27112251	Dextran Sulfate	Munyaka PM	Acute dextran sulfate sodium (DSS)-induced colitis promotes gut microbial dysbiosis in mice.	Journal of basic microbiology	2016	11
19380832	imiquimod	van der Fits L	Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis.	Journal of immunology	2009	218
21483750	imiquimod	Swindell WR	Genome-wide expression profiling of five mouse models identifies similarities and differences with human psoriasis.	PloS one	2011	45
21982596	imiquimod	Cai Y	Pivotal role of dermal IL-17-producing γδ T cells in skin inflammation.	Immunity	2011	185
22131335	imiquimod	Van Belle AB	IL-22 is required for imiquimod-induced psoriasiform skin inflammation in mice.	Journal of immunology	2012	71
22546855	imiquimod	Pantelyushin S	Rorγt+ innate lymphocytes and γδ T cells initiate psoriasiform plaque formation in mice.	The Journal of clinical investigation	2012	100
23463003	imiquimod	Walter A	Aldara activates TLR7-independent immune defence.	Nature communications	2013	33
23754427	imiquimod	Wohn C	Langerin(neg) conventional dendritic cells produce IL-23 to drive psoriatic plaque formation in mice.	Proceedings of the National Academy of Sciences of the United States of America	2013	37
24254490	imiquimod	Flutter B	TLRs to cytokines: mechanistic insights from the imiquimod mouse model of psoriasis.	European journal of immunology	2013	29
24759321	imiquimod	Riol-Blanco L	Nociceptive sensory neurons drive interleukin-23-mediated psoriasiform skin inflammation.	Nature	2014	55
24909886	imiquimod	Di Meglio P	Activation of the aryl hydrocarbon receptor dampens the severity of inflammatory skin conditions.	Immunity	2014	39
25092341	imiquimod	Ha HL	IL-17 drives psoriatic inflammation via distinct, target cell-specific mechanisms.	Proceedings of the National Academy of Sciences of the United States of America	2014	24
26831084	imiquimod	Patial S	Enhanced stability of tristetraprolin mRNA protects mice against immune-mediated inflammatory pathologies.	Proceedings of the National Academy of Sciences of the United States of America	2016	12
27568078	imiquimod	Srivastava A	MicroRNA-146a suppresses IL-17-mediated skin inflammation and is genetically associated with psoriasis.	The Journal of allergy and clinical immunology	2017	6
28356382	imiquimod	Martin JC	Limited Presence of IL-22 Binding Protein, a Natural IL-22 Inhibitor, Strengthens Psoriatic Skin Inflammation.	Journal of immunology	2017	6
11257133	Galactosylceramides	Smyth MJ	Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis.	The Journal of experimental medicine	2001	92
11533710	Galactosylceramides	Hong S	The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice.	Nature medicine	2001	133
12093876	Galactosylceramides	Crowe NY	A critical role for natural killer T cells in immunosurveillance of methylcholanthrene-induced sarcomas.	The Journal of experimental medicine	2002	102
14657217	Galactosylceramides	Schmieg J	Superior protection against malaria and melanoma metastases by a C-glycoside analogue of the natural killer T cell ligand alpha-Galactosylceramide.	The Journal of experimental medicine	2003	115
16138194	Galactosylceramides	Parekh VV	Glycolipid antigen induces long-term natural killer T cell anergy in mice.	The Journal of clinical investigation	2005	146
24913977	Galactosylceramides	Macho-Fernandez E	Targeted delivery of α-galactosylceramide to CD8α+ dendritic cells optimizes type I NKT cell-based antitumor responses.	Journal of immunology	2014	23
26362265	Galactosylceramides	Lee YJ	Tissue-Specific Distribution of iNKT Cells Impacts Their Cytokine Response.	Immunity	2015	36
16491118	decitabine	Aguilera O	Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer.	Oncogene	2006	93
18577219	decitabine	Silber J	miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells.	BMC medicine	2008	301
19308264	decitabine	Garzia L	MicroRNA-199b-5p impairs cancer stem cells through negative regulation of HES1 in medulloblastoma.	PloS one	2009	79
21772049	decitabine	Kalac M	HDAC inhibitors and decitabine are highly synergistic and associated with unique gene-expression and epigenetic profiles in models of DLBCL.	Blood	2011	37
21828137	decitabine	Shaknovich R	DNA methyltransferase 1 and DNA methylation patterning contribute to germinal center B-cell differentiation.	Blood	2011	40
22002305	decitabine	Ramachandran I	Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.	Oncogene	2012	35
22237753	decitabine	Sun CY	Suppression of Klotho expression by protein-bound uremic toxins is associated with increased DNA methyltransferase expression and DNA hypermethylation.	Kidney international	2012	35
22461695	decitabine	Yang D	Decitabine and vorinostat cooperate to sensitize colon carcinoma cells to Fas ligand-induced apoptosis in vitro and tumor suppression in vivo.	Journal of immunology	2012	30
23079745	decitabine	Kim JK	Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b.	Hepatology	2013	68
23318422	decitabine	Xiang Y	MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine.	Oncogene	2014	49
23707781	decitabine	Letouzé E	SDH mutations establish a hypermethylator phenotype in paraganglioma.	Cancer cell	2013	119
25445694	decitabine	Li SY	Combination therapy with epigenetic-targeted and chemotherapeutic drugs delivered by nanoparticles to enhance the chemotherapy response and overcome resistance by breast cancer stem cells.	Journal of controlled release 	2015	20
27623509	decitabine	Lucarini V	Combining Type I Interferons and 5-Aza-2'-Deoxycitidine to Improve Anti-Tumor Response against Melanoma.	The Journal of investigative dermatology	2017	7
15059890	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	Stiff T	ATM and DNA-PK function redundantly to phosphorylate H2AX after exposure to ionizing radiation.	Cancer research	2004	300
18267957	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	Ha T	Lipopolysaccharide-induced myocardial protection against ischaemia/reperfusion injury is mediated through a PI3K/Akt-dependent mechanism.	Cardiovascular research	2008	54
18718903	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	Ouchi N	Follistatin-like 1, a secreted muscle protein, promotes endothelial cell function and revascularization in ischemic tissue through a nitric-oxide synthase-dependent mechanism.	The Journal of biological chemistry	2008	80
19435898	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	Mukherjee B	EGFRvIII and DNA double-strand break repair: a molecular mechanism for radioresistance in glioblastoma.	Cancer research	2009	74
20145128	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	Ward CS	Noninvasive detection of target modulation following phosphatidylinositol 3-kinase inhibition using hyperpolarized 13C magnetic resonance spectroscopy.	Cancer research	2010	66
22252008	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	Maycotte P	Chloroquine sensitizes breast cancer cells to chemotherapy independent of autophagy.	Autophagy	2012	86
25533999	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	Wang Z	bFGF attenuates endoplasmic reticulum stress and mitochondrial injury on myocardial ischaemia/reperfusion via activation of PI3K/Akt/ERK1/2 pathway.	Journal of cellular and molecular medicine	2015	16
11526243	Ethylnitrosourea	Yuan Y	AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations.	Proceedings of the National Academy of Sciences of the United States of America	2001	97
15485918	Ethylnitrosourea	Gangloff YG	Disruption of the mouse mTOR gene leads to early postimplantation lethality and prohibits embryonic stem cell development.	Molecular and cellular biology	2004	139
16155213	Ethylnitrosourea	Flenniken AM	A Gja1 missense mutation in a mouse model of oculodentodigital dysplasia.	Development	2005	82
18318598	Ethylnitrosourea	Heazlewood CK	Aberrant mucin assembly in mice causes endoplasmic reticulum stress and spontaneous inflammation resembling ulcerative colitis.	PLoS medicine	2008	191
23267013	Ethylnitrosourea	Beisner DR	The intramembrane protease Sppl2a is required for B cell and DC development and survival via cleavage of the invariant chain.	The Journal of experimental medicine	2013	25
23872636	Ethylnitrosourea	Tarkar A	DYX1C1 is required for axonemal dynein assembly and ciliary motility.	Nature genetics	2013	62
12379867	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	Ourednik J	Neural stem cells display an inherent mechanism for rescuing dysfunctional neurons.	Nature biotechnology	2002	95
12702778	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	Teismann P	Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration.	Proceedings of the National Academy of Sciences of the United States of America	2003	145
15026254	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	Song DD	Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTP.	Experimental neurology	2004	81
17675560	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	Reynolds AD	Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson's disease.	Journal of leukocyte biology	2007	98
18167537	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	Benner EJ	Nitrated alpha-synuclein immunity accelerates degeneration of nigral dopaminergic neurons.	PloS one	2008	88
19196989	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	Chen PC	Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: Critical role for the astrocyte.	Proceedings of the National Academy of Sciences of the United States of America	2009	152
20016100	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	Andres-Mateos E	Unexpected lack of hypersensitivity in LRRK2 knock-out mice to MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine).	The Journal of neuroscience 	2009	48
20418503	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	Chen Y	Dual autonomous mitochondrial cell death pathways are activated by Nix/BNip3L and induce cardiomyopathy.	Proceedings of the National Academy of Sciences of the United States of America	2010	51
21056667	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	L'Episcopo F	Reactive astrocytes and Wnt/β-catenin signaling link nigrostriatal injury to repair in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.	Neurobiology of disease	2011	50
21228155	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	Rieker C	Nucleolar disruption in dopaminergic neurons leads to oxidative damage and parkinsonism through repression of mammalian target of rapamycin signaling.	The Journal of neuroscience 	2011	42
22323720	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	L'Episcopo F	Plasticity of subventricular zone neuroprogenitors in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) mouse model of Parkinson's disease involves cross talk between inflammatory and Wnt/β-catenin signaling pathways: functional consequences for neuroprotection and repair.	The Journal of neuroscience 	2012	40
23041626	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	Martens LH	Progranulin deficiency promotes neuroinflammation and neuron loss following toxin-induced injury.	The Journal of clinical investigation	2012	58
23077045	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	Morganti JM	The soluble isoform of CX3CL1 is necessary for neuroprotection in a mouse model of Parkinson's disease.	The Journal of neuroscience 	2012	38
23242137	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	Shao W	Suppression of neuroinflammation by astrocytic dopamine D2 receptors via αB-crystallin.	Nature	2013	56
23424051	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	Ayton S	Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease.	Annals of neurology	2013	38
25437550	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	Poulin JF	Defining midbrain dopaminergic neuron diversity by single-cell gene expression profiling.	Cell reports	2014	45
27084336	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	Zhou Y	MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson's disease.	Molecular neurodegeneration	2016	27
19265662	temozolomide	Bleau AM	PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells.	Cell stem cell	2009	239
21116835	temozolomide	Zhu X	Systemic delivery of neutralizing antibody targeting CCL2 for glioma therapy.	Journal of neuro-oncology	2011	39
21768296	temozolomide	Mitchell DA	Monoclonal antibody blockade of IL-2 receptor α during lymphopenia selectively depletes regulatory T cells in mice and humans.	Blood	2011	45
21948969	temozolomide	Hong M	Chemotherapy induces intratumoral expression of chemokines in cutaneous melanoma, favoring T-cell infiltration and tumor control.	Cancer research	2011	57
22984531	temozolomide	Safdie F	Fasting enhances the response of glioma to chemo- and radiotherapy.	PloS one	2012	33
24608791	temozolomide	Auffinger B	Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy.	Cell death and differentiation	2014	58
25437539	temozolomide	Stewart E	Targeting the DNA repair pathway in Ewing sarcoma.	Cell reports	2014	30
25867026	temozolomide	Sesen J	Metformin inhibits growth of human glioblastoma cells and enhances therapeutic response.	PloS one	2015	25
26188279	temozolomide	Yu Z	NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.	Cancer letters	2015	19
26431379	temozolomide	Yu Z	Metformin and temozolomide act synergistically to inhibit growth of glioma cells and glioma stem cells in vitro and in vivo.	Oncotarget	2015	22
16356836	resveratrol	Garvin S	Resveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo.	Cancer letters	2006	67
17086191	resveratrol	Baur JA	Resveratrol improves health and survival of mice on a high-calorie diet.	Nature	2006	1098
18835033	resveratrol	Wang RH	Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice.	Cancer cell	2008	260
19041676	resveratrol	Karuppagounder SS	Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease.	Neurochemistry international	2009	96
19326431	resveratrol	Narayanan NK	Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice.	International journal of cancer	2009	60
19503100	resveratrol	Boily G	SirT1-null mice develop tumors at normal rates but are poorly protected by resveratrol.	Oncogene	2009	52
19940103	resveratrol	Singh UP	Resveratrol (trans-3,5,4'-trihydroxystilbene) induces silent mating type information regulation-1 and down-regulates nuclear transcription factor-kappaB activation to abrogate dextran sulfate sodium-induced colitis.	The Journal of pharmacology and experimental therapeutics	2010	47
20332304	resveratrol	Cui X	Resveratrol suppresses colitis and colon cancer associated with colitis.	Cancer prevention research	2010	49
20335659	resveratrol	He W	Sirt1 activation protects the mouse renal medulla from oxidative injury.	The Journal of clinical investigation	2010	83
20418481	resveratrol	Ungvari Z	Resveratrol confers endothelial protection via activation of the antioxidant transcription factor Nrf2.	American journal of physiology. Heart and circulatory physiology	2010	107
20493163	resveratrol	Hwang JW	Cigarette smoke-induced autophagy is regulated by SIRT1-PARP-1-dependent mechanism: implication in pathogenesis of COPD.	Archives of biochemistry and biophysics	2010	51
20974732	resveratrol	Miller RA	Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice.	The journals of gerontology. Series A, Biological sciences and medical sciences	2011	291
21107122	resveratrol	Shindler KS	Oral resveratrol reduces neuronal damage in a model of multiple sclerosis.	Journal of neuro-ophthalmology 	2010	44
21115502	resveratrol	Planavila A	Sirt1 acts in association with PPARα to protect the heart from hypertrophy, metabolic dysregulation, and inflammation.	Cardiovascular research	2011	44
21304978	resveratrol	Shankar S	Resveratrol inhibits pancreatic cancer stem cell characteristics in human and KrasG12D transgenic mice by inhibiting pluripotency maintaining factors and epithelial-mesenchymal transition.	PloS one	2011	79
21454355	resveratrol	Jackson JR	Long-term supplementation with resveratrol alleviates oxidative stress but does not attenuate sarcopenia in aged mice.	The journals of gerontology. Series A, Biological sciences and medical sciences	2011	38
21982274	resveratrol	Chang J	Low-dose pterostilbene, but not resveratrol, is a potent neuromodulator in aging and Alzheimer's disease.	Neurobiology of aging	2012	31
22118570	resveratrol	Capiralla H	Resveratrol mitigates lipopolysaccharide- and Aβ-mediated microglial inflammation by inhibiting the TLR4/NF-κB/STAT signaling cascade.	Journal of neurochemistry	2012	43
22253880	resveratrol	Selsby JT	Rescue of dystrophic skeletal muscle by PGC-1α involves a fast to slow fiber type shift in the mdx mouse.	PloS one	2012	46
22269797	resveratrol	Tillu DV	Resveratrol engages AMPK to attenuate ERK and mTOR signaling in sensory neurons and inhibits incision-induced acute and chronic pain.	Molecular pain	2012	35
22648295	resveratrol	Yuan Y	Activation of peroxisome proliferator-activated receptor-γ coactivator 1α ameliorates mitochondrial dysfunction and protects podocytes from aldosterone-induced injury.	Kidney international	2012	32
23217256	resveratrol	Liu B	Resveratrol rescues SIRT1-dependent adult stem cell decline and alleviates progeroid features in laminopathy-based progeria.	Cell metabolism	2012	34
23274061	resveratrol	Kanamori H	Resveratrol reverses remodeling in hearts with large, old myocardial infarctions through enhanced autophagy-activating AMP kinase pathway.	The American journal of pathology	2013	25
23293221	resveratrol	Liu M	Resveratrol protects against age-associated infertility in mice.	Human reproduction	2013	34
23764428	resveratrol	Lofrumento DD	Neuroprotective effects of resveratrol in an MPTP mouse model of Parkinson's-like disease: possible role of SOCS-1 in reducing pro-inflammatory responses.	Innate immunity	2014	30
23832548	resveratrol	Wan J	M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease.	Hepatology	2014	75
24093677	resveratrol	Jimenez-Gomez Y	Resveratrol improves adipose insulin signaling and reduces the inflammatory response in adipose tissue of rhesus monkeys on high-fat, high-sugar diet.	Cell metabolism	2013	40
24095927	resveratrol	Ni HM	Critical role of FoxO3a in alcohol-induced autophagy and hepatotoxicity.	The American journal of pathology	2013	44
24184811	resveratrol	Li Y	Hepatic SIRT1 attenuates hepatic steatosis and controls energy balance in mice by inducing fibroblast growth factor 21.	Gastroenterology	2014	44
24356887	resveratrol	Huang XZ	Sirt1 activation ameliorates renal fibrosis by inhibiting the TGF-β/Smad3 pathway.	Journal of cellular biochemistry	2014	27
24629563	resveratrol	Yang SJ	Resveratrol ameliorates hepatic metaflammation and inhibits NLRP3 inflammasome activation.	Metabolism	2014	20
24651677	resveratrol	Warboys CM	Disturbed flow promotes endothelial senescence via a p53-dependent pathway.	Arteriosclerosis, thrombosis, and vascular biology	2014	25
25440059	resveratrol	Scheibye-Knudsen M	A high-fat diet and NAD(+) activate Sirt1 to rescue premature aging in cockayne syndrome.	Cell metabolism	2014	52
25527776	resveratrol	Chen T	Activation of SIRT3 by resveratrol ameliorates cardiac fibrosis and improves cardiac function via the TGF-β/Smad3 pathway.	American journal of physiology. Heart and circulatory physiology	2015	29
25737402	resveratrol	Li W	Intra-articular resveratrol injection prevents osteoarthritis progression in a mouse model by activating SIRT1 and thereby silencing HIF-2α.	Journal of orthopaedic research 	2015	17
25884904	resveratrol	Ji Q	Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.	BMC cancer	2015	28
25938543	resveratrol	Dai W	By reducing hexokinase 2, resveratrol induces apoptosis in HCC cells addicted to aerobic glycolysis and inhibits tumor growth in mice.	Oncotarget	2015	24
26223300	resveratrol	Cai H	Cancer chemoprevention: Evidence of a nonlinear dose response for the protective effects of resveratrol in humans and mice.	Science translational medicine	2015	23
26592738	resveratrol	Liu J	Mitochondrial Dysfunction Launches Dexamethasone-Induced Skeletal Muscle Atrophy via AMPK/FOXO3 Signaling.	Molecular pharmaceutics	2016	10
26750922	resveratrol	Wu H	Resveratrol ameliorates myocardial fibrosis by inhibiting ROS/ERK/TGF-β/periostin pathway in STZ-induced diabetic mice.	BMC cardiovascular disorders	2016	14
27522058	resveratrol	Sosulski ML	Sirtuin 3 Deregulation Promotes Pulmonary Fibrosis.	The journals of gerontology. Series A, Biological sciences and medical sciences	2017	9
10611368	thioflavin T	Bales KR	Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease.	Proceedings of the National Academy of Sciences of the United States of America	1999	101
12438441	thioflavin T	Neumann M	Misfolded proteinase K-resistant hyperphosphorylated alpha-synuclein in aged transgenic mice with locomotor deterioration and in human alpha-synucleinopathies.	The Journal of clinical investigation	2002	104
12736345	thioflavin T	Wilcock DM	Intracranially administered anti-Abeta antibodies reduce beta-amyloid deposition by mechanisms both independent of and associated with microglial activation.	The Journal of neuroscience 	2003	90
14985348	thioflavin T	Davis J	Early-onset and robust cerebral microvascular accumulation of amyloid beta-protein in transgenic mice expressing low levels of a vasculotropic Dutch/Iowa mutant form of amyloid beta-protein precursor.	The Journal of biological chemistry	2004	121
15466394	thioflavin T	Casas C	Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Abeta42 accumulation in a novel Alzheimer transgenic model.	The American journal of pathology	2004	116
16207713	thioflavin T	Koldamova R	Lack of ABCA1 considerably decreases brain ApoE level and increases amyloid deposition in APP23 mice.	The Journal of biological chemistry	2005	95
16982417	thioflavin T	Mueller-Steiner S	Antiamyloidogenic and neuroprotective functions of cathepsin B: implications for Alzheimer's disease.	Neuron	2006	104
17021169	thioflavin T	Oakley H	Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation.	The Journal of neuroscience 	2006	472
20640189	thioflavin T	Melchior B	Dual induction of TREM2 and tolerance-related transcript, Tmem176b, in amyloid transgenic mice: implications for vaccine-based therapies for Alzheimer's disease.	ASN neuro	2010	47
21427723	thioflavin T	Cohen TJ	The acetylation of tau inhibits its function and promotes pathological tau aggregation.	Nature communications	2011	113
23467355	thioflavin T	Kim WS	Deletion of Abca7 increases cerebral amyloid-β accumulation in the J20 mouse model of Alzheimer's disease.	The Journal of neuroscience 	2013	41
24281246	thioflavin T	Kohli N	Oral delivery of bioencapsulated proteins across blood-brain and blood-retinal barriers.	Molecular therapy 	2014	29
9362523	Oligodeoxyribonucleotides	Chu RS	CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity.	The Journal of experimental medicine	1997	169
15809417	Oligodeoxyribonucleotides	Tanga FY	The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy.	Proceedings of the National Academy of Sciences of the United States of America	2005	176
18183029	Oligodeoxyribonucleotides	Stevens SL	Toll-like receptor 9: a new target of ischemic preconditioning in the brain.	Journal of cerebral blood flow and metabolism 	2008	72
22535248	Oligodeoxyribonucleotides	Oka T	Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure.	Nature	2012	221
14732704	sphingosine 1-phosphate	Allende ML	Expression of the sphingosine 1-phosphate receptor, S1P1, on T-cells controls thymic emigration.	The Journal of biological chemistry	2004	121
15138255	sphingosine 1-phosphate	Kono M	The sphingosine-1-phosphate receptors S1P1, S1P2, and S1P3 function coordinately during embryonic angiogenesis.	The Journal of biological chemistry	2004	129
15852018	sphingosine 1-phosphate	Petrache I	Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in mice.	Nature medicine	2005	179
16980623	sphingosine 1-phosphate	Kohno M	Intracellular role for sphingosine kinase 1 in intestinal adenoma cell proliferation.	Molecular and cellular biology	2006	89
17090686	sphingosine 1-phosphate	Oskouian B	Sphingosine-1-phosphate lyase potentiates apoptosis via p53- and p38-dependent pathways and is down-regulated in colon cancer.	Proceedings of the National Academy of Sciences of the United States of America	2006	76
17284444	sphingosine 1-phosphate	Kono M	Deafness and stria vascularis defects in S1P2 receptor-null mice.	The Journal of biological chemistry	2007	67
17293497	sphingosine 1-phosphate	Means CK	Sphingosine 1-phosphate S1P2 and S1P3 receptor-mediated Akt activation protects against in vivo myocardial ischemia-reperfusion injury.	American journal of physiology. Heart and circulatory physiology	2007	76
17710232	sphingosine 1-phosphate	Skoura A	Essential role of sphingosine 1-phosphate receptor 2 in pathological angiogenesis of the mouse retina.	The Journal of clinical investigation	2007	74
18815359	sphingosine 1-phosphate	Snider AJ	A role for sphingosine kinase 1 in dextran sulfate sodium-induced colitis.	FASEB journal 	2009	69
18824518	sphingosine 1-phosphate	Kawamori T	Role for sphingosine kinase 1 in colon carcinogenesis.	FASEB journal 	2009	86
20584883	sphingosine 1-phosphate	Thangada S	Cell-surface residence of sphingosine 1-phosphate receptor 1 on lymphocytes determines lymphocyte egress kinetics.	The Journal of experimental medicine	2010	60
21555855	sphingosine 1-phosphate	Oo ML	Engagement of S1P₁-degradative mechanisms leads to vascular leak in mice.	The Journal of clinical investigation	2011	63
22298596	sphingosine 1-phosphate	Nagahashi M	Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis.	Cancer research	2012	90
22664872	sphingosine 1-phosphate	Nijnik A	The role of sphingosine-1-phosphate transporter Spns2 in immune system function.	Journal of immunology	2012	32
22707406	sphingosine 1-phosphate	Ponnusamy S	Communication between host organism and cancer cells is transduced by systemic sphingosine kinase 1/sphingosine 1-phosphate signalling to regulate tumour metastasis.	EMBO molecular medicine	2012	41
22939756	sphingosine 1-phosphate	Price MM	A specific sphingosine kinase 1 inhibitor attenuates airway hyperresponsiveness and inflammation in a mast cell-dependent murine model of allergic asthma.	The Journal of allergy and clinical immunology	2013	36
23103166	sphingosine 1-phosphate	Mendoza A	The transporter Spns2 is required for secretion of lymph but not plasma sphingosine-1-phosphate.	Cell reports	2012	37
23273921	sphingosine 1-phosphate	Liang J	Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer.	Cancer cell	2013	151
23321671	sphingosine 1-phosphate	Lotinun S	Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation.	The Journal of clinical investigation	2013	54
23861887	sphingosine 1-phosphate	Rex K	Sphingosine kinase activity is not required for tumor cell viability.	PloS one	2013	26
23995678	sphingosine 1-phosphate	Herzog BH	Podoplanin maintains high endothelial venule integrity by interacting with platelet CLEC-2.	Nature	2013	70
24812668	sphingosine 1-phosphate	Cruz-Orengo L	Enhanced sphingosine-1-phosphate receptor 2 expression underlies female CNS autoimmunity susceptibility.	The Journal of clinical investigation	2014	23
25049382	sphingosine 1-phosphate	Tränkner D	Population of sensory neurons essential for asthmatic hyperreactivity of inflamed airways.	Proceedings of the National Academy of Sciences of the United States of America	2014	30
25274307	sphingosine 1-phosphate	Muppidi JR	Loss of signalling via Gα13 in germinal centre B-cell-derived lymphoma.	Nature	2014	40
25347472	sphingosine 1-phosphate	Degagné E	Sphingosine-1-phosphate lyase downregulation promotes colon carcinogenesis through STAT3-activated microRNAs.	The Journal of clinical investigation	2014	34
25680461	sphingosine 1-phosphate	Ji F	K6PC-5, a novel sphingosine kinase 1 (SphK1) activator, alleviates dexamethasone-induced damages to osteoblasts through activating SphK1-Akt signaling.	Biochemical and biophysical research communications	2015	19
25831442	sphingosine 1-phosphate	Proia RL	Emerging biology of sphingosine-1-phosphate: its role in pathogenesis and therapy.	The Journal of clinical investigation	2015	63
25979079	sphingosine 1-phosphate	Schweitzer KS	Endothelial disruptive proinflammatory effects of nicotine and e-cigarette vapor exposures.	American journal of physiology. Lung cellular and molecular physiology	2015	30
26053123	sphingosine 1-phosphate	Blaho VA	HDL-bound sphingosine-1-phosphate restrains lymphopoiesis and neuroinflammation.	Nature	2015	26
26082434	sphingosine 1-phosphate	Panneer Selvam S	Binding of the sphingolipid S1P to hTERT stabilizes telomerase at the nuclear periphery by allosterically mimicking protein phosphorylation.	Science signaling	2015	20
26268607	sphingosine 1-phosphate	Galvani S	HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P1 to limit vascular inflammation.	Science signaling	2015	34
27956387	sphingosine 1-phosphate	Powell JA	Targeting sphingosine kinase 1 induces MCL1-dependent cell death in acute myeloid leukemia.	Blood	2017	5
28052056	sphingosine 1-phosphate	van der Weyden L	Genome-wide in vivo screen identifies novel host regulators of metastatic colonization.	Nature	2017	19
28175299	sphingosine 1-phosphate	Moruno-Manchon JF	Inhibiting sphingosine kinase 2 mitigates mutant Huntingtin-induced neurodegeneration in neuron models of Huntington disease.	Human molecular genetics	2017	7
18586243	4-hydroxy-2-nonenal	Tang SC	Toll-like receptor-4 mediates neuronal apoptosis induced by amyloid beta-peptide and the membrane lipid peroxidation product 4-hydroxynonenal.	Experimental neurology	2008	61
19955483	4-hydroxy-2-nonenal	McClung JM	p38 MAPK links oxidative stress to autophagy-related gene expression in cachectic muscle wasting.	American journal of physiology. Cell physiology	2010	64
20406135	4-hydroxy-2-nonenal	Lu Z	PGC-1 alpha regulates expression of myocardial mitochondrial antioxidants and myocardial oxidative stress after chronic systolic overload.	Antioxidants & redox signaling	2010	51
20705694	4-hydroxy-2-nonenal	Ma H	Aldehyde dehydrogenase 2 (ALDH2) rescues myocardial ischaemia/reperfusion injury: role of autophagy paradox and toxic aldehyde.	European heart journal	2011	64
24722988	4-hydroxy-2-nonenal	Shearn CT	Identification of 5' AMP-activated kinase as a target of reactive aldehydes during chronic ingestion of high concentrations of ethanol.	The Journal of biological chemistry	2014	20
15758046	Immunotoxins	Matsusaka T	Genetic engineering of glomerular sclerosis in the mouse via control of onset and severity of podocyte-specific injury.	Journal of the American Society of Nephrology 	2005	75
20215554	Immunotoxins	Wayne AS	Anti-CD22 immunotoxin RFB4(dsFv)-PE38 (BL22) for CD22-positive hematologic malignancies of childhood: preclinical studies and phase I clinical trial.	Clinical cancer research 	2010	57
17981559	epigallocatechin gallate	Shankar S	EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer.	Frontiers in bioscience 	2008	56
19883714	epigallocatechin gallate	Lambert JD	Hepatotoxicity of high oral dose (-)-epigallocatechin-3-gallate in mice.	Food and chemical toxicology 	2010	58
21641991	epigallocatechin gallate	Tsai PY	Epigallocatechin-3-gallate prevents lupus nephritis development in mice via enhancing the Nrf2 antioxidant pathway and inhibiting NLRP3 inflammasome activation.	Free radical biology & medicine	2011	47
21965273	epigallocatechin gallate	Wang H	Green tea polyphenol EGCG suppresses lung cancer cell growth through upregulating miR-210 expression caused by stabilizing HIF-1α.	Carcinogenesis	2011	45
25875356	epigallocatechin gallate	Pan H	Mitochondrial modulation by Epigallocatechin 3-Gallate ameliorates cisplatin induced renal injury through decreasing oxidative/nitrative stress, inflammation and NF-kB in mice.	PloS one	2015	15
12900522	Clodronic Acid	Ishida S	VEGF164-mediated inflammation is required for pathological, but not physiological, ischemia-induced retinal neovascularization.	The Journal of experimental medicine	2003	99
15561971	Clodronic Acid	Day YJ	Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: role of macrophages.	American journal of physiology. Renal physiology	2005	93
16239969	Clodronic Acid	Nakao S	Infiltration of COX-2-expressing macrophages is a prerequisite for IL-1 beta-induced neovascularization and tumor growth.	The Journal of clinical investigation	2005	76
16424086	Clodronic Acid	Summan M	Macrophages and skeletal muscle regeneration: a clodronate-containing liposome depletion study.	American journal of physiology. Regulatory, integrative and comparative physiology	2006	78
16832418	Clodronic Acid	Zeisberger SM	Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach.	British journal of cancer	2006	150
16861385	Clodronic Acid	Zhao M	Alveolar macrophage activation is a key initiation signal for acute lung ischemia-reperfusion injury.	American journal of physiology. Lung cellular and molecular physiology	2006	62
16877434	Clodronic Acid	Checchin D	Potential role of microglia in retinal blood vessel formation.	Investigative ophthalmology & visual science	2006	70
17322368	Clodronic Acid	van Amerongen MJ	Macrophage depletion impairs wound healing and increases left ventricular remodeling after myocardial injury in mice.	The American journal of pathology	2007	126
17644211	Clodronic Acid	Rivera CA	Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis.	Journal of hepatology	2007	145
19332785	Clodronic Acid	Huang X	PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis.	Proceedings of the National Academy of Sciences of the United States of America	2009	130
20145121	Clodronic Acid	Meng Y	Blockade of tumor necrosis factor alpha signaling in tumor-associated macrophages as a radiosensitizing strategy.	Cancer research	2010	48
20923880	Clodronic Acid	Kreisel D	In vivo two-photon imaging reveals monocyte-dependent neutrophil extravasation during pulmonary inflammation.	Proceedings of the National Academy of Sciences of the United States of America	2010	119
21106959	Clodronic Acid	Kanematsu Y	Critical roles of macrophages in the formation of intracranial aneurysm.	Stroke	2011	50
21305607	Clodronic Acid	Alexander KA	Osteal macrophages promote in vivo intramembranous bone healing in a mouse tibial injury model.	Journal of bone and mineral research 	2011	83
21865316	Clodronic Acid	Hibino N	A critical role for macrophages in neovessel formation and the development of stenosis in tissue-engineered vascular grafts.	FASEB journal 	2011	58
22273460	Clodronic Acid	Bonde AK	Intratumoral macrophages contribute to epithelial-mesenchymal transition in solid tumors.	BMC cancer	2012	55
22411067	Clodronic Acid	Dixon LJ	Caspase-1-mediated regulation of fibrogenesis in diet-induced steatohepatitis.	Laboratory investigation; a journal of technical methods and pathology	2012	37
22673886	Clodronic Acid	Ferenbach DA	Macrophage/monocyte depletion by clodronate, but not diphtheria toxin, improves renal ischemia/reperfusion injury in mice.	Kidney international	2012	41
22822022	Clodronic Acid	Dhaliwal K	Monocytes control second-phase neutrophil emigration in established lipopolysaccharide-induced murine lung injury.	American journal of respiratory and critical care medicine	2012	31
23645836	Clodronic Acid	De Filippo K	Mast cell and macrophage chemokines CXCL1/CXCL2 control the early stage of neutrophil recruitment during tissue inflammation.	Blood	2013	97
24492801	Clodronic Acid	Filbey KJ	Innate and adaptive type 2 immune cell responses in genetically controlled resistance to intestinal helminth infection.	Immunology and cell biology	2014	25
25225663	Clodronic Acid	Zasłona Z	Resident alveolar macrophages suppress, whereas recruited monocytes promote, allergic lung inflammation in murine models of asthma.	Journal of immunology	2014	32
25270069	Clodronic Acid	Belliere J	Specific macrophage subtypes influence the progression of rhabdomyolysis-induced kidney injury.	Journal of the American Society of Nephrology 	2015	18
25536148	Clodronic Acid	Schmall A	Macrophage and cancer cell cross-talk via CCR2 and CX3CR1 is a fundamental mechanism driving lung cancer.	American journal of respiratory and critical care medicine	2015	20
26522085	Clodronic Acid	Hanna BS	Depletion of CLL-associated patrolling monocytes and macrophages controls disease development and repairs immune dysfunction in vivo.	Leukemia	2016	19
15934930	Curcumin	Ryu H	Sodium phenylbutyrate prolongs survival and regulates expression of anti-apoptotic genes in transgenic amyotrophic lateral sclerosis mice.	Journal of neurochemistry	2005	84
16092118	Curcumin	Li L	Liposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis.	Cancer	2005	99
16243823	Curcumin	Aggarwal BB	Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice.	Clinical cancer research 	2005	105
17545551	Curcumin	Lin YG	Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-kappaB pathway.	Clinical cancer research 	2007	87
18339878	Curcumin	Subramaniam D	Diphenyl difluoroketone: a curcumin derivative with potent in vivo anticancer activity.	Cancer research	2008	50
18417733	Curcumin	Begum AN	Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease.	The Journal of pharmacology and experimental therapeutics	2008	102
18593936	Curcumin	Chadalapaka G	Curcumin decreases specificity protein expression in bladder cancer cells.	Cancer research	2008	57
19605645	Curcumin	Ma QL	Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin.	The Journal of neuroscience 	2009	104
20132469	Curcumin	Laird MD	Curcumin attenuates cerebral edema following traumatic brain injury in mice: a possible role for aquaporin-4?	Journal of neurochemistry	2010	41
20550967	Curcumin	Koronyo-Hamaoui M	Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model.	NeuroImage	2011	79
20934487	Curcumin	Li YY	Increased expression of miRNA-146a in Alzheimer's disease transgenic mouse models.	Neuroscience letters	2011	36
22030090	Curcumin	Tu SP	Curcumin induces the differentiation of myeloid-derived suppressor cells and inhibits their interaction with cancer cells and related tumor growth.	Cancer prevention research	2012	40
23457487	Curcumin	Yu J	Curcumin down-regulates DNA methyltransferase 1 and plays an anti-leukemic role in acute myeloid leukemia.	PloS one	2013	31
23548270	Curcumin	Yu CC	miR145 targets the SOX9/ADAM17 axis to inhibit tumor-initiating cells and IL-6-mediated paracrine effects in head and neck cancer.	Cancer research	2013	40
24848068	Curcumin	Pan Y	Inhibition of JNK phosphorylation by a novel curcumin analog prevents high glucose-induced inflammation and apoptosis in cardiomyocytes and the development of diabetic cardiomyopathy.	Diabetes	2014	25
25653233	Curcumin	Toden S	Curcumin mediates chemosensitization to 5-fluorouracil through miRNA-induced suppression of epithelial-to-mesenchymal transition in chemoresistant colorectal cancer.	Carcinogenesis	2015	21
26116834	Curcumin	Taverna S	Curcumin inhibits in vitro and in vivo chronic myelogenous leukemia cells growth: a possible role for exosomal disposal of miR-21.	Oncotarget	2015	15
12902545	3,5-diethoxycarbonyl-1,4-dihydrocollidine	Wang X	The origin and liver repopulating capacity of murine oval cells.	Proceedings of the National Academy of Sciences of the United States of America	2003	109
17929301	3,5-diethoxycarbonyl-1,4-dihydrocollidine	Apte U	Wnt/beta-catenin signaling mediates oval cell response in rodents.	Hepatology	2008	60
19105206	3,5-diethoxycarbonyl-1,4-dihydrocollidine	Sackett SD	Foxl1 is a marker of bipotential hepatic progenitor cells in mice.	Hepatology	2009	48
21520179	3,5-diethoxycarbonyl-1,4-dihydrocollidine	Chu AS	Lineage tracing demonstrates no evidence of cholangiocyte epithelial-to-mesenchymal transition in murine models of hepatic fibrosis.	Hepatology	2011	71
23620592	3,5-diethoxycarbonyl-1,4-dihydrocollidine	Tao GZ	Wnt/β-catenin signaling protects mouse liver against oxidative stress-induced apoptosis through the inhibition of forkhead transcription factor FoxO3.	The Journal of biological chemistry	2013	28
24619556	3,5-diethoxycarbonyl-1,4-dihydrocollidine	Zhang Y	E2F1 is a novel fibrogenic gene that regulates cholestatic liver fibrosis through the Egr-1/SHP/EID1 network.	Hepatology	2014	30
24902765	3,5-diethoxycarbonyl-1,4-dihydrocollidine	Coombes JD	Osteopontin neutralisation abrogates the liver progenitor cell response and fibrogenesis in mice.	Gut	2015	17
12930788	pioglitazone	Yan Q	Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer's disease.	The Journal of neuroscience 	2003	121
15817521	pioglitazone	Heneka MT	Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice.	Brain 	2005	139
18212290	pioglitazone	Ohman MK	Visceral adipose tissue inflammation accelerates atherosclerosis in apolipoprotein E-deficient mice.	Circulation	2008	54
19690061	pioglitazone	Fujisaka S	Regulatory mechanisms for adipose tissue M1 and M2 macrophages in diet-induced obese mice.	Diabetes	2009	180
21339485	pioglitazone	Feig JE	Reversal of hyperlipidemia with a genetic switch favorably affects the content and inflammatory state of macrophages in atherosclerotic plaques.	Circulation	2011	77
22240811	pioglitazone	Kono T	PPAR-γ activation restores pancreatic islet SERCA2 levels and prevents β-cell dysfunction under conditions of hyperglycemic and cytokine stress.	Molecular endocrinology	2012	35
22722857	pioglitazone	Cipolletta D	PPAR-γ is a major driver of the accumulation and phenotype of adipose tissue Treg cells.	Nature	2012	224
22911155	pioglitazone	Majer O	Type I interferons promote fatal immunopathology by regulating inflammatory monocytes and neutrophils during Candida infections.	PLoS pathogens	2012	48
27527983	pioglitazone	Simeone TA	Regulation of brain PPARgamma2 contributes to ketogenic diet anti-seizure efficacy.	Experimental neurology	2017	7
18083785	fasudil	Kolavennu V	Targeting of RhoA/ROCK signaling ameliorates progression of diabetic nephropathy independent of glucose control.	Diabetes	2008	56
20308363	fasudil	Stockton RA	Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity.	The Journal of experimental medicine	2010	95
22034008	fasudil	McDonald DA	Fasudil decreases lesion burden in a murine model of cerebral cavernous malformation disease.	Stroke	2012	35
22397316	fasudil	Bowerman M	Fasudil improves survival and promotes skeletal muscle development in a mouse model of spinal muscular atrophy.	BMC medicine	2012	35
23434591	fasudil	Zhou Y	Inhibition of mechanosensitive signaling in myofibroblasts ameliorates experimental pulmonary fibrosis.	The Journal of clinical investigation	2013	94
15749854	Trinitrobenzenesulfonic Acid	Di Giacinto C	Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells.	Journal of immunology	2005	114
17312139	Trinitrobenzenesulfonic Acid	Hontecillas R	Peroxisome proliferator-activated receptor gamma is required for regulatory CD4+ T cell-mediated protection against colitis.	Journal of immunology	2007	58
19135996	Trinitrobenzenesulfonic Acid	González MA	Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses.	Gastroenterology	2009	155
20080610	Trinitrobenzenesulfonic Acid	Di L	Inhibition of the K+ channel KCa3.1 ameliorates T cell-mediated colitis.	Proceedings of the National Academy of Sciences of the United States of America	2010	44
20980995	Trinitrobenzenesulfonic Acid	Meylan F	The TNF-family cytokine TL1A drives IL-13-dependent small intestinal inflammation.	Mucosal immunology	2011	48
23749550	Trinitrobenzenesulfonic Acid	Margolis KG	Pharmacological reduction of mucosal but not neuronal serotonin opposes inflammation in mouse intestine.	Gut	2014	29
23945234	Trinitrobenzenesulfonic Acid	Liu W	Intestinal epithelial vitamin D receptor signaling inhibits experimental colitis.	The Journal of clinical investigation	2013	54
25277410	Trinitrobenzenesulfonic Acid	Zhou Q	MicroRNA 29 targets nuclear factor-κB-repressing factor and Claudin 1 to increase intestinal permeability.	Gastroenterology	2015	24
26801887	Trinitrobenzenesulfonic Acid	Lin W	Raf kinase inhibitor protein mediates intestinal epithelial cell apoptosis and promotes IBDs in humans and mice.	Gut	2017	6
12021203	rosiglitazone	Lecka-Czernik B	Divergent effects of selective peroxisome proliferator-activated receptor-gamma 2 ligands on adipocyte versus osteoblast differentiation.	Endocrinology	2002	108
16515786	rosiglitazone	Pedersen WA	Rosiglitazone attenuates learning and memory deficits in Tg2576 Alzheimer mice.	Experimental neurology	2006	89
16547072	rosiglitazone	Adachi M	Peroxisome proliferator activated receptor gamma in colonic epithelial cells protects against experimental inflammatory bowel disease.	Gut	2006	65
17332064	rosiglitazone	Lazarenko OP	Rosiglitazone induces decreases in bone mass and strength that are reminiscent of aged bone.	Endocrinology	2007	88
17457822	rosiglitazone	Zhao X	Hematoma resolution as a target for intracerebral hemorrhage treatment: role for peroxisome proliferator-activated receptor gamma in microglia/macrophages.	Annals of neurology	2007	97
17592079	rosiglitazone	Sorrentino SA	Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: restoration by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.	Circulation	2007	88
18948087	rosiglitazone	Yi JH	PPARgamma agonist rosiglitazone is neuroprotective after traumatic brain injury via anti-inflammatory and anti-oxidative mechanisms.	Brain research	2008	52
19211925	rosiglitazone	González-Périz A	Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins.	FASEB journal 	2009	142
19245367	rosiglitazone	Schintu N	PPAR-gamma-mediated neuroprotection in a chronic mouse model of Parkinson's disease.	The European journal of neuroscience	2009	51
19520921	rosiglitazone	Nisbet RE	Rosiglitazone attenuates chronic hypoxia-induced pulmonary hypertension in a mouse model.	American journal of respiratory cell and molecular biology	2010	87
20007851	rosiglitazone	Shen Z	Involvement of adiponectin-SIRT1-AMPK signaling in the protective action of rosiglitazone against alcoholic fatty liver in mice.	American journal of physiology. Gastrointestinal and liver physiology	2010	64
20336061	rosiglitazone	Escribano L	Rosiglitazone rescues memory impairment in Alzheimer's transgenic mice: mechanisms involving a reduced amyloid and tau pathology.	Neuropsychopharmacology 	2010	43
20622120	rosiglitazone	Lu X	PPAR{gamma} regulates hypoxia-induced Nox4 expression in human pulmonary artery smooth muscle cells through NF-{kappa}B.	American journal of physiology. Lung cellular and molecular physiology	2010	59
21723971	rosiglitazone	Krings A	Bone marrow fat has brown adipose tissue characteristics, which are attenuated with aging and diabetes.	Bone	2012	65
22652199	rosiglitazone	Chen L	Dynamic regulation of platelet-derived growth factor receptor α expression in alveolar fibroblasts during realveolarization.	American journal of respiratory cell and molecular biology	2012	45
25134730	rosiglitazone	Pisanu A	Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-γ agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson's disease.	Neurobiology of disease	2014	31
17909050	triptolide	Phillips PA	Triptolide induces pancreatic cancer cell death via inhibition of heat shock protein 70.	Cancer research	2007	89
25109336	triptolide	Sarkar TR	GD3 synthase regulates epithelial-mesenchymal transition and metastasis in breast cancer.	Oncogene	2015	19
26447544	triptolide	Jiang QW	Synergistic anticancer effects of triptolide and celastrol, two main compounds from thunder god vine.	Oncotarget	2015	20
16651429	tripterine	Yang H	Celastrol, a triterpene extracted from the Chinese "Thunder of God Vine," is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice.	Cancer research	2006	146
18202019	tripterine	Zhang T	A novel Hsp90 inhibitor to disrupt Hsp90/Cdc37 complex against pancreatic cancer cells.	Molecular cancer therapeutics	2008	92
20160026	tripterine	Pang X	Celastrol suppresses angiogenesis-mediated tumor growth through inhibition of AKT/mammalian target of rapamycin pathway.	Cancer research	2010	44
20211007	tripterine	Paris D	Reduction of beta-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer's disease.	Journal of neuroinflammation	2010	43
24667175	tripterine	Lee HW	Celastrol inhibits gastric cancer growth by induction of apoptosis and autophagy.	BMB reports	2014	26
25139619	tripterine	Fribley AM	Celastrol induces unfolded protein response-dependent cell death in head and neck cancer.	Experimental cell research	2015	15
25611379	tripterine	Li HY	Celastrol induces apoptosis and autophagy via the ROS/JNK signaling pathway in human osteosarcoma cells: an in vitro and in vivo study.	Cell death & disease	2015	33
26344102	tripterine	Ma X	Celastrol Protects against Obesity and Metabolic Dysfunction through Activation of a HSF1-PGC1α Transcriptional Axis.	Cell metabolism	2015	27
26631113	tripterine	Uttarkar S	Targeting acute myeloid leukemia with a small molecule inhibitor of the Myb/p300 interaction.	Blood	2016	15
12172542	lipoxin A4	Levy BD	Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A(4).	Nature medicine	2002	89
18568027	lipoxin A4	Haworth O	Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A4 to promote the resolution of allergic airway inflammation.	Nature immunology	2008	125
19483113	lipoxin A4	El Kebir D	15-epi-lipoxin A4 inhibits myeloperoxidase signaling and enhances resolution of acute lung injury.	American journal of respiratory and critical care medicine	2009	65
22215599	lipoxin A4	Bozinovski S	Serum amyloid A opposes lipoxin A₄ to mediate glucocorticoid refractory lung inflammation in chronic obstructive pulmonary disease.	Proceedings of the National Academy of Sciences of the United States of America	2012	52
18354236	pristane	Lee PY	A novel type I IFN-producing cell subset in murine lupus.	Journal of immunology	2008	52
20368280	pristane	Haas KM	Protective and pathogenic roles for B cells during systemic autoimmunity in NZB/W F1 mice.	Journal of immunology	2010	51
18316578	Angiogenesis Inhibitors	Fernando NT	Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.	Clinical cancer research 	2008	55
19249680	Angiogenesis Inhibitors	Pàez-Ribes M	Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis.	Cancer cell	2009	699
20194633	Angiogenesis Inhibitors	Helfrich I	Resistance to antiangiogenic therapy is directed by vascular phenotype, vessel stabilization, and maturation in malignant melanoma.	The Journal of experimental medicine	2010	50
25117977	Angiogenesis Inhibitors	Baker GJ	Mechanisms of glioma formation: iterative perivascular glioma growth and invasion leads to tumor progression, VEGF-independent vascularization, and resistance to antiangiogenic therapy.	Neoplasia	2014	30
26908627	Angiogenesis Inhibitors	Bid HK	The Bromodomain BET Inhibitor JQ1 Suppresses Tumor Angiogenesis in Models of Childhood Sarcoma.	Molecular cancer therapeutics	2016	11
15549107	8-(3-chlorostyryl)caffeine	Singh SK	Identification of human brain tumour initiating cells.	Nature	2004	1948
17483311	8-(3-chlorostyryl)caffeine	Beier D	CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles.	Cancer research	2007	326
18559513	8-(3-chlorostyryl)caffeine	Zhang M	Identification of tumor-initiating cells in a p53-null mouse model of breast cancer.	Cancer research	2008	119
19351838	8-(3-chlorostyryl)caffeine	Wakimoto H	Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors.	Cancer research	2009	124
20028757	8-(3-chlorostyryl)caffeine	Charafe-Jauffret E	Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer.	Clinical cancer research 	2010	238
20832727	8-(3-chlorostyryl)caffeine	Iliopoulos D	Loss of miR-200 inhibition of Suz12 leads to polycomb-mediated repression required for the formation and maintenance of cancer stem cells.	Molecular cell	2010	136
21098716	8-(3-chlorostyryl)caffeine	Krishnamurthy S	Endothelial cell-initiated signaling promotes the survival and self-renewal of cancer stem cells.	Cancer research	2010	78
21224357	8-(3-chlorostyryl)caffeine	Liu S	Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks.	Cancer research	2011	167
21498635	8-(3-chlorostyryl)caffeine	Silva IA	Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival.	Cancer research	2011	133
18509315	3-methyladenine	Periyasamy-Thandavan S	Autophagy is cytoprotective during cisplatin injury of renal proximal tubular cells.	Kidney international	2008	85
18640276	3-methyladenine	Pan T	Neuroprotection of rapamycin in lactacystin-induced neurodegeneration via autophagy enhancement.	Neurobiology of disease	2008	62
20075199	3-methyladenine	Jiang M	Autophagy is a renoprotective mechanism during in vitro hypoxia and in vivo ischemia-reperfusion injury.	The American journal of pathology	2010	106
21437926	3-methyladenine	Carchman EH	Heme oxygenase-1-mediated autophagy protects against hepatocyte cell death and hepatic injury from infection/sepsis in mice.	Hepatology	2011	66
21659648	3-methyladenine	Zheng Q	Autophagy and p62 in cardiac proteinopathy.	Circulation research	2011	65
21920942	3-methyladenine	Carmignac V	Autophagy is increased in laminin α2 chain-deficient muscle and its inhibition improves muscle morphology in a mouse model of MDC1A.	Human molecular genetics	2011	43
22062220	3-methyladenine	Yang HZ	TLR4 activity is required in the resolution of pulmonary inflammation and fibrosis after acute and chronic lung injury.	The American journal of pathology	2012	32
22406827	3-methyladenine	Guo XL	Targeting autophagy potentiates chemotherapy-induced apoptosis and proliferation inhibition in hepatocarcinoma cells.	Cancer letters	2012	44
22498478	3-methyladenine	Kobayashi S	Suppression of autophagy is protective in high glucose-induced cardiomyocyte injury.	Autophagy	2012	31
22719070	3-methyladenine	Wojtkowiak JW	Chronic autophagy is a cellular adaptation to tumor acidic pH microenvironments.	Cancer research	2012	45
23800795	3-methyladenine	Zhang X	Cerebral ischemia-reperfusion-induced autophagy protects against neuronal injury by mitochondrial clearance.	Autophagy	2013	60
25484094	3-methyladenine	Mitter SK	Dysregulated autophagy in the RPE is associated with increased susceptibility to oxidative stress and AMD.	Autophagy	2014	51
25653352	3-methyladenine	Fields J	HIV-1 Tat alters neuronal autophagy by modulating autophagosome fusion to the lysosome: implications for HIV-associated neurocognitive disorders.	The Journal of neuroscience 	2015	19
25789971	3-methyladenine	Ghavami S	Autophagy is a regulator of TGF-β1-induced fibrogenesis in primary human atrial myofibroblasts.	Cell death & disease	2015	29
26311737	3-methyladenine	Tsai JP	Licochalcone A induces autophagy through PI3K/Akt/mTOR inactivation and autophagy suppression enhances Licochalcone A-induced apoptosis of human cervical cancer cells.	Oncotarget	2015	22
23064361	tauroursodeoxycholic acid	Young CN	ER stress in the brain subfornical organ mediates angiotensin-dependent hypertension.	The Journal of clinical investigation	2012	61
23336977	tauroursodeoxycholic acid	Cao SS	The unfolded protein response and chemical chaperones reduce protein misfolding and colitis in mice.	Gastroenterology	2013	50
24576409	tauroursodeoxycholic acid	Galán M	Mechanism of endoplasmic reticulum stress-induced vascular endothelial dysfunction.	Biochimica et biophysica acta	2014	34
17579604	Poly I-C	Meyer U	Adult behavioral and pharmacological dysfunctions following disruption of the fetal brain balance between pro-inflammatory and IL-10-mediated anti-inflammatory signaling.	Molecular psychiatry	2008	60
18023140	Poly I-C	Meyer U	Adult brain and behavioral pathological markers of prenatal immune challenge during early/middle and late fetal development in mice.	Brain, behavior, and immunity	2008	120
18032677	Poly I-C	Cameron JS	Toll-like receptor 3 is a potent negative regulator of axonal growth in mammals.	The Journal of neuroscience 	2007	61
20610642	Poly I-C	Benko S	NLRC5 limits the activation of inflammatory pathways.	Journal of immunology	2010	58
22308357	Poly I-C	Shime H	Toll-like receptor 3 signaling converts tumor-supporting myeloid cells to tumoricidal effectors.	Proceedings of the National Academy of Sciences of the United States of America	2012	50
22747753	Poly I-C	Krstic D	Systemic immune challenges trigger and drive Alzheimer-like neuropathology in mice.	Journal of neuroinflammation	2012	68
23677472	Poly I-C	Oderup C	Canonical and noncanonical Wnt proteins program dendritic cell responses for tolerance.	Journal of immunology	2013	31
25015821	Poly I-C	Polykratis A	Cutting edge: RIPK1 Kinase inactive mice are viable and protected from TNF-induced necroptosis in vivo.	Journal of immunology	2014	53
25869642	Poly I-C	Khorooshi R	Induction of endogenous Type I interferon within the central nervous system plays a protective role in experimental autoimmune encephalomyelitis.	Acta neuropathologica	2015	17
14514658	sulforafan	Singh AV	Sulforaphane induces caspase-mediated apoptosis in cultured PC-3 human prostate cancer cells and retards growth of PC-3 xenografts in vivo.	Carcinogenesis	2004	94
15764812	sulforafan	Singh SV	Sulforaphane-induced cell death in human prostate cancer cells is initiated by reactive oxygen species.	The Journal of biological chemistry	2005	94
16912211	sulforafan	Xu C	Inhibition of 7,12-dimethylbenz(a)anthracene-induced skin tumorigenesis in C57BL/6 mice by sulforaphane is mediated by nuclear factor E2-related factor 2.	Cancer research	2006	112
17962605	sulforafan	Zhao X	Transcription factor Nrf2 protects the brain from damage produced by intracerebral hemorrhage.	Stroke	2007	68
18566435	sulforafan	Innamorato NG	The transcription factor Nrf2 is a therapeutic target against brain inflammation.	Journal of immunology	2008	99
20388854	sulforafan	Li Y	Sulforaphane, a dietary component of broccoli/broccoli sprouts, inhibits breast cancer stem cells.	Clinical cancer research 	2010	126
20530687	sulforafan	Rausch V	Synergistic activity of sorafenib and sulforaphane abolishes pancreatic cancer stem cell characteristics.	Cancer research	2010	46
20940707	sulforafan	Kallifatidis G	Sulforaphane increases drug-mediated cytotoxicity toward cancer stem-like cells of pancreas and prostate.	Molecular therapy 	2011	45
23129257	sulforafan	Li SH	Sulforaphane regulates self-renewal of pancreatic cancer stem cells through the modulation of Sonic hedgehog-GLI pathway.	Molecular and cellular biochemistry	2013	30
24025640	sulforafan	Jiang T	Nrf2 suppresses lupus nephritis through inhibition of oxidative injury and the NF-κB-mediated inflammatory response.	Kidney international	2014	25
24637114	sulforafan	Pekovic-Vaughan V	The circadian clock regulates rhythmic activation of the NRF2/glutathione-mediated antioxidant defense pathway to modulate pulmonary fibrosis.	Genes & development	2014	44
25268649	sulforafan	Zhang Z	Sulforaphane prevents the development of cardiomyopathy in type 2 diabetic mice probably by reversing oxidative stress-induced inhibition of LKB1/AMPK pathway.	Journal of molecular and cellular cardiology	2014	29
25328080	sulforafan	Zhao X	Cleaning up after ICH: the role of Nrf2 in modulating microglia function and hematoma clearance.	Journal of neurochemistry	2015	22
25593219	sulforafan	Sun C	Sulforaphane alleviates muscular dystrophy in mdx mice by activation of Nrf2.	Journal of applied physiology	2015	20
26269198	sulforafan	Greaney AJ	Sulforaphane inhibits multiple inflammasomes through an Nrf2-independent mechanism.	Journal of leukocyte biology	2016	12
27075683	sulforafan	Yang G	A pharmacological inhibitor of NLRP3 inflammasome prevents non-alcoholic fatty liver disease in a mouse model induced by high fat diet.	Scientific reports	2016	12
27903744	sulforafan	Gu J	Metallothionein Is Downstream of Nrf2 and Partially Mediates Sulforaphane Prevention of Diabetic Cardiomyopathy.	Diabetes	2017	7
11016644	vorinostat	Butler LM	Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo.	Cancer research	2000	143
12576549	vorinostat	Hockly E	Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease.	Proceedings of the National Academy of Sciences of the United States of America	2003	214
15596714	vorinostat	Shao Y	Apoptotic and autophagic cell death induced by histone deacetylase inhibitors.	Proceedings of the National Academy of Sciences of the United States of America	2004	169
17325656	vorinostat	Lin HS	Anti-rheumatic activities of histone deacetylase (HDAC) inhibitors in vivo in collagen-induced arthritis in rodents.	British journal of pharmacology	2007	58
18413790	vorinostat	Fournel M	MGCD0103, a novel isotype-selective histone deacetylase inhibitor, has broad spectrum antitumor activity in vitro and in vivo.	Molecular cancer therapeutics	2008	75
18568076	vorinostat	Reddy P	Histone deacetylase inhibition modulates indoleamine 2,3-dioxygenase-dependent DC functions and regulates experimental graft-versus-host disease in mice.	The Journal of clinical investigation	2008	98
19789319	vorinostat	Palmieri D	Vorinostat inhibits brain metastatic colonization in a model of triple-negative breast cancer and induces DNA double-strand breaks.	Clinical cancer research 	2009	47
21840928	vorinostat	Mutsaers CA	Reversible molecular pathology of skeletal muscle in spinal muscular atrophy.	Human molecular genetics	2011	41
24396039	vorinostat	Xie M	Histone deacetylase inhibition blunts ischemia/reperfusion injury by inducing cardiomyocyte autophagy.	Circulation	2014	68
24603818	vorinostat	Sanders YY	Histone deacetylase inhibition promotes fibroblast apoptosis and ameliorates pulmonary fibrosis in mice.	The European respiratory journal	2014	24
26280576	vorinostat	Benito E	HDAC inhibitor-dependent transcriptome and memory reinstatement in cognitive decline models.	The Journal of clinical investigation	2015	19
26888431	vorinostat	Alam MS	Chronic administration of an HDAC inhibitor treats both neurological and systemic Niemann-Pick type C disease in a mouse model.	Science translational medicine	2016	16
16049343	acetovanillone	Al-Shabrawey M	Inhibition of NAD(P)H oxidase activity blocks vascular endothelial growth factor overexpression and neovascularization during ischemic retinopathy.	The American journal of pathology	2005	75
19265038	acetovanillone	Collins AR	Age-accelerated atherosclerosis correlates with failure to upregulate antioxidant genes.	Circulation research	2009	79
20526041	acetovanillone	Ketonen J	Periadventitial adipose tissue promotes endothelial dysfunction via oxidative stress in diet-induced obese C57Bl/6 mice.	Circulation journal 	2010	48
22050439	acetovanillone	Choi SH	Inhibition of NADPH oxidase promotes alternative and anti-inflammatory microglial activation during neuroinflammation.	Journal of neurochemistry	2012	47
22485176	acetovanillone	Zhang QG	Critical role of NADPH oxidase in neuronal oxidative damage and microglia activation following traumatic brain injury.	PloS one	2012	54
23326634	acetovanillone	Ding Z	Oxidant stress in mitochondrial DNA damage, autophagy and inflammation in atherosclerosis.	Scientific reports	2013	39
23348010	acetovanillone	Jiang Z	Social isolation exacerbates schizophrenia-like phenotypes via oxidative stress in cortical interneurons.	Biological psychiatry	2013	28
24571599	acetovanillone	Hernandes MS	The role of Nox2-derived ROS in the development of cognitive impairment after sepsis.	Journal of neuroinflammation	2014	22
15028725	AICA ribonucleotide	Kim EK	C75, a fatty acid synthase inhibitor, reduces food intake via hypothalamic AMP-activated protein kinase.	The Journal of biological chemistry	2004	74
16176927	AICA ribonucleotide	Rattan R	5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside inhibits cancer cell proliferation in vitro and in vivo via AMP-activated protein kinase.	The Journal of biological chemistry	2005	108
19625624	AICA ribonucleotide	Guo D	The AMPK agonist AICAR inhibits the growth of EGFRvIII-expressing glioblastomas by inhibiting lipogenesis.	Proceedings of the National Academy of Sciences of the United States of America	2009	84
21659335	AICA ribonucleotide	Ljubicic V	Chronic AMPK activation evokes the slow, oxidative myogenic program and triggers beneficial adaptations in mdx mouse skeletal muscle.	Human molecular genetics	2011	35
22006269	AICA ribonucleotide	Sanchez AM	AMPK promotes skeletal muscle autophagy through activation of forkhead FoxO3a and interaction with Ulk1.	Journal of cellular biochemistry	2012	66
23936035	AICA ribonucleotide	Howell GM	Augmenting autophagy to treat acute kidney injury during endotoxemia in mice.	PloS one	2013	43
24135141	AICA ribonucleotide	Dugan LL	AMPK dysregulation promotes diabetes-related reduction of superoxide and mitochondrial function.	The Journal of clinical investigation	2013	89
24304883	AICA ribonucleotide	Declèves AE	Regulation of lipid accumulation by AMP-activated kinase corrected in high fat diet-induced kidney injury.	Kidney international	2014	30
15087398	JM 3100	Tavor S	CXCR4 regulates migration and development of human acute myelogenous leukemia stem cells in transplanted NOD/SCID mice.	Cancer research	2004	78
15533866	JM 3100	Abbott JD	Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury.	Circulation	2004	208
15574767	JM 3100	Smith MC	CXCR4 regulates growth of both primary and metastatic breast cancer.	Cancer research	2004	213
16489019	JM 3100	Yasumoto K	Role of the CXCL12/CXCR4 axis in peritoneal carcinomatosis of gastric cancer.	Cancer research	2006	62
17893878	JM 3100	Kajiyama H	Involvement of SDF-1alpha/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma.	International journal of cancer	2008	79
18538590	JM 3100	Tsuboi N	Human neutrophil Fcgamma receptors initiate and play specialized nonredundant roles in antibody-mediated inflammatory diseases.	Immunity	2008	50
19050309	JM 3100	Nervi B	Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100.	Blood	2009	148
19588204	JM 3100	Matsusue R	Hepatic stellate cells promote liver metastasis of colon cancer cells by the action of SDF-1/CXCR4 axis.	Annals of surgical oncology	2009	45
20179352	JM 3100	Kioi M	Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice.	The Journal of clinical investigation	2010	207
20437584	JM 3100	Fan Y	Endothelial progenitor cell transplantation improves long-term stroke outcome in mice.	Annals of neurology	2010	91
20534467	JM 3100	Jujo K	CXCR4 blockade augments bone marrow progenitor cell recruitment to the neovasculature and reduces mortality after myocardial infarction.	Proceedings of the National Academy of Sciences of the United States of America	2010	64
21618540	JM 3100	Ping YF	The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling.	The Journal of pathology	2011	52
21742774	JM 3100	Righi E	CXCL12/CXCR4 blockade induces multimodal antitumor effects that prolong survival in an immunocompetent mouse model of ovarian cancer.	Cancer research	2011	51
21959218	JM 3100	Krishnamurthy P	Interleukin-10 deficiency impairs bone marrow-derived endothelial progenitor cell survival and function in ischemic myocardium.	Circulation research	2011	43
22871210	JM 3100	Zhang SS	CD133(+)CXCR4(+) colon cancer cells exhibit metastatic potential and predict poor prognosis of patients.	BMC medicine	2012	46
23002097	JM 3100	Garibaldi BT	Regulatory T cells reduce acute lung injury fibroproliferation by decreasing fibrocyte recruitment.	American journal of respiratory cell and molecular biology	2013	35
23168453	JM 3100	Huang J	CXCR4 antagonist AMD3100 protects blood-brain barrier integrity and reduces inflammatory response after focal ischemia in mice.	Stroke	2013	46
23630186	JM 3100	Gassenmaier M	CXC chemokine receptor 4 is essential for maintenance of renal cell carcinoma-initiating cells and predicts metastasis.	Stem cells	2013	27
25444927	JM 3100	Guan G	The HIF-1α/CXCR4 pathway supports hypoxia-induced metastasis of human osteosarcoma cells.	Cancer letters	2015	16
26031918	JM 3100	Cho BS	Antileukemia activity of the novel peptidic CXCR4 antagonist LY2510924 as monotherapy and in combination with chemotherapy.	Blood	2015	20
26996301	JM 3100	Wang HH	Mesenchymal stem cells generate pericytes to promote tumor recurrence via vasculogenesis after stereotactic body radiation therapy.	Cancer letters	2016	12
11238559	sodium sulfate	Bertolotti A	Increased sensitivity to dextran sodium sulfate colitis in IRE1beta-deficient mice.	The Journal of clinical investigation	2001	118
11927615	sodium sulfate	Kabashima K	The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut.	The Journal of clinical investigation	2002	116
12376619	sodium sulfate	Chen Y	Protection of the intestinal mucosa by intraepithelial gamma delta T cells.	Proceedings of the National Academy of Sciences of the United States of America	2002	121
12682225	sodium sulfate	Ortega-Cava CF	Strategic compartmentalization of Toll-like receptor 4 in the mouse gut.	Journal of immunology	2003	76
14762789	sodium sulfate	Rachmilewitz D	Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis.	Gastroenterology	2004	173
15615857	sodium sulfate	Pull SL	Activated macrophages are an adaptive element of the colonic epithelial progenitor niche necessary for regenerative responses to injury.	Proceedings of the National Academy of Sciences of the United States of America	2005	181
16344067	sodium sulfate	Castaneda FE	Targeted deletion of metalloproteinase 9 attenuates experimental colitis in mice: central role of epithelial-derived MMP.	Gastroenterology	2005	70
17200722	sodium sulfate	Brown SL	Myd88-dependent positioning of Ptgs2-expressing stromal cells maintains colonic epithelial proliferation during injury.	The Journal of clinical investigation	2007	88
17397543	sodium sulfate	Froicu M	Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury.	BMC immunology	2007	82
18166353	sodium sulfate	Cummins EP	The hydroxylase inhibitor dimethyloxalylglycine is protective in a murine model of colitis.	Gastroenterology	2008	126
18250470	sodium sulfate	Steinbrecher KA	Loss of epithelial RelA results in deregulated intestinal proliferative/apoptotic homeostasis and susceptibility to inflammation.	Journal of immunology	2008	76
18514073	sodium sulfate	Vetrano S	Unique role of junctional adhesion molecule-a in maintaining mucosal homeostasis in inflammatory bowel disease.	Gastroenterology	2008	53
18796297	sodium sulfate	Ito R	Involvement of IL-17A in the pathogenesis of DSS-induced colitis in mice.	Biochemical and biophysical research communications	2008	58
19221015	sodium sulfate	Mennigen R	Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis.	American journal of physiology. Gastrointestinal and liver physiology	2009	92
19273626	sodium sulfate	Taylor BC	TSLP regulates intestinal immunity and inflammation in mouse models of helminth infection and colitis.	The Journal of experimental medicine	2009	113
19564350	sodium sulfate	Pickert G	STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing.	The Journal of experimental medicine	2009	246
21109593	sodium sulfate	Petersson J	Importance and regulation of the colonic mucus barrier in a mouse model of colitis.	American journal of physiology. Gastrointestinal and liver physiology	2011	75
21118981	sodium sulfate	Hu B	Inflammation-induced tumorigenesis in the colon is regulated by caspase-1 and NLRC4.	Proceedings of the National Academy of Sciences of the United States of America	2010	101
22131549	sodium sulfate	Monk JM	Th17 cell accumulation is decreased during chronic experimental colitis by (n-3) PUFA in Fat-1 mice.	The Journal of nutrition	2012	31
22354874	sodium sulfate	Hyun YS	Role of IL-17A in the development of colitis-associated cancer.	Carcinogenesis	2012	40
22508383	sodium sulfate	Groβ P	IL-33 attenuates development and perpetuation of chronic intestinal inflammation.	Inflammatory bowel diseases	2012	37
23426893	sodium sulfate	Johansson ME	Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis.	Gut	2014	127
23781104	sodium sulfate	Zindl CL	IL-22-producing neutrophils contribute to antimicrobial defense and restitution of colonic epithelial integrity during colitis.	Proceedings of the National Academy of Sciences of the United States of America	2013	62
23793223	sodium sulfate	Bersudsky M	Non-redundant properties of IL-1α and IL-1β during acute colon inflammation in mice.	Gut	2014	39
24025712	sodium sulfate	Torres S	Proteome profiling of cancer-associated fibroblasts identifies novel proinflammatory signatures and prognostic markers for colorectal cancer.	Clinical cancer research 	2013	45
24453980	sodium sulfate	Weber B	TREM-1 deficiency can attenuate disease severity without affecting pathogen clearance.	PLoS pathogens	2014	30
24487592	sodium sulfate	Westphalen CB	Long-lived intestinal tuft cells serve as colon cancer-initiating cells.	The Journal of clinical investigation	2014	84
24850431	sodium sulfate	Demon D	Caspase-11 is expressed in the colonic mucosa and protects against dextran sodium sulfate-induced colitis.	Mucosal immunology	2014	22
24931456	sodium sulfate	Liu S	A microRNA 221- and 222-mediated feedback loop maintains constitutive activation of NFκB and STAT3 in colorectal cancer cells.	Gastroenterology	2014	31
25367573	sodium sulfate	Moriwaki K	The necroptosis adaptor RIPK3 promotes injury-induced cytokine expression and tissue repair.	Immunity	2014	44
25548224	sodium sulfate	Oficjalska K	Protective role for caspase-11 during acute experimental murine colitis.	Journal of immunology	2015	17
25915426	sodium sulfate	Yang YR	Elevated O-GlcNAcylation promotes colonic inflammation and tumorigenesis by modulating NF-κB signaling.	Oncotarget	2015	18
26107252	sodium sulfate	Wilson JE	Inflammasome-independent role of AIM2 in suppressing colon tumorigenesis via DNA-PK and Akt.	Nature medicine	2015	40
26174764	sodium sulfate	Muzaki AR	Intestinal CD103(+)CD11b(-) dendritic cells restrain colitis via IFN-γ-induced anti-inflammatory response in epithelial cells.	Mucosal immunology	2016	22
26590314	sodium sulfate	Medina-Contreras O	Cutting Edge: IL-36 Receptor Promotes Resolution of Intestinal Damage.	Journal of immunology	2016	17
26655906	sodium sulfate	Hu S	The DNA Sensor AIM2 Maintains Intestinal Homeostasis via Regulation of Epithelial Antimicrobial Host Defense.	Cell reports	2015	19
26783184	sodium sulfate	Scheibe K	IL-36R signalling activates intestinal epithelial cells and fibroblasts and promotes mucosal healing in vivo.	Gut	2017	10
27864128	sodium sulfate	Kim HB	Prostaglandin E2 Activates YAP and a Positive-Signaling Loop to Promote Colon Regeneration After Colitis but Also Carcinogenesis in Mice.	Gastroenterology	2017	9
11600888	Cuprizone	Arnett HA	TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination.	Nature neuroscience	2001	204
15862213	Cuprizone	Song SK	Demyelination increases radial diffusivity in corpus callosum of mouse brain.	NeuroImage	2005	446
20154684	Cuprizone	Liu L	CXCR2-positive neutrophils are essential for cuprizone-induced demyelination: relevance to multiple sclerosis.	Nature neuroscience	2010	62
20535036	Cuprizone	Xie M	Rostrocaudal analysis of corpus callosum demyelination and axon damage across disease stages refines diffusion tensor imaging correlations with pathological features.	Journal of neuropathology and experimental neurology	2010	57
21106820	Cuprizone	Jha S	The inflammasome sensor, NLRP3, regulates CNS inflammation and demyelination via caspase-1 and interleukin-18.	The Journal of neuroscience 	2010	59
23266461	Cuprizone	Skripuletz T	Astrocytes regulate myelin clearance through recruitment of microglia during cuprizone-induced demyelination.	Brain 	2013	57
24920623	Cuprizone	Fulmer CG	Astrocyte-derived BDNF supports myelin protein synthesis after cuprizone-induced demyelination.	The Journal of neuroscience 	2014	35
25631124	Cuprizone	Cantoni C	TREM2 regulates microglial cell activation in response to demyelination in vivo.	Acta neuropathologica	2015	29
25779633	Cuprizone	Lampron A	Inefficient clearance of myelin debris by microglia impairs remyelinating processes.	The Journal of experimental medicine	2015	41
25893602	Cuprizone	Poliani PL	TREM2 sustains microglial expansion during aging and response to demyelination.	The Journal of clinical investigation	2015	42
25948275	Cuprizone	Hamada MS	Myelin loss and axonal ion channel adaptations associated with gray matter neuronal hyperexcitability.	The Journal of neuroscience 	2015	21
15226415	4-phenylbutyric acid	Qi X	Sodium 4-phenylbutyrate protects against cerebral ischemic injury.	Molecular pharmacology	2004	71
19145227	4-phenylbutyric acid	Ricobaraza A	Phenylbutyrate ameliorates cognitive deficit and reduces tau pathology in an Alzheimer's disease mouse model.	Neuropsychopharmacology 	2009	99
21069780	4-phenylbutyric acid	Ricobaraza A	Phenylbutyrate rescues dendritic spine loss associated with memory deficits in a mouse model of Alzheimer disease.	Hippocampus	2012	52
22539597	4-phenylbutyric acid	Kassan M	Endoplasmic reticulum stress is involved in cardiac damage and vascular endothelial dysfunction in hypertensive mice.	Arteriosclerosis, thrombosis, and vascular biology	2012	53
24200693	4-phenylbutyric acid	Lam HC	Histone deacetylase 6-mediated selective autophagy regulates COPD-associated cilia dysfunction.	The Journal of clinical investigation	2013	57
24691439	4-phenylbutyric acid	Zode GS	Ocular-specific ER stress reduction rescues glaucoma in murine glucocorticoid-induced glaucoma.	The Journal of clinical investigation	2014	28
10219240	2-phenyl-5,5-dimethyltetrahydro-1,4-oxazine	Hirota H	Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress.	Cell	1999	117
11689889	2-phenyl-5,5-dimethyltetrahydro-1,4-oxazine	Wettschureck N	Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Galphaq/Galpha11 in cardiomyocytes.	Nature medicine	2001	85
15668741	2-phenyl-5,5-dimethyltetrahydro-1,4-oxazine	Doganci A	The IL-6R alpha chain controls lung CD4+CD25+ Treg development and function during allergic airway inflammation in vivo.	The Journal of clinical investigation	2005	92
17493959	2-phenyl-5,5-dimethyltetrahydro-1,4-oxazine	Nishihara M	IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.	International immunology	2007	67
18641358	2-phenyl-5,5-dimethyltetrahydro-1,4-oxazine	Fielding CA	IL-6 regulates neutrophil trafficking during acute inflammation via STAT3.	Journal of immunology	2008	72
19173740	2-phenyl-5,5-dimethyltetrahydro-1,4-oxazine	Savale L	Impact of interleukin-6 on hypoxia-induced pulmonary hypertension and lung inflammation in mice.	Respiratory research	2009	57
19185844	2-phenyl-5,5-dimethyltetrahydro-1,4-oxazine	Bollrath J	gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis.	Cancer cell	2009	256
20042582	2-phenyl-5,5-dimethyltetrahydro-1,4-oxazine	Matsumoto S	Essential roles of IL-6 trans-signaling in colonic epithelial cells, induced by the IL-6/soluble-IL-6 receptor derived from lamina propria macrophages, on the development of colitis-associated premalignant cancer in a murine model.	Journal of immunology	2010	54
20530204	2-phenyl-5,5-dimethyltetrahydro-1,4-oxazine	Sander LE	Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function.	The Journal of experimental medicine	2010	93
20713517	2-phenyl-5,5-dimethyltetrahydro-1,4-oxazine	Inda MM	Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma.	Genes & development	2010	172
20953899	2-phenyl-5,5-dimethyltetrahydro-1,4-oxazine	Seike T	Interaction between lung cancer cells and astrocytes via specific inflammatory cytokines in the microenvironment of brain metastasis.	Clinical & experimental metastasis	2011	38
21148800	2-phenyl-5,5-dimethyltetrahydro-1,4-oxazine	Greenhill CJ	IL-6 trans-signaling modulates TLR4-dependent inflammatory responses via STAT3.	Journal of immunology	2011	47
21926464	2-phenyl-5,5-dimethyltetrahydro-1,4-oxazine	Fisher DT	IL-6 trans-signaling licenses mouse and human tumor microvascular gateways for trafficking of cytotoxic T cells.	The Journal of clinical investigation	2011	54
22891351	2-phenyl-5,5-dimethyltetrahydro-1,4-oxazine	Couto JP	STAT3 negatively regulates thyroid tumorigenesis.	Proceedings of the National Academy of Sciences of the United States of America	2012	43
22969429	2-phenyl-5,5-dimethyltetrahydro-1,4-oxazine	Bailey CC	Ifitm3 limits the severity of acute influenza in mice.	PLoS pathogens	2012	87
23153532	2-phenyl-5,5-dimethyltetrahydro-1,4-oxazine	Calon A	Dependency of colorectal cancer on a TGF-β-driven program in stromal cells for metastasis initiation.	Cancer cell	2012	157
23345334	2-phenyl-5,5-dimethyltetrahydro-1,4-oxazine	Wang Z	Tumor-derived IL-35 promotes tumor growth by enhancing myeloid cell accumulation and angiogenesis.	Journal of immunology	2013	38
24523541	2-phenyl-5,5-dimethyltetrahydro-1,4-oxazine	Campbell IL	Trans-signaling is a dominant mechanism for the pathogenic actions of interleukin-6 in the brain.	The Journal of neuroscience 	2014	28
24804649	2-phenyl-5,5-dimethyltetrahydro-1,4-oxazine	Judd LM	Inhibition of the JAK2/STAT3 pathway reduces gastric cancer growth in vitro and in vivo.	PloS one	2014	20
25731159	2-phenyl-5,5-dimethyltetrahydro-1,4-oxazine	Taniguchi K	A gp130-Src-YAP module links inflammation to epithelial regeneration.	Nature	2015	84
27096320	2-phenyl-5,5-dimethyltetrahydro-1,4-oxazine	Zhang C	CD5 Binds to Interleukin-6 and Induces a Feed-Forward Loop with the Transcription Factor STAT3 in B Cells to Promote Cancer.	Immunity	2016	13
15599396	lysophosphatidic acid	Boucharaba A	Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer.	The Journal of clinical investigation	2004	103
15875025	lysophosphatidic acid	Ye X	LPA3-mediated lysophosphatidic acid signalling in embryo implantation and spacing.	Nature	2005	119
18066075	lysophosphatidic acid	Tager AM	The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak.	Nature medicine	2008	187
19001604	lysophosphatidic acid	Yu S	Lysophosphatidic acid receptors determine tumorigenicity and aggressiveness of ovarian cancer cells.	Journal of the National Cancer Institute	2008	62
19477432	lysophosphatidic acid	Liu S	Expression of autotaxin and lysophosphatidic acid receptors increases mammary tumorigenesis, invasion, and metastases.	Cancer cell	2009	128
21041624	lysophosphatidic acid	Su F	Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer.	Proceedings of the National Academy of Sciences of the United States of America	2010	56
23322166	lysophosphatidic acid	Sakai N	LPA1-induced cytoskeleton reorganization drives fibrosis through CTGF-dependent fibroblast proliferation.	FASEB journal 	2013	40
24706986	lysophosphatidic acid	Haak AJ	Targeting the myofibroblast genetic switch: inhibitors of myocardin-related transcription factor/serum response factor-regulated gene transcription prevent fibrosis in a murine model of skin injury.	The Journal of pharmacology and experimental therapeutics	2014	26
25024203	lysophosphatidic acid	Xiong S	Pla2g16 phospholipase mediates gain-of-function activities of mutant p53.	Proceedings of the National Academy of Sciences of the United States of America	2014	24
26109050	lysophosphatidic acid	Moroishi T	A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis.	Genes & development	2015	56
26224810	lysophosphatidic acid	Bouchareb R	Autotaxin Derived From Lipoprotein(a) and Valve Interstitial Cells Promotes Inflammation and Mineralization of the Aortic Valve.	Circulation	2015	21
27981605	lysophosphatidic acid	Kaffe E	Hepatocyte autotaxin expression promotes liver fibrosis and cancer.	Hepatology	2017	8
11025665	Semaxinib	Bergers G	Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis.	Nature cell biology	2000	588
12727920	Semaxinib	Bergers G	Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors.	The Journal of clinical investigation	2003	337
21868504	Semaxinib	Ciuclan L	A novel murine model of severe pulmonary arterial hypertension.	American journal of respiratory and critical care medicine	2011	61
25956031	Semaxinib	Good RB	Endothelial to Mesenchymal Transition Contributes to Endothelial Dysfunction in Pulmonary Arterial Hypertension.	The American journal of pathology	2015	28
15824102	4-azidophenylpropionamide	Wong HK	beta Subunits of voltage-gated sodium channels are novel substrates of beta-site amyloid precursor protein-cleaving enzyme (BACE1) and gamma-secretase.	The Journal of biological chemistry	2005	110
16242627	4-azidophenylpropionamide	Almeida CG	Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses.	Neurobiology of disease	2005	125
17035538	4-azidophenylpropionamide	Cruz JC	p25/cyclin-dependent kinase 5 induces production and intraneuronal accumulation of amyloid beta in vivo.	The Journal of neuroscience 	2006	70
17070803	4-azidophenylpropionamide	Zhang C	Long-lasting impairment in hippocampal neurogenesis associated with amyloid deposition in a knock-in mouse model of familial Alzheimer's disease.	Experimental neurology	2007	65
17121991	4-azidophenylpropionamide	Sun X	Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression.	Proceedings of the National Academy of Sciences of the United States of America	2006	122
17368446	4-azidophenylpropionamide	Mac Donald CL	Detection of traumatic axonal injury with diffusion tensor imaging in a mouse model of traumatic brain injury.	Experimental neurology	2007	94
17998412	4-azidophenylpropionamide	Firuzi O	5-Lipoxygenase gene disruption reduces amyloid-beta pathology in a mouse model of Alzheimer's disease.	FASEB journal 	2008	61
18258852	4-azidophenylpropionamide	Terwel D	Amyloid activates GSK-3beta to aggravate neuronal tauopathy in bigenic mice.	The American journal of pathology	2008	65
18562603	4-azidophenylpropionamide	Maier M	Complement C3 deficiency leads to accelerated amyloid beta plaque deposition and neurodegeneration and modulation of the microglia/macrophage phenotype in amyloid precursor protein transgenic mice.	The Journal of neuroscience 	2008	87
19320056	4-azidophenylpropionamide	McAlpine FE	Inhibition of soluble TNF signaling in a mouse model of Alzheimer's disease prevents pre-plaque amyloid-associated neuropathology.	Neurobiology of disease	2009	77
19453301	4-azidophenylpropionamide	Kasher PR	Direct evidence for axonal transport defects in a novel mouse model of mutant spastin-induced hereditary spastic paraplegia (HSP) and human HSP patients.	Journal of neurochemistry	2009	46
19523444	4-azidophenylpropionamide	Killick R	Deletion of Irs2 reduces amyloid deposition and rescues behavioural deficits in APP transgenic mice.	Biochemical and biophysical research communications	2009	50
19705461	4-azidophenylpropionamide	Mori T	Overexpression of human S100B exacerbates cerebral amyloidosis and gliosis in the Tg2576 mouse model of Alzheimer's disease.	Glia	2010	53
19828212	4-azidophenylpropionamide	Vogt DL	Abnormal neuronal networks and seizure susceptibility in mice overexpressing the APP intracellular domain.	Neurobiology of aging	2011	35
20434528	4-azidophenylpropionamide	Dawson HN	Loss of tau elicits axonal degeneration in a mouse model of Alzheimer's disease.	Neuroscience	2010	52
21613482	4-azidophenylpropionamide	Winton MJ	Intraneuronal APP, not free Aβ peptides in 3xTg-AD mice: implications for tau versus Aβ-mediated Alzheimer neurodegeneration.	The Journal of neuroscience 	2011	50
22539346	4-azidophenylpropionamide	Xiao Q	Role of phosphatidylinositol clathrin assembly lymphoid-myeloid leukemia (PICALM) in intracellular amyloid precursor protein (APP) processing and amyloid plaque pathogenesis.	The Journal of biological chemistry	2012	42
11751413	gefitinib	Moulder SL	Epidermal growth factor receptor (HER1) tyrosine kinase inhibitor ZD1839 (Iressa) inhibits HER2/neu (erbB2)-overexpressing breast cancer cells in vitro and in vivo.	Cancer research	2001	99
16648858	gefitinib	Ferby I	Mig6 is a negative regulator of EGF receptor-mediated skin morphogenesis and tumor formation.	Nature medicine	2006	95
16672372	gefitinib	Ji H	Epidermal growth factor receptor variant III mutations in lung tumorigenesis and sensitivity to tyrosine kinase inhibitors.	Proceedings of the National Academy of Sciences of the United States of America	2006	73
16705038	gefitinib	Politi K	Lung adenocarcinomas induced in mice by mutant EGF receptors found in human lung cancers respond to a tyrosine kinase inhibitor or to down-regulation of the receptors.	Genes & development	2006	130
17470737	gefitinib	Arpino G	Treatment of human epidermal growth factor receptor 2-overexpressing breast cancer xenografts with multiagent HER-targeted therapy.	Journal of the National Cancer Institute	2007	62
18568074	gefitinib	Guix M	Acquired resistance to EGFR tyrosine kinase inhibitors in cancer cells is mediated by loss of IGF-binding proteins.	The Journal of clinical investigation	2008	177
18632637	gefitinib	Shimamura T	Hsp90 inhibition suppresses mutant EGFR-T790M signaling and overcomes kinase inhibitor resistance.	Cancer research	2008	57
22057914	gefitinib	Cheng Y	MK-2206, a novel allosteric inhibitor of Akt, synergizes with gefitinib against malignant glioma via modulating both autophagy and apoptosis.	Molecular cancer therapeutics	2012	40
22362908	gefitinib	Liu N	Genetic or pharmacologic blockade of EGFR inhibits renal fibrosis.	Journal of the American Society of Nephrology 	2012	41
22414764	gefitinib	Blivet-Van Eggelpoël MJ	Epidermal growth factor receptor and HER-3 restrict cell response to sorafenib in hepatocellular carcinoma cells.	Journal of hepatology	2012	39
22844075	gefitinib	Nakagawa T	Combined therapy with mutant-selective EGFR inhibitor and Met kinase inhibitor for overcoming erlotinib resistance in EGFR-mutant lung cancer.	Molecular cancer therapeutics	2012	31
23307622	gefitinib	Cufí S	Autophagy-related gene 12 (ATG12) is a novel determinant of primary resistance to HER2-targeted therapies: utility of transcriptome analysis of the autophagy interactome to guide breast cancer treatment.	Oncotarget	2012	33
23461856	gefitinib	Ma L	Cancer stem-like cell properties are regulated by EGFR/AKT/β-catenin signaling and preferentially inhibited by gefitinib in nasopharyngeal carcinoma.	The FEBS journal	2013	26
24165158	gefitinib	Rho JK	MET and AXL inhibitor NPS-1034 exerts efficacy against lung cancer cells resistant to EGFR kinase inhibitors because of MET or AXL activation.	Cancer research	2014	30
24535670	gefitinib	de Bruin EC	Reduced NF1 expression confers resistance to EGFR inhibition in lung cancer.	Cancer discovery	2014	42
24939055	gefitinib	Qu Y	Antitumor activity of selective MEK1/2 inhibitor AZD6244 in combination with PI3K/mTOR inhibitor BEZ235 in gefitinib-resistant NSCLC xenograft models.	Journal of experimental & clinical cancer research 	2014	24
24983493	gefitinib	Zhou JY	MicroRNA-34a overcomes HGF-mediated gefitinib resistance in EGFR mutant lung cancer cells partly by targeting MET.	Cancer letters	2014	21
25925741	gefitinib	Dong S	The long non-coding RNA, GAS5, enhances gefitinib-induced cell death in innate EGFR tyrosine kinase inhibitor-resistant lung adenocarcinoma cells with wide-type EGFR via downregulation of the IGF-1R expression.	Journal of hematology & oncology	2015	26
26282169	gefitinib	Soucheray M	Intratumoral Heterogeneity in EGFR-Mutant NSCLC Results in Divergent Resistance Mechanisms in Response to EGFR Tyrosine Kinase Inhibition.	Cancer research	2015	19
27251290	gefitinib	Jia Y	Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors.	Nature	2016	47
28271729	gefitinib	Ahn MJ	EGFR TKI combination with immunotherapy in non-small cell lung cancer.	Expert opinion on drug safety	2017	10
12876200	BH 3	Ranger AM	Bad-deficient mice develop diffuse large B cell lymphoma.	Proceedings of the National Academy of Sciences of the United States of America	2003	78
17606912	BH 3	Brooks C	Bak regulates mitochondrial morphology and pathology during apoptosis by interacting with mitofusins.	Proceedings of the National Academy of Sciences of the United States of America	2007	110
20436477	BH 3	Zaltsman Y	MTCH2/MIMP is a major facilitator of tBID recruitment to mitochondria.	Nature cell biology	2010	57
20460269	BH 3	Pedrini S	ALS-linked mutant SOD1 damages mitochondria by promoting conformational changes in Bcl-2.	Human molecular genetics	2010	43
23680104	BH 3	Cao X	The novel BH3 α-helix mimetic JY-1-106 induces apoptosis in a subset of cancer cells (lung cancer, colon cancer and mesothelioma) by disrupting Bcl-xL and Mcl-1 protein-protein interactions with Bak.	Molecular cancer	2013	25
24019208	BH 3	Abulwerdi F	A novel small-molecule inhibitor of mcl-1 blocks pancreatic cancer growth in vitro and in vivo.	Molecular cancer therapeutics	2014	49
24141421	BH 3	Maejima Y	Mst1 inhibits autophagy by promoting the interaction between Beclin1 and Bcl-2.	Nature medicine	2013	92
24488097	BH 3	Fiori ME	Antitumor effect of miR-197 targeting in p53 wild-type lung cancer.	Cell death and differentiation	2014	24
25879458	BH 3	Baratz R	Transiently lowering tumor necrosis factor-α synthesis ameliorates neuronal cell loss and cognitive impairments induced by minimal traumatic brain injury in mice.	Journal of neuroinflammation	2015	20
28017613	BH 3	Sarosiek KA	Developmental Regulation of Mitochondrial Apoptosis by c-Myc Governs Age- and Tissue-Specific Sensitivity to Cancer Therapeutics.	Cancer cell	2017	15
11927628	alpha-galactosylceramide	Pellicci DG	A natural killer T (NKT) cell developmental pathway iInvolving a thymus-dependent NK1.1(-)CD4(+) CD1d-dependent precursor stage.	The Journal of experimental medicine	2002	108
16275765	alpha-galactosylceramide	Crowe NY	Differential antitumor immunity mediated by NKT cell subsets in vivo.	The Journal of experimental medicine	2005	122
17372206	alpha-galactosylceramide	Porubsky S	Normal development and function of invariant natural killer T cells in mice with isoglobotrihexosylceramide (iGb3) deficiency.	Proceedings of the National Academy of Sciences of the United States of America	2007	79
19234176	alpha-galactosylceramide	Parekh VV	PD-1/PD-L blockade prevents anergy induction and enhances the anti-tumor activities of glycolipid-activated invariant NKT cells.	Journal of immunology	2009	69
17160391	sorafenib	Chang YS	Sorafenib (BAY 43-9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft models.	Cancer chemotherapy and pharmacology	2007	108
19726678	sorafenib	Bai S	MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib.	The Journal of biological chemistry	2009	157
20616044	sorafenib	Wüstehube J	Cerebral cavernous malformation protein CCM1 inhibits sprouting angiogenesis by activating DELTA-NOTCH signaling.	Proceedings of the National Academy of Sciences of the United States of America	2010	47
20884624	sorafenib	Chen KF	Sorafenib overcomes TRAIL resistance of hepatocellular carcinoma cells through the inhibition of STAT3.	Clinical cancer research 	2010	50
21368833	sorafenib	Inuzuka H	SCF(FBW7) regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction.	Nature	2011	195
21858812	sorafenib	Shimizu S	Inhibition of autophagy potentiates the antitumor effect of the multikinase inhibitor sorafenib in hepatocellular carcinoma.	International journal of cancer	2012	56
22318717	sorafenib	Ma WL	Hepatic androgen receptor suppresses hepatocellular carcinoma metastasis through modulation of cell migration and anoikis.	Hepatology	2012	35
22368270	sorafenib	Man CH	Sorafenib treatment of FLT3-ITD(+) acute myeloid leukemia: favorable initial outcome and mechanisms of subsequent nonresponsiveness associated with the emergence of a D835 mutation.	Blood	2012	62
22446485	sorafenib	Rahmani M	Inhibition of Bcl-2 antiapoptotic members by obatoclax potently enhances sorafenib-induced apoptosis in human myeloid leukemia cells through a Bim-dependent process.	Blood	2012	36
22958930	sorafenib	Chu SH	FLT3-ITD knockin impairs hematopoietic stem cell quiescence/homeostasis, leading to myeloproliferative neoplasm.	Cell stem cell	2012	40
23299930	sorafenib	Liang Y	Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1α inhibition in hepatocellular carcinoma.	Hepatology	2013	53
23434734	sorafenib	Pignochino Y	The Combination of Sorafenib and Everolimus Abrogates mTORC1 and mTORC2 upregulation in osteosarcoma preclinical models.	Clinical cancer research 	2013	26
23796475	sorafenib	Kapanadze T	Regulation of accumulation and function of myeloid derived suppressor cells in different murine models of hepatocellular carcinoma.	Journal of hepatology	2013	33
24242874	sorafenib	Chen Y	Differential effects of sorafenib on liver versus tumor fibrosis mediated by stromal-derived factor 1 alpha/C-X-C receptor type 4 axis and myeloid differentiation antigen-positive myeloid cell infiltration in mice.	Hepatology	2014	32
24687604	sorafenib	Horwitz E	Human and mouse VEGFA-amplified hepatocellular carcinomas are highly sensitive to sorafenib treatment.	Cancer discovery	2014	21
24700742	sorafenib	Xiang Q	Cabozantinib suppresses tumor growth and metastasis in hepatocellular carcinoma by a dual blockade of VEGFR2 and MET.	Clinical cancer research 	2014	26
25053293	sorafenib	Fernando J	A mesenchymal-like phenotype and expression of CD44 predict lack of apoptotic response to sorafenib in liver tumor cells.	International journal of cancer	2015	23
25216638	sorafenib	Rudalska R	In vivo RNAi screening identifies a mechanism of sorafenib resistance in liver cancer.	Nature medicine	2014	43
25865556	sorafenib	Han T	PTPN11/Shp2 overexpression enhances liver cancer progression and predicts poor prognosis of patients.	Journal of hepatology	2015	19
26592953	sorafenib	Govaere O	Laminin-332 sustains chemoresistance and quiescence as part of the human hepatic cancer stem cell niche.	Journal of hepatology	2016	13
26924089	sorafenib	Zhou SL	Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib.	Gastroenterology	2016	22
12748309	sunitinib	Abrams TJ	SU11248 inhibits KIT and platelet-derived growth factor receptor beta in preclinical models of human small cell lung cancer.	Molecular cancer therapeutics	2003	147
17942672	sunitinib	Ebos JM	Multiple circulating proangiogenic factors induced by sunitinib malate are tumor-independent and correlate with antitumor efficacy.	Proceedings of the National Academy of Sciences of the United States of America	2007	115
19015530	sunitinib	Louvet C	Tyrosine kinase inhibitors reverse type 1 diabetes in nonobese diabetic mice.	Proceedings of the National Academy of Sciences of the United States of America	2008	60
19244102	sunitinib	Xin H	Sunitinib inhibition of Stat3 induces renal cell carcinoma tumor cell apoptosis and reduces immunosuppressive cells.	Cancer research	2009	142
19249681	sunitinib	Ebos JM	Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis.	Cancer cell	2009	509
19887629	sunitinib	Lee SL	Hypoxia-induced pathological angiogenesis mediates tumor cell dissemination, invasion, and metastasis in a zebrafish tumor model.	Proceedings of the National Academy of Sciences of the United States of America	2009	59
20501804	sunitinib	Hammers HJ	Reversible epithelial to mesenchymal transition and acquired resistance to sunitinib in patients with renal cell carcinoma: evidence from a xenograft study.	Molecular cancer therapeutics	2010	56
21237299	sunitinib	Greten TF	Myeloid derived suppressor cells in human diseases.	International immunopharmacology	2011	112
21315783	sunitinib	Finke J	MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy.	International immunopharmacology	2011	73
22308314	sunitinib	Conley SJ	Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia.	Proceedings of the National Academy of Sciences of the United States of America	2012	160
22484816	sunitinib	Maione F	Semaphorin 3A overcomes cancer hypoxia and metastatic dissemination induced by antiangiogenic treatment in mice.	The Journal of clinical investigation	2012	36
22965162	sunitinib	Piao Y	Glioblastoma resistance to anti-VEGF therapy is associated with myeloid cell infiltration, stem cell accumulation, and a mesenchymal phenotype.	Neuro-oncology	2012	54
25149532	sunitinib	Babae N	Systemic miRNA-7 delivery inhibits tumor angiogenesis and growth in murine xenograft glioblastoma.	Oncotarget	2014	26
25200065	sunitinib	Zhang D	Twist1 expression induced by sunitinib accelerates tumor cell vasculogenic mimicry by increasing the population of CD133+ cells in triple-negative breast cancer.	Molecular cancer	2014	25
25361735	sunitinib	Huang H	VEGF suppresses T-lymphocyte infiltration in the tumor microenvironment through inhibition of NF-κB-induced endothelial activation.	FASEB journal 	2015	22
25381264	sunitinib	Ciamporcero E	Combination strategy targeting VEGF and HGF/c-met in human renal cell carcinoma models.	Molecular cancer therapeutics	2015	19
25861727	sunitinib	Costa PM	MiRNA-21 silencing mediated by tumor-targeted nanoparticles combined with sunitinib: A new multimodal gene therapy approach for glioblastoma.	Journal of controlled release 	2015	22
27595394	sunitinib	Chen W	Targeting renal cell carcinoma with a HIF-2 antagonist.	Nature	2016	39
19372391	5-hydroxymethylcytosine	Tahiliani M	Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1.	Science	2009	1432
21803851	5-hydroxymethylcytosine	Li Z	Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies.	Blood	2011	163
22722204	5-hydroxymethylcytosine	Nakamura T	PGC7 binds histone H3K9me2 to protect against conversion of 5mC to 5hmC in early embryos.	Nature	2012	109
23827711	5-hydroxymethylcytosine	Song SJ	The oncogenic microRNA miR-22 targets the TET2 tumor suppressor to promote hematopoietic stem cell self-renewal and transformation.	Cell stem cell	2013	95
23828890	5-hydroxymethylcytosine	Lister R	Global epigenomic reconfiguration during mammalian brain development.	Science	2013	449
24270360	5-hydroxymethylcytosine	Jeong M	Large conserved domains of low DNA methylation maintained by Dnmt3a.	Nature genetics	2014	88
25867473	5-hydroxymethylcytosine	Cimmino L	TET1 is a tumor suppressor of hematopoietic malignancy.	Nature immunology	2015	48
25915124	5-hydroxymethylcytosine	Etchegaray JP	The histone deacetylase SIRT6 controls embryonic stem cell fate via TET-mediated production of 5-hydroxymethylcytosine.	Nature cell biology	2015	34
21501693	resolvin D1	Wang B	Resolvin D1 protects mice from LPS-induced acute lung injury.	Pulmonary pharmacology & therapeutics	2011	43
22013115	resolvin D1	Titos E	Resolvin D1 and its precursor docosahexaenoic acid promote resolution of adipose tissue inflammation by eliciting macrophage polarization toward an M2-like phenotype.	Journal of immunology	2011	96
22237406	resolvin D1	Odusanwo O	Resolvin D1 prevents TNF-α-mediated disruption of salivary epithelial formation.	American journal of physiology. Cell physiology	2012	32
22449948	resolvin D1	Krishnamoorthy S	Resolvin D1 receptor stereoselectivity and regulation of inflammation and proresolving microRNAs.	The American journal of pathology	2012	63
22499990	resolvin D1	Norling LV	Resolvin D1 limits polymorphonuclear leukocyte recruitment to inflammatory loci: receptor-dependent actions.	Arteriosclerosis, thrombosis, and vascular biology	2012	76
22785226	resolvin D1	Eickmeier O	Aspirin-triggered resolvin D1 reduces mucosal inflammation and promotes resolution in a murine model of acute lung injury.	Mucosal immunology	2013	51
22844113	resolvin D1	Clària J	Resolvin D1 and resolvin D2 govern local inflammatory tone in obese fat.	Journal of immunology	2012	55
23484005	resolvin D1	Hsiao HM	A novel anti-inflammatory and pro-resolving role for resolvin D1 in acute cigarette smoke-induced lung inflammation.	PloS one	2013	50
24238341	resolvin D1	Li Y	Plasticity of leukocytic exudates in resolving acute inflammation is regulated by MicroRNA and proresolving mediators.	Immunity	2013	26
25870158	resolvin D1	Kain V	Resolvin D1 activates the inflammation resolving response at splenic and ventricular site following myocardial infarction leading to improved ventricular function.	Journal of molecular and cellular cardiology	2015	23
21451123	PD 0325901	Lyubynska N	A MEK inhibitor abrogates myeloproliferative disease in Kras mutant mice.	Science translational medicine	2011	42
22064351	PD 0325901	Konopleva M	MEK inhibition enhances ABT-737-induced leukemia cell apoptosis via prevention of ERK-activated MCL-1 induction and modulation of MCL-1/BIM complex.	Leukemia	2012	45
22350410	PD 0325901	Mulholland DJ	Pten loss and RAS/MAPK activation cooperate to promote EMT and metastasis initiated from prostate cancer stem/progenitor cells.	Cancer research	2012	134
22836754	PD 0325901	Wang J	B-Raf activation cooperates with PTEN loss to drive c-Myc expression in advanced prostate cancer.	Cancer research	2012	31
23221341	PD 0325901	Jessen WJ	MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors.	The Journal of clinical investigation	2013	74
24315826	PD 0325901	Collins MA	MAPK signaling is required for dedifferentiation of acinar cells and development of pancreatic intraepithelial neoplasia in mice.	Gastroenterology	2014	22
24711431	PD 0325901	McFadden DG	p53 constrains progression to anaplastic thyroid carcinoma in a Braf-mutant mouse model of papillary thyroid cancer.	Proceedings of the National Academy of Sciences of the United States of America	2014	32
28215705	PD 0325901	Burgess MR	KRAS Allelic Imbalance Enhances Fitness and Modulates MAP Kinase Dependence in Cancer.	Cell	2017	6
18493258	necrostatin-1	You Z	Necrostatin-1 reduces histopathology and improves functional outcome after controlled cortical impact in mice.	Journal of cerebral blood flow and metabolism 	2008	82
20571523	necrostatin-1	Northington FJ	Necrostatin decreases oxidative damage, inflammation, and injury after neonatal HI.	Journal of cerebral blood flow and metabolism 	2011	62
22237751	necrostatin-1	Linkermann A	Rip1 (receptor-interacting protein kinase 1) mediates necroptosis and contributes to renal ischemia/reperfusion injury.	Kidney international	2012	99
22371307	necrostatin-1	Linkermann A	Dichotomy between RIP1- and RIP3-mediated necroptosis in tumor necrosis factor-α-induced shock.	Molecular medicine	2012	38
22553001	necrostatin-1	Oerlemans MI	Inhibition of RIP1-dependent necrosis prevents adverse cardiac remodeling after myocardial ischemia-reperfusion in vivo.	Basic research in cardiology	2012	54
23319235	necrostatin-1	Roychowdhury S	Absence of receptor interacting protein kinase 3 prevents ethanol-induced liver injury.	Hepatology	2013	67
25208916	necrostatin-1	Koks CA	Newcastle disease virotherapy induces long-term survival and tumor-specific immune memory in orthotopic glioma through the induction of immunogenic cell death.	International journal of cancer	2015	41
26775841	necrostatin-1	Ju T	Targeting colorectal cancer cells by a novel sphingosine kinase 1 inhibitor PF-543.	Biochemical and biophysical research communications	2016	15
27487218	necrostatin-1	Strilic B	Tumour-cell-induced endothelial cell necroptosis via death receptor 6 promotes metastasis.	Nature	2016	19
27532042	necrostatin-1	Karunakaran D	Targeting macrophage necroptosis for therapeutic and diagnostic interventions in atherosclerosis.	Science advances	2016	19
15272267	beta-amyloid peptide 1-42 (E22delta) click peptide	Ross CA	Protein aggregation and neurodegenerative disease.	Nature medicine	2004	573
15731448	beta-amyloid peptide 1-42 (E22delta) click peptide	Stokin GB	Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease.	Science	2005	310
15917461	beta-amyloid peptide 1-42 (E22delta) click peptide	Jankowsky JL	Environmental enrichment mitigates cognitive deficits in a mouse model of Alzheimer's disease.	The Journal of neuroscience 	2005	97
16279840	beta-amyloid peptide 1-42 (E22delta) click peptide	Jankowsky JL	Persistent amyloidosis following suppression of Abeta production in a transgenic model of Alzheimer disease.	PLoS medicine	2005	96
17478722	beta-amyloid peptide 1-42 (E22delta) click peptide	Roberson ED	Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model.	Science	2007	519
18218341	beta-amyloid peptide 1-42 (E22delta) click peptide	Reddy PH	Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease.	Trends in molecular medicine	2008	185
18497889	beta-amyloid peptide 1-42 (E22delta) click peptide	Pickford F	The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice.	The Journal of clinical investigation	2008	267
18516051	beta-amyloid peptide 1-42 (E22delta) click peptide	Town T	Blocking TGF-beta-Smad2/3 innate immune signaling mitigates Alzheimer-like pathology.	Nature medicine	2008	164
18587408	beta-amyloid peptide 1-42 (E22delta) click peptide	Faghihi MA	Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase.	Nature medicine	2008	314
18957217	beta-amyloid peptide 1-42 (E22delta) click peptide	Sun B	Cystatin C-cathepsin B axis regulates amyloid beta levels and associated neuronal deficits in an animal model of Alzheimer's disease.	Neuron	2008	53
19211891	beta-amyloid peptide 1-42 (E22delta) click peptide	Scholtzova H	Induction of toll-like receptor 9 signaling as a method for ameliorating Alzheimer's disease-related pathology.	The Journal of neuroscience 	2009	56
19228952	beta-amyloid peptide 1-42 (E22delta) click peptide	Meilandt WJ	Neprilysin overexpression inhibits plaque formation but fails to reduce pathogenic Abeta oligomers and associated cognitive deficits in human amyloid precursor protein transgenic mice.	The Journal of neuroscience 	2009	58
19242475	beta-amyloid peptide 1-42 (E22delta) click peptide	Laurén J	Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers.	Nature	2009	435
19710322	beta-amyloid peptide 1-42 (E22delta) click peptide	Yan P	Characterizing the appearance and growth of amyloid plaques in APP/PS1 mice.	The Journal of neuroscience 	2009	80
19951690	beta-amyloid peptide 1-42 (E22delta) click peptide	Sun B	Imbalance between GABAergic and Glutamatergic Transmission Impairs Adult Neurogenesis in an Animal Model of Alzheimer's Disease.	Cell stem cell	2009	52
20071513	beta-amyloid peptide 1-42 (E22delta) click peptide	Wesson DW	Olfactory dysfunction correlates with amyloid-beta burden in an Alzheimer's disease mouse model.	The Journal of neuroscience 	2010	69
20308787	beta-amyloid peptide 1-42 (E22delta) click peptide	Li Y	GLP-1 receptor stimulation reduces amyloid-beta peptide accumulation and cytotoxicity in cellular and animal models of Alzheimer's disease.	Journal of Alzheimer's disease 	2010	65
20445063	beta-amyloid peptide 1-42 (E22delta) click peptide	Gimbel DA	Memory impairment in transgenic Alzheimer mice requires cellular prion protein.	The Journal of neuroscience 	2010	144
20547128	beta-amyloid peptide 1-42 (E22delta) click peptide	Cortes-Canteli M	Fibrinogen and beta-amyloid association alters thrombosis and fibrinolysis: a possible contributing factor to Alzheimer's disease.	Neuron	2010	65
20573181	beta-amyloid peptide 1-42 (E22delta) click peptide	Pham E	Progressive accumulation of amyloid-beta oligomers in Alzheimer's disease and in amyloid precursor protein transgenic mice is accompanied by selective alterations in synaptic scaffold proteins.	The FEBS journal	2010	66
20603455	beta-amyloid peptide 1-42 (E22delta) click peptide	Thambisetty M	Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease.	Archives of general psychiatry	2010	94
20660248	beta-amyloid peptide 1-42 (E22delta) click peptide	Lebson L	Trafficking CD11b-positive blood cells deliver therapeutic genes to the brain of amyloid-depositing transgenic mice.	The Journal of neuroscience 	2010	44
20844121	beta-amyloid peptide 1-42 (E22delta) click peptide	Crews L	Increased BMP6 levels in the brains of Alzheimer's disease patients and APP transgenic mice are accompanied by impaired neurogenesis.	The Journal of neuroscience 	2010	44
20861373	beta-amyloid peptide 1-42 (E22delta) click peptide	Jana A	Fibrillar amyloid-beta-activated human astroglia kill primary human neurons via neutral sphingomyelinase: implications for Alzheimer's disease.	The Journal of neuroscience 	2010	48
21158978	beta-amyloid peptide 1-42 (E22delta) click peptide	Morgan D	Immunotherapy for Alzheimer's disease.	Journal of internal medicine	2011	56
21159977	beta-amyloid peptide 1-42 (E22delta) click peptide	Liu Q	Neuronal LRP1 knockout in adult mice leads to impaired brain lipid metabolism and progressive, age-dependent synapse loss and neurodegeneration.	The Journal of neuroscience 	2010	61
21159979	beta-amyloid peptide 1-42 (E22delta) click peptide	Liu Z	CX3CR1 in microglia regulates brain amyloid deposition through selective protofibrillar amyloid-β phagocytosis.	The Journal of neuroscience 	2010	94
21186265	beta-amyloid peptide 1-42 (E22delta) click peptide	Yang DS	Reversal of autophagy dysfunction in the TgCRND8 mouse model of Alzheimer's disease ameliorates amyloid pathologies and memory deficits.	Brain 	2011	117
21273420	beta-amyloid peptide 1-42 (E22delta) click peptide	Zhu Y	CD45 deficiency drives amyloid-β peptide oligomers and neuronal loss in Alzheimer's disease mice.	The Journal of neuroscience 	2011	39
21354232	beta-amyloid peptide 1-42 (E22delta) click peptide	Kamari Y	Lack of interleukin-1α or interleukin-1β inhibits transformation of steatosis to steatohepatitis and liver fibrosis in hypercholesterolemic mice.	Journal of hepatology	2011	50
21622869	beta-amyloid peptide 1-42 (E22delta) click peptide	Ather JL	Serum amyloid A activates the NLRP3 inflammasome and promotes Th17 allergic asthma in mice.	Journal of immunology	2011	63
21846727	beta-amyloid peptide 1-42 (E22delta) click peptide	Emmer KL	E46K human alpha-synuclein transgenic mice develop Lewy-like and tau pathology associated with age-dependent, detrimental motor impairment.	The Journal of biological chemistry	2011	38
22116809	beta-amyloid peptide 1-42 (E22delta) click peptide	Hartz AM	Amyloid-β contributes to blood-brain barrier leakage in transgenic human amyloid precursor protein mice and in humans with cerebral amyloid angiopathy.	Stroke	2012	38
23152608	beta-amyloid peptide 1-42 (E22delta) click peptide	Lauritzen I	The β-secretase-derived C-terminal fragment of βAPP, C99, but not Aβ, is a key contributor to early intraneuronal lesions in triple-transgenic mouse hippocampus.	The Journal of neuroscience 	2012	40
23164821	beta-amyloid peptide 1-42 (E22delta) click peptide	Killick R	Clusterin regulates β-amyloid toxicity via Dickkopf-1-driven induction of the wnt-PCP-JNK pathway.	Molecular psychiatry	2014	41
23413811	beta-amyloid peptide 1-42 (E22delta) click peptide	Hawkes CA	Regional differences in the morphological and functional effects of aging on cerebral basement membranes and perivascular drainage of amyloid-β from the mouse brain.	Aging cell	2013	26
26542570	beta-amyloid peptide 1-42 (E22delta) click peptide	Makley LN	Pharmacological chaperone for α-crystallin partially restores transparency in cataract models.	Science	2015	21
9267033	thymosin beta(1)	Davies SW	Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation.	Cell	1997	464
9528852	thymosin beta(1)	Jensen DE	BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression.	Oncogene	1998	143
16625205	thymosin beta(1)	Komatsu M	Loss of autophagy in the central nervous system causes neurodegeneration in mice.	Nature	2006	979
16923396	thymosin beta(1)	Gong B	Ubiquitin hydrolase Uch-L1 rescues beta-amyloid-induced decreases in synaptic function and contextual memory.	Cell	2006	123
17218260	thymosin beta(1)	Wang X	NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN.	Cell	2007	205
17786241	thymosin beta(1)	Fielitz J	Myosin accumulation and striated muscle myopathy result from the loss of muscle RING finger 1 and 3.	The Journal of clinical investigation	2007	82
17965779	thymosin beta(1)	Li HH	Atrogin-1 inhibits Akt-dependent cardiac hypertrophy in mice via ubiquitin-dependent coactivation of Forkhead proteins.	The Journal of clinical investigation	2007	91
18346206	thymosin beta(1)	Ramesh Babu J	Genetic inactivation of p62 leads to accumulation of hyperphosphorylated tau and neurodegeneration.	Journal of neurochemistry	2008	61
18552861	thymosin beta(1)	Melino G	Itch: a HECT-type E3 ligase regulating immunity, skin and cancer.	Cell death and differentiation	2008	57
18701681	thymosin beta(1)	Bedford L	Depletion of 26S proteasomes in mouse brain neurons causes neurodegeneration and Lewy-like inclusions resembling human pale bodies.	The Journal of neuroscience 	2008	86
20637659	thymosin beta(1)	Huang H	K33-linked polyubiquitination of T cell receptor-zeta regulates proteolysis-independent T cell signaling.	Immunity	2010	43
21051661	thymosin beta(1)	Su H	Perturbation of cullin deneddylation via conditional Csn8 ablation impairs the ubiquitin-proteasome system and causes cardiomyocyte necrosis and dilated cardiomyopathy in mice.	Circulation research	2011	37
21455181	thymosin beta(1)	Ikeda F	SHARPIN forms a linear ubiquitin ligase complex regulating NF-κB activity and apoptosis.	Nature	2011	194
11533658	cholecystokinin C-terminal flanking peptide	Ryo A	Pin1 regulates turnover and subcellular localization of beta-catenin by inhibiting its interaction with APC.	Nature cell biology	2001	132
12891359	cholecystokinin C-terminal flanking peptide	Liou YC	Role of the prolyl isomerase Pin1 in protecting against age-dependent neurodegeneration.	Nature	2003	108
12941275	cholecystokinin C-terminal flanking peptide	Xie Z	Serine 732 phosphorylation of FAK by Cdk5 is important for microtubule organization, nuclear movement, and neuronal migration.	Cell	2003	94
16554819	cholecystokinin C-terminal flanking peptide	Pastorino L	The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-beta production.	Nature	2006	135
16751189	cholecystokinin C-terminal flanking peptide	Qin W	Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction.	The Journal of biological chemistry	2006	163
16818723	cholecystokinin C-terminal flanking peptide	Ku NO	A disease- and phosphorylation-related nonmechanical function for keratin 8.	The Journal of cell biology	2006	62
17502423	cholecystokinin C-terminal flanking peptide	Wang X	Ubiquitination of serine, threonine, or lysine residues on the cytoplasmic tail can induce ERAD of MHC-I by viral E3 ligase mK3.	The Journal of cell biology	2007	114
17636028	cholecystokinin C-terminal flanking peptide	Tian Y	TAZ promotes PC2 degradation through a SCFbeta-Trcp E3 ligase complex.	Molecular and cellular biology	2007	58
17803913	cholecystokinin C-terminal flanking peptide	Greten FR	NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta.	Cell	2007	189
17906618	cholecystokinin C-terminal flanking peptide	Plun-Favreau H	The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1.	Nature cell biology	2007	151
18184780	cholecystokinin C-terminal flanking peptide	Terunuma M	Deficits in phosphorylation of GABA(A) receptors by intimately associated protein kinase C activity underlie compromised synaptic inhibition during status epilepticus.	The Journal of neuroscience 	2008	57
18255032	cholecystokinin C-terminal flanking peptide	Pennuto M	Ablation of the UPR-mediator CHOP restores motor function and reduces demyelination in Charcot-Marie-Tooth 1B mice.	Neuron	2008	84
18539900	cholecystokinin C-terminal flanking peptide	Kundu M	Ulk1 plays a critical role in the autophagic clearance of mitochondria and ribosomes during reticulocyte maturation.	Blood	2008	164
19799873	cholecystokinin C-terminal flanking peptide	Yuskaitis CJ	Lithium ameliorates altered glycogen synthase kinase-3 and behavior in a mouse model of fragile X syndrome.	Biochemical pharmacology	2010	71
19925672	cholecystokinin C-terminal flanking peptide	Kaidanovich-Beilin O	Abnormalities in brain structure and behavior in GSK-3alpha mutant mice.	Molecular brain	2009	60
19950280	cholecystokinin C-terminal flanking peptide	Joosten LA	Inflammatory arthritis in caspase 1 gene-deficient mice: contribution of proteinase 3 to caspase 1-independent production of bioactive interleukin-1beta.	Arthritis and rheumatism	2009	84
20140016	cholecystokinin C-terminal flanking peptide	Wang J	Pim1 kinase synergizes with c-MYC to induce advanced prostate carcinoma.	Oncogene	2010	46
20303298	cholecystokinin C-terminal flanking peptide	Nava P	Interferon-gamma regulates intestinal epithelial homeostasis through converging beta-catenin signaling pathways.	Immunity	2010	75
20580720	cholecystokinin C-terminal flanking peptide	Lee G	Phosphoinositide 3-kinase signaling mediates beta-catenin activation in intestinal epithelial stem and progenitor cells in colitis.	Gastroenterology	2010	57
21368761	cholecystokinin C-terminal flanking peptide	Zhang H	Functional complementation between FADD and RIP1 in embryos and lymphocytes.	Nature	2011	154
21502512	cholecystokinin C-terminal flanking peptide	Schwaeble WJ	Targeting of mannan-binding lectin-associated serine protease-2 confers protection from myocardial and gastrointestinal ischemia/reperfusion injury.	Proceedings of the National Academy of Sciences of the United States of America	2011	58
21637291	cholecystokinin C-terminal flanking peptide	Dagda RK	Mitochondrially localized PKA reverses mitochondrial pathology and dysfunction in a cellular model of Parkinson's disease.	Cell death and differentiation	2011	39
22490684	cholecystokinin C-terminal flanking peptide	Nai A	Deletion of TMPRSS6 attenuates the phenotype in a mouse model of β-thalassemia.	Blood	2012	41
23306062	cholecystokinin C-terminal flanking peptide	Laine A	Senescence sensitivity of breast cancer cells is defined by positive feedback loop between CIP2A and E2F1.	Cancer discovery	2013	32
18157088	12-keto-9(2)-octadecen-13-olide	Witt CC	Cooperative control of striated muscle mass and metabolism by MuRF1 and MuRF2.	The EMBO journal	2008	62
19587288	12-keto-9(2)-octadecen-13-olide	Dziewczapolski G	Deletion of the alpha 7 nicotinic acetylcholine receptor gene improves cognitive deficits and synaptic pathology in a mouse model of Alzheimer's disease.	The Journal of neuroscience 	2009	54
21856714	12-keto-9(2)-octadecen-13-olide	Testa-Silva G	Hyperconnectivity and slow synapses during early development of medial prefrontal cortex in a mouse model for mental retardation and autism.	Cerebral cortex	2012	36
10541552	Amy1 protein, mouse	Eischen CM	Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis.	Genes & development	1999	279
10541554	Amy1 protein, mouse	Jacobs JJ	Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF.	Genes & development	1999	175
16878133	Amy1 protein, mouse	Dews M	Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster.	Nature genetics	2006	347
17728759	Amy1 protein, mouse	Gorrini C	Tip60 is a haplo-insufficient tumour suppressor required for an oncogene-induced DNA damage response.	Nature	2007	105
22120667	Amy1 protein, mouse	Murga M	Exploiting oncogene-induced replicative stress for the selective killing of Myc-driven tumors.	Nature structural & molecular biology	2011	107
22195962	Amy1 protein, mouse	Hitosugi T	Tyrosine phosphorylation of mitochondrial pyruvate dehydrogenase kinase 1 is important for cancer metabolism.	Molecular cell	2011	72
